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Abstract 
The innate immune system is the first line of defence against invading pathogens and 
is responsible for both initial pathogen recognition and mounting an effective 
immunological response. The recognition of conserved pathogen-associated 
molecular patterns can be carried out by a number of families of innate immune 
receptors, including Toll-like receptors. Toll-like receptors can respond to a diverse 
range of microbial signals and elicit a targeted immune response against the invading 
pathogen. A key regulator of inflammation is IL-1β, which can be secreted from 
activated cells and mediate a strong inflammatory response. The regulation of its 
release is a tightly controlled signalling event, as its dysregulation has been linked 
with the pathogenesis of a variety of diseases including Alzheimer’s disease and 
rheumatoid arthritis. The signalling complex which controls IL-1β release is known 
as the inflammasome, which requires two signals to facilitate its activation. The 
work in this thesis demonstrates a role for the E3 ubiquitin ligase Pellino2 in the 
specific activation of the NLRP3 inflammasome. Using a newly generated Pellino2-
deficient mouse, it was determined that Pellino2 played no role during TLR induced 
NF-κB or MAPK signalling. However, Peli2-/- mice were more resistant to the lethal 
effects of LPS induced septic shock and this correlated with reduced serum IL-1β 
levels. Pellino2-deficient mice were shown to exhibit diminished NLRP3 
inflammasome activation, correlating with reduced levels of NLRP3 ubiquitination 
and thus, lower levels of IL-1β secretion. While Pellino2 does not directly mediate 
the ubiquitination of NLRP3, it was observed that Pellino2-deficiency promoted the 
increased interaction of NLRP3 with hyperphosphorylated IRAK1. The data 
presented in this thesis defines for the first time a physiological role for Pellino2 in 
innate immune signalling with a particular function in mediating activation of the 
NLRP3 inflammasome.    
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1.1 The Immune System 
The immune system is multifaceted, consisting of many molecules, cells and organs 
which together, orchestrate protection against infective pathogens. Early research in 
the field lead to the broad characterisation of two separate phases of the immune 
response: the innate and adaptive systems. This is not a true dichotomy however, as 
there is a great degree of interaction and crosstalk between both (Lanier and Sun, 
2009). The distinction between these two branching systems lies primarily in the 
degree of specificity to antigens, the speed of the response and the generation of a 
long lasting immunological memory (Kurtz, 2005). The innate immune system acts 
rapidly, targeting a wide range of pathogens through recognition of distinct 
conserved pathogenic components. This is mediated by antigen presenting cells 
(APC) such as macrophages and dendritic cells (DC), which can interact directly 
with invading pathogens and facilitate an appropriate response (Guilliams et al., 
2014). The adaptive response occurs later and is primarily mediated by the B and T 
lymphocytes. A T-cell response requires stimulation by activated APCs, which 
present pathogen-derived peptides to the T-cell and dictate their differentiation and 
polarisation (Kapsenberg, 2003). Activated T-cells assist B-cells in the production of 
antibodies which are targeted against specific epitopes present on the invading 
microorganism. Antibody production is a key event in the generation of an 
immunological memory and is the basis of effective vaccination (Nutt et al., 2015). 
The importance of T-cells in immunity is highlighted during human 
immunodeficiency virus (HIV) infection, where the CD4 subset of T-cells are 
severely diminished, resulting in the increased susceptibility to a secondary 
opportunistic infection (Pope and Haase, 2003). The ability of the immune system to 
be able to define self from non-self is vital in the generation of a long lasting 
immune response, as a breakdown in this system can lead to autoimmunity (Wu et 
al., 2009).   
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1.2 The Innate Immune System  
The innate immune system is a highly evolutionarily conserved system which is the 
first line of defence during a pathogen invasion and is responsible for the broad 
spectrum clearance of the vast majority of microbes. The protective layers of the 
innate immune system extends from physical barrier to entry such as the skin and 
mucosal barriers (Peterson and Artis, 2014), to the more complex interplay between 
varieties of specialised cells (Nguyen et al., 2002). The innate immune system was 
originally thought to be a simplistic response which only served to prime the more 
complex adaptive response. As a result, the bulk of early research into the immune 
system focused on this adaptive response (O’Neill et al., 2013). A key question 
which was unanswered at the time was how the secretion of pro-inflammatory 
factors such as interleukin-1β (IL-1β) were regulated (Dinarello, 1991). The concept 
of cells recognising microbial products as priming signal to link an early and late 
immune response was first pioneered by Charles Janeway in 1989 (Janeway, 1989). 
The discovery of toll-like receptors (TLRs) and their ability to recognise conserved 
pathogen associated molecular patterns (PAMPs) opened the door to a major new 
area of immune research, innate immune signalling (Lemaitre et al., 1996; 
Medzhitov et al., 1997). Stimulated TLRs were shown to lead to the activation of a 
variety of immune-related genes and thus result in the secretion of cytokines and 
chemokines which can contribute to cell trafficking, inflammation and anti-viral 
responses (Hoshino et al., 1999). This initial signalling by pattern recognition 
receptors (PRRs) underlies and directs the functions of a range of innate immune 
cells including macrophages and DCs, leading to an effective adaptive response. 
Continued research into PRRs has led to a more complete and nuanced 
understanding of the complexity of this initial signalling event.  
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1.4 Pattern Recognition Receptors 
Mounting appropriate and specialised responses to specific pathogens is vital in 
maintaining an adequate immune response. This is achieved by a range of PRRs 
which can recognise PAMPs from bacterial, viral, fungal and parasitic origin. The 
controlled induction of inflammation through the signalling of these molecules 
provides protection against infection and can lead to tissue regeneration following 
this acute response (Medzhitov, 2008). It is essential that the motifs which PRRs 
recognise are distinct from self-molecules, as any breakdown in the differentiation 
between self and non-self would lead to an auto-immune environment, potentially 
leading to detrimental outcomes such as septic shock (Rittirsch et al., 2008). While 
effective allorecognition is vital, an important distinction must be made with respect 
to certain danger associated molecular patterns (DAMPs), some of which originate 
from the host in times of cellular stress or tissue damage during pathogenic insult 
(Srikrishna and Freeze, 2009). These signals often arise during an immune response 
and as such can be recognised by certain PRRs (Mills, 2011). The cellular 
localisation of PRRs is also fundamentally important in facilitating their pathogenic 
recognition. Bacterial and fungal PAMPs are often encountered extracellularly and 
thus, the associated PRRs are localised to the plasma membrane. Contrastingly, viral 
PAMPs are generally recognised by PRRs located in the cytoplasm (Nishiya and 
DeFranco, 2004). PRRs are highly expressed in sentinel cells such as macrophages 
and DCs, but are also present on B-cells (Dorner et al., 2009). 
Currently, five families of PRRs have been described: TLRs, nucleotide-binding 
oligomerisation domain (NOD)-like receptors (NLRs), Pyrin and HIN domain-
containing protein (PYHIN) family, retinoic acid-inducible gene 1 (RIG-I)-like 
receptors (RLRs) and C-type lectin receptors (CLRs) (Kutikhin and Yuzhalin, 2012; 
Mogensen, 2009). Each family consists of numerous members, all recognising a 
diverse range of ligands. Upon activation, complex signalling cascades are initiated 
downstream of the PRR, which can culminate in the upregulation of inflammatory 
cytokines, chemokines and type 1 interferons (IFN) (Perry et al., 2005). This leads to 
the development of a cytokine milieu capable of inducing a pro-inflammatory state 
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and can influence the future immune responses to the invading pathogens. The 
signalling involved is rapid and can trigger immune responses based on the receptors 
activated as well as cross-talk between receptors (Tan et al., 2014). 
 
1.5 Toll-like Receptors and Their History 
TLRs were the first family of PRRs to be identified and are the most well studied to 
date. Early research into the area of innate immunity focused on the determination of 
a cellular receptor to the gram negative bacterial cell membrane lipopolysaccharide 
(LPS) due to its useful adjuvant properties (Seppälä and Mäkelä, 1984). The cell 
surface molecule CD14 was shown to be indispensable in eliciting a cellular 
response to LPS (Wright et al., 1990), but the LPS receptor itself proved elusive. 
Determining the receptor through the use of classical binding studies proved difficult 
due to the hydrophobic nature of LPS (Beutler, 2011). The first key discovery which 
led to the identification of the TLRs arose from research carried out in the fruit fly 
Drosopila melanogaster. The sequencing of the receptor IL-1R type 1 (IL-1R1), was 
shown to share homology with the D. melanogaster protein Toll, previously thought 
to only function as a maternal effect gene in embryonic development (Anderson et 
al., 1985).  
In 1996, Hoffman and Lemaitre published their seminal paper demonstrating the role 
of Toll signalling in the production of the antifungal molecule peptide drosomycin in 
adult Drosophila during fungal infection (Lemaitre et al., 1996). This work 
highlighted for the first time that Toll and IL-1R not only shared common structural 
similarities, but functional ones.  This work was expanded upon by Medzhitov and 
Janeway in 1997, when they cloned and characterised the first human Toll-like 
protein, now known as TLR4. It was shown that transfection of a constitutively 
activated form of TLR4 into human cells could activate NF-κB and lead to the 
induction of pro-inflammatory cytokines as well as B7.1 (CD80), an important co-
stimulatory molecule for the maturation and activation of naïve T cells (Medzhitov et 
al., 1997). This was the first link between the innate and adaptive response, verifying 
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Janeway’s early hypothesis of the importance of innate signalling in shaping the 
adaptive response (Medzhitov et al., 1997). This discovery sparked a great interest in 
the field of PRRs and quickly resulted in the identification of a family of TLRs 
(Rock et al., 1998).  
TLRs are transmembrane receptors which localise either on the cell surface or within 
intracellular compartments. TLRs consist of an extra-cellular domain composed of 
tandem leucine-rich repeats (LRRs), a membrane spanning component and a 
cytosolic Toll/IL-1R (TIR) domain. The extracellular domain is responsible for 
ligand recognition and its crystal structure shows that LRRs form a loop structure 
(Bell et al., 2005; Choe et al., 2005). Upon ligand binding, TLRs dimerise to form 
either homodimers or heterodimers which facilitates the cytosolic TIR domains to 
act as a scaffold allowing the formation of a signalling complex (Xu et al., 2000). To 
date, 13 mammalian TLRs have been identified. TLRs1-9 have a shared function 
between mice and humans, but while TLR10 is present in humans, it is a non-
functional pseudogene in mice. TLR11-13 are functional in mice, but human TLR11 
is also a non-functional pseudogene, while TLR12 and TL13 does not exist in the 
human genome (Akira et al., 2006; Kawai and Akira, 2009). 
 
1.5.1 TLR2 Forms Heterodimers to Detect an Extensive 
Range of Ligands  
Early work implicated LPS as a ligand of TLR2 (Yang et al., 1998), but this was 
clarified using TLR2 knockout mice, which were equally sensitive to LPS as wild 
type (WT) mice (Takeuchi et al., 1999). Instead, the latter study demonstrated a role 
for TLR2 in detecting gram-positive bacteria and further research has shown that 
TLR2 can identify a wide range of agents and ligands. These include measles virus 
(Bieback et al., 2002), bacterial tri-acylated lipoproteins (Aliprantis et al., 1999; Lien 
et al., 1999), lipoteichoic acid and peptidoglycan as well as the fungal cell wall 
component zymosan (Underhill et al., 1999). TLR2 is capable of recognising such a 
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diverse range of ligands due in part to its ability to form heterodimers with other 
TLRs. It has been suggested that homodimers of TLR2 may also form, but to date, 
this has not been demonstrated (M. S. Jin et al., 2007). TLR2 is capable of forming 
heterodimers with TLR1, TLR6 and TLR10 (Oliveira-Nascimento et al., 2012). 
Interestingly, while the various TLR2-containing heterodimers facilitates the 
recognition of an array of ligands, the functional downstream signalling responses 
are the same, implicating the evolutionary expansion of recognition, while 
maintaining the downstream signalling response (Farhat et al., 2008). 
TLR1/2 recognises triacylated lipoproteins as well as mycobacterial products while 
TLR2/6 recognises diacylated lipoproteins. Synthetic lipopeptides can be used to 
specifically target either TLR1/2 or TLR2/6 heterodimers. Pam3CSK4 is a synthetic 
triacylated lipopeptide which can bind TLR1/2 (M. S. Jin et al., 2007) while 
Pam2CSK4 is a synthetic diacylated lipoprotein and binds TLR2/6 (Kang et al., 
2009). CD36 is a member of the scavenger receptor type B family and is known to 
act as a co-receptor for diacylglyceride signalling in combination with TLR2/6. The 
requirement of CD36 to act as a co-receptor during triacylglyceride recognition is 
redundant however, demonstrating the selectivity with which this signalling can 
occur (Hoebe et al., 2005). To date, both the specific ligand and the signalling 
consequences for the TLR2/10 heterodimer are unknown (Guan et al., 2010). 
Zymosan is a yeast-derived polysaccharide consisting of β-glucan and mannan 
(Brown et al., 2002) and is recognised by both TLR2/6 and dendritic-cell-associated 
C-type lectin-1 (Dectin-1). Dectin-1 is a membrane bound receptor capable of direct 
binding to β-glucans and the induction of a spleen tyrosine kinase (SYK) dependent 
signalling pathway (Underhill et al., 2005). The response to zymosan occurs 
synergistically between both dectin-1 and TLR2/6, resulting in an augmented 
inflammatory response and improved microbial phagocytosis (Gantner et al., 2003). 
Dectin-1 has also been shown to co-localise with TLR2 upon zymosan stimulation, 
highlighting the possibility of the formation of a signalling complex similar to other 
TLR2 heterodimers (Brown et al., 2003).  
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1.5.2 TLR 3 Recognises Double-Stranded RNA 
TLR3 is an endosomal PRR and was first shown to recognise double-stranded RNA 
(dsRNA), which is an intermediate pattern that occurs during the replication cycle of 
many viruses (Weber et al., 2006). TLR3 signalling was also demonstrated to lead to 
the activation of NF-κB and the production of type I IFNs (Alexopoulou et al., 
2001). This discovery implicated TLR3 as a key regulator in the recognition and 
response to a variety of viruses. Since this initial characterisation, TLR3 has also 
been shown to recognise non-viral signals such as self mRNA released from necrotic 
cells as a DAMP (Karikó et al., 2004). Interestingly, this effect is not seen during 
apoptotic events, implicating a role for TLR3 in the response to tissue stress or injury 
(Cavassani et al., 2008). A synthetic analogue of dsRNA often used to activate 
TLR3 in vitro is known as polyriboinosinic:polyribocytidylic acid (poly(I:C)). The 
effectiveness of the activation is dependent on the molecular mass of the poly(I:C) 
used, with longer forms inducing a more robust TLR3 dependent response (Zhou et 
al., 2013). While TLR3 is a highly expressed receptor in most innate immune cells, 
it is not expressed in either neutrophils (Hayashi et al., 2003) or plasmacytoid 
dendritic cells (pDC) (Edwards et al., 2003). 
The importance of the contribution of TLR3 to in vivo viral clearance remains 
controversial. Encephalomyocarditis virus (EMCV) and mouse cytomegalovirus 
(MCMV) infection of the TLR3
-/-
 mouse model have shown that the absence of 
TLR3 leads to reduced survival, correlating with increased viral load and reduced 
antiviral cytokine secretion (Hardarson et al., 2007; Tabeta et al., 2004). However, 
another study comparing the role of TLR3 in various murine viral infections showed 
that TLR3
-/-
 mice show no difference in susceptibility to reovirus, lymphocytic 
choriomeningitis virus (LCMV) and vesicular stomatitis virus (VSV), implicating a 
redundancy in TLR3 signalling (Edelmann et al., 2004). The TLR3
-/-
  mouse model 
has also been shown to be largely resistant to West Nile virus (WNV), as a TLR3 
mediated inflammatory response is required for a compromised blood-brain barrier 
leading to encephalitis and death (Wang et al., 2004). Pneumonia induced by 
influenza A virus showed that while TLR3
-/-
 mice exhibited reduced viral clearance 
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in the lungs, they showed increased rates of survival in this acute model due to a 
reduction in secreted inflammatory mediators (Le Goffic et al., 2006).  
Similar to data from mice, the functional role of TLR3 in humans remains 
ambiguous. A polymorphism of TLR3 at Leu412Phe has been shown to confer 
protection against HIV-1 (Sironi et al., 2012) and tick-borne encephalitis virus 
(TBEV) (Kindberg et al., 2011). Conversely, this polymorphism is also associated 
with increased susceptibility to enteroviral myocarditis due to reduced activation of 
NF-κB and type I IFN (Gorbea et al., 2010). Human TLR3 has been shown to be 
critical in the immunity to herpes simplex virus 1 (HSV-1) in children, as 
demonstrated by independent TLR3 genetic mutations in patients exhibiting HSV-1 
encephalitis (Zhang et al., 2007). 
 
1.5.3 TLR4: The LPS Receptor 
TLR4 is one of the most well studied TLRs and is primarily responsible for the 
recognition of LPS (Chow et al., 1999; Hoshino et al., 1999; Poltorak et al., 1998). 
As mentioned previously, early work focusing on LPS recognition showed that 
TLR2 potentially played a role in LPS signalling. However this was shown not to be 
the case as it was demonstrated that mutation of the TLR4 gene impaired LPS 
recognition while TLR2 mutation did not (Heine et al., 1999; Poltorak et al., 1998; 
Underhill et al., 1999). 
LPS is a major component of the gram-negative bacterial cell wall and low 
concentrations are capable of inducing a robust and rapid inflammatory response, 
making LPS a key signal in the early response to infection (Kamio and Nikaido, 
1976; Raetz and Whitfield, 2002). LPS is composed of three domains: the lipid A 
hydrophobic anchor, a nonrepeating oligosaccharide and the distal polysaccharide, 
known as the O antigen (Raetz and Whitfield, 2002). The lipid A component of LPS 
can be subjected to extensive modification by the bacteria both during and after 
synthesis. These modifications which include acylation (Guo et al., 1998) and the 
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modification of phosphate groups (Gunn et al., 1998) can lead to a diverse range of 
lipid A structures which can vary greatly between bacteria. These modifications can 
result in immune evasion and environmental adaption (Guo et al., 1998). While 
TLR4 can directly recognise the lipid A moiety of LPS, modifications to bacterial 
lipid A can impair or entirely disrupt this binding (Hajjar et al., 2002). 
Myeloid differentiation factor 2 (MD-2) contains no transmembrane or intracellular 
domains and forms a complex with the extracellular component of TLR4 (Kim et al., 
2007). LPS binding protein (LBP) is a soluble protein circulating at low 
concentrations in serum. Upon infection, LBP recognises and binds LPS (Lamping et 
al., 1998) and traffics LPS to the membrane-bound receptor CD14 (Pugin et al., 
1993). This further transports the LPS to the TLR4-MD-2 complex resulting in 
signal transduction.  
While TLR4 plays a key role in the response to gram-negative bacteria, it has also 
been shown to respond to several other PAMPs such as the F protein of respiratory 
syncytial virus (RSV) (Kurt-Jones et al., 2000) and teichuronic acid, a cell wall 
component of the gram-positive bacteria Micrococcus luteus (Yang et al., 2001). 
Various host derived endogenous signals can also illicit a TLR4 response, such as 
heat shock protein 60 (HSP60) (Ohashi et al., 2000), Fibrinogen type III extra 
domain A (Okamura et al., 2001), saturated fatty acids (Tsukumo et al., 2007) and 
minimally oxidized low-density lipoproteins (Choi et al., 2009) which are usually 
secreted during tissue damage. These ligands are all structurally dissimilar, 
highlighting the potential for ligands to bind different regions of the receptor or, as 
the case with TLR4-MD-2, use different accessory molecules to facilitate binding 
(Kim et al., 2007). 
 
1.5.4 TLR5 Modulates the Gut Microflora 
TLR5 is localised at the cell surface and recognises flagellin from gram-negative and 
gram-positive bacteria (Hayashi et al., 2001). The flagellum consists of filaments of 
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the protein flagellin; it extrudes from the surface of bacteria and functions as a 
source of motility and adhesion (Ramos et al., 2004). Rotation of these filaments at 
hundreds of revolutions per second generates taxis (Yonekura et al., 2003). The 
number of individual flagella on a single Candidatus Ovobacter for example can 
exceed 400 and form prominent flagellar tufts (Fenchel and Thar, 2004).    
The focus of most TLR5 research has centred on its function in the intestine. A 
healthy gut microbiome contains low levels of flagella (Bambou et al., 2004), 
however a recent study shows that TLR5
-/-
 mice exhibit increased numbers of 
commensals expressing higher levels of flagella (Cullender et al., 2013). This is 
associated with an increased rate of intestinal breaching of bacteria leading to 
dysbiosis. Interestingly, the loss of TLR5 in these mice also correlates to reduced 
levels of anti-flagellin IgA. The authors concluded that the anti-flagellin antibodies 
maintain gut homeostasis by first binding and immobilising flagellated bacteria and 
then as a signalling molecule which can alter the composition of the gut microbiome. 
This hints at a complex crosstalk between the microbiota and the host immune 
system. 
Single nucleotide polymorphisms (SNPs) in TLR5 may serve as useful biomarkers 
for a wide range of diseases. For example, the single dominant nucleotide 
polymorphism in TLR5 (TLR5
R392X
) (Hawn et al., 2003) is one of the most frequent 
polymorphisms to occur in the TLR family and is associated with Legionnaires 
disease, urinary tract infections (Hawn et al., 2009, 2003), colorectal cancer 
(Klimosch et al., 2013) and bronchopulmonary dysplasia (Sampath et al., 2012). The 
possible role of TLR5 in cancers is particularly intriguing, as the composition of the 
gut microbiota has been shown to shape the response to both chemotherapy and 
immunotherapy (Viaud et al., 2013). 
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1.5.5 Endosomal TLR 7/8/9 
Like TLR3, TLR7, 8 and 9 are located on the endosomes of cells. However, they 
differ from TLR3 in their ligand recognition as well as their downstream signalling 
pathways. TLR7 and 8 form a heterodimer that recognises the synthetic 
imidazoquinoline family of antiviral derivatives, loxoribine and GU-rich ssRNAs 
(Diebold et al., 2004; Heil et al., 2004, 2003; Hemmi et al., 2002) while TLR9 is a 
homodimer (Latz et al., 2007) and recognises unmethylated CpG-rich dsDNA 
(Hemmi et al., 2000). 
While myeloid DCs express TLR8 (Ganguly et al., 2009), pDCs have a limited TLR 
expression profile but predominantly express TLR7 and TLR9. This small 
population of cells compromise only between 0.2 and 0.8% of all mononuclear cells 
in the blood. However, they are capable of producing high levels of Type I IFNs in 
response to a viral infection, making them specialised viral sensing cells (Birmachu 
et al., 2007). Systemic lupus erythematosus (SLE) is an autoimmune disease 
characterised by the production of auto-antibodies (Tan et al., 1982).  It was found 
that TLR9 and TLR8-deficient mice exhibited accelerated and severe SLE disease, 
while TLR7 deficient mice were protected against SLE. It was also determined that 
in the absence of TLR9 and TLR8, TLR7 levels could be upregulated, leading to the 
promotion of auto-antibodies (Christensen et al., 2006; Demaria et al., 2010; 
Nickerson et al., 2010). 
 
1.5.6 Human Orphan TLR 10 
TLR10 has proven difficult to study because of the lack of an available mouse model 
due to TLR10 being present as a pseudogene in mice. As such, there is comparatively 
little known about its signalling pathway and the determination of its agonist has 
remained elusive. Early work using human cells determined that TLR10 is highly 
expressed in B-cells and pDCs (Chuang and Ulevitch, 2001) and can interact with 
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TLR2 in vitro. However, B-cells have been shown to be unresponsive to TLR2 
agonists which implicates no phenotypical interaction in vivo (Berkeredjian-Ding et 
al., 2005; Hasan et al., 2005). Further work clarified that TLR2 is upregulated in a 
certain subsets of differentiating CD19
inter
 B-cells, highlighting a possible role for 
TLR2/TLR10 in the maturation of B-cells or germinal cell formation (Ganley-Leal et 
al., 2006). Interestingly, TLR10 is expressed in T regulatory cells and regulated by 
transcription factor forkhead box P3 (FOXP3), but its physiological relevance is still 
unclear (Bell et al., 2007). 
Recent evidence has implicated TLR10 in the response to influenza virus, where it 
can modulate the secretion of type I and III IFNs and also pro-inflammatory 
cytokines (Lee et al., 2014). The upregulation of TLR10 protein expression is higher 
following a H5N1 infection when compared with a less pathogenic H1N1 infection, 
highlighting the possibility that TLR10 may moderate the cellular response to certain 
infections. 
 
1.5.7 Murine TLR 11/12/13  
The first defined ligand for TLR11 was the intracellular protozoa Toxoplasma gondii 
profilin-like molecule (Yarovinsky et al., 2005). Profilin is secreted from the parasite 
and is responsible for actin polymerisation and functions in parasites as a means of 
motility (Dobrowolski and Sibley, 1996; Plattner et al., 2008). TLR11 is an 
intracellular receptor and requires the endoplasmic reticulum (ER) protein 
UNC93B1 for its functioning. However, intracellular infection of DCs with T. gondii 
did not illicit a necessary response for clearance (Pifer et al., 2011). The TLR11 
interaction with profilin occurs within endolysosomes, suggesting that recognition 
must occur prior to intracellular infection (Pifer and Yarovinsky, 2011). TLR12, 
another murine specific TLR, has been shown to complex with TLR11 and facilitates 
the recognition of profilin (Raetz et al., 2013). It is interesting to note that both 
TLR11 and TLR5 are responsible for detection of molecules involved in the 
movement of pathogens. The ability to recognise motility molecules from both 
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protozoa and bacteria demonstrates the specific recognition of vital components of 
pathogens. 
TLR13 recognises a 23S ribosomal RNA (rRNA) from bacteria such as 
Saccharopolyspora erythraea (Oldenburg et al., 2012). The sequence of 23s rRNA 
that TLR13 recognises is also the binding region of macrolide, lincosamide, and 
streptogramin group (MLS) antibiotics. It was shown that modifications to 23s 
rRNA which induced MLS resistance, also rendered the bacteria undetectable to 
TLR13. The authors hypothesise that an ancient form of natural antibiotic resistance 
(D’Costa et al., 2011) occurred in bacteria which rendered TLR13 redundant in 
many mammals, which is why it is not found in humans (Oldenburg et al., 2012).  
 
1.6 MyD88 Dependent TLR Pathway 
Upon TLR engagement, complex downstream signalling pathways are initiated (Fig. 
1.1). Myeloid differentiation primary response gene 88 (MyD88) is an adapter 
protein, which can directly bind all TLRs except TLR3 (Adachi et al., 1998). Upon 
ligand binding, MyD88 associates with the cytoplasmic tail of the TLR and serves as 
a signalling platform to rapidly initiate a signalling cascade. The end-point of this 
pathway is the activation of NF-κB, the transcription factor vital for the production 
of inflammatory cytokines and anti-microbial mediators (Warner and Núñez, 2013). 
This MyD88 dependent pathway is a highly conserved and critically important 
signalling pathway responsible for the initiation of both innate and adaptive 
responses.  
MyD88 is composed of three main domains: a death domain (DD), an intermediate 
domain and a TIR domain (Hardiman et al., 1996). MyD88 association with TLRs 
occurs via a TIR-TIR domain interaction following TLR dimerisation and leads to 
the initiation of a larger signalling cascade (Ohnishi et al., 2009). The adapter 
molecule MyD88-adapter-like (MAL) can also associate with MyD88 at the TIR 
domain during TLR4 (Fitzgerald et al., 2001),  TLR2/5 and TLR1/2 (Yamamoto et 
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al., 2002) activation. The protein complex which forms upon TLR receptor 
association is known as the myddosome and consists of the serine/threonine kinases 
interleukin-1 receptor-associated kinase 1 (IRAK1), IRAK2 and IRAK4. The 
complex first requires the oligomerisation of MyD88 molecules, which further 
recruits IRAK4 via DD interactions, leading to its oligomerisation (Lin et al., 2010; 
Li et al., 2002). IRAK1 and IRAK2 are then recruited to the complex, where IRAK4 
can phosphorylate both, leading to the promotion of their auto-phosphorylation. 
Interestingly, both IRAK1 and IRAK4 have been shown to directly phosphorylate 
MAL and lead to its degradation, resulting in a negative regulation of TLR signalling 
(Dunne et al., 2010). Activated IRAK1 or IRAK2 can then leave the complex and 
further associate with TNFR-associated factor 6 (TRAF6). The involvement of 
IRAK1 during this signalling event is primarily thought to result in the initiation of a 
rapid signalling response, while IRAK2 results in a more sustained signal and is not 
subject to acute degradation (Martin and Kollewe, 2001; Meylan and Tschopp, 
2008). Upon activation, IRAK1 is subject to auto-phosphorylation and ubiquitination 
leading to its proteosomal degradation (Conze et al., 2008; Yamin and Miller, 1997).  
TRAF6 is an E3 ligase and in conjunction with the ubiquitin conjugating complex 
Ubc13-Uev1A, also known as TRAF6-regulated IKK activator 1 (TRIKA1), can 
auto-ubiquitinate and form free K63 linked ubiquitin chains, which are associated 
with signal propagation (Deng et al., 2000). TRAF6 can also ubiquitinate IRAK1 
(Conze et al., 2008) and TRIKA2 (Wang et al., 2001) in a K63 manner. TRIKA2 is a 
protein complex composed of TGFβ-activated kinase (TAK1), TAK1 binding 
protein 1 (TAB1), TAB2 and TAB3. TRAF6 associates with this complex through 
interaction and ubiquitination of TAK1, mediated by the binding of TAB2 and 
TAB3 to ubiquitinated TRAF6 (Kanayama et al., 2004). This activated protein 
kinase complex acts as a signalling junction, dictating the regulation of both the NF-
κB and AP-1 responses. 
The transcription factor NF-κB is normally sequestered by IκBα in the cytosol of 
resting cells (Napetschnig and Wu, 2013). However pathways like IL-1 and TLRs 
can trigger the above MyD88-dependent pathway to promote phosphorylation and 
ubiquitination of IκBα leading to its degradation and the further dissociation of the 
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IκBα–NF-κB complex. NF-κB is then free to translocate to the nucleus and regulate 
gene activity (Z. J. Chen et al., 1996). The NF-κB family is composed of five 
members, RelA, RelB, c-Rel, p50 and p52 and plays a central role in the immune 
response and during cellular development (Vallabhapurapu and Karin, 2009). IκBα 
phosphorylation is mediated by the IκB kinase (IKK) complex of proteins, which 
consist of IKKα (Z. J. Chen et al., 1996), IKKβ (DiDonato et al., 1997) and IKKγ 
(also known as NEMO) (Yamaoka et al., 1998). TRAF6 is also capable of 
ubiquitinating NEMO, which facilitates the interaction of the IKK complex with 
TAK1 resulting in its activation (Sun et al., 2004). Activated TAK1 can 
phosphorylate IKK (Wang et al., 2001), which leads to IκBα degradation and 
subsequent NF-κB activation. TAK1 can also regulate activation of the mitogen-
activated protein (MAP) kinase kinase kinase (MAP3K) pathway (Wang et al., 
2001). TAK1 phosphorylates MKK6, which leads to the activation of the c-Jun N-
terminal kinase (JNK), P38 and extracellular signal-regulated kinase (ERK) 
activation, leading to the activation of the transcription factor AP-1. 
MyD88 has also been shown to play a role in antiviral interferon regulatory factor 
(IRF) signalling. MyD88 is capable of associating with IRF7 through death domain 
interaction in a complex also involving TRAF6 (Kawai et al., 2004). This MyD88-
IRF7 association occurs strongly in differentiated pDCs upon TLR9 and TLR7/8 
stimulation (Hemmi et al., 2003; Hochrein et al., 2004).  IRF7 activation leads to a 
type-I interferon production and is required for a robust anti-viral immune response 
(Honda et al., 2005). The activation of another member of the IRF family, IRF5 by 
TLRs has also been shown to be dependent on MyD88 signalling and mediated by 
TRAF6 (Balkhi et al., 2008; Schoenemeyer et al., 2005). 
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Fig 1.1 TLR1-9 Signalling Pathways 
See sections 1.6 and 1.7 for detailed descriptions of the signalling pathways shown 
here. Red arrows indicate TRIF dependent signalling, while black arrows represent 
MyD88 signalling. Yellow circles containing “UB” represent ubiquitination, whole 
circles containing “P” represent phosphorylation. 
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1.7 TRIF Dependent TLR Pathway  
TLR3 signals via the adapter molecule TIR-domain-containing adapter-inducing 
interferon-β (TRIF) which leads to the activation of both IRF3 and NF-κB (Hoebe et 
al., 2003; Yamamoto et al., 2003). TLR4 is also capable of signaling through TRIF 
but requires prior association with a bridging adapter molecule TRIF-related adaptor 
molecule (TRAM) (Rowe et al., 2006; Yamamoto et al., 2003b).  Upon LPS/TLR 
binding, the MyD88 pathway is initiated. TLR4 can then be endocytosed and can 
activate TRAM-TRIF dependent signaling in early endosomes. Therefore, cellular 
localization can play a key role in the recruitment of downstream adapter molecules 
to the TLR TIR domains (Kagan et al., 2008). 
Receptor-interacting protein-1 (RIP1) along with TRAF6, can associate with TRIF 
and cooperate synergistically in the downstream activation of NF-κB (Meylan et al., 
2004; Sato et al., 2003). Polyubiquitination of RIP1 is necessary for the recruitment 
of TAK1 and IKK complexes, leading to their activation (Ea et al., 2006). The 
requirement of RIP1 and not the IRAK family of proteins differentiates TLR3 
dependent NF-κB activation from the other TLRs (Meylan et al., 2004). TANK-
binding kinase 1 (TBK1) and IKKε also associates with TRIF and lead to the 
phosphorylation of IRF3 and the induction of an antiviral response (Fitzgerald et al., 
2003; Sharma et al., 2003). 
 
1.8 Inflammasome-mediated Processing of IL-1β and IL-18 
The secretion of the inflammatory cytokine IL-1β is tightly regulated due to its 
ability to induce systemic inflammation. IL-1β is produced in an inactive form (pro 
IL-1β) and sequestered in the cytoplasm before cleavage and activation by caspase-
1. The steps leading to this activation were unknown until the concept of an 
inflammasome was first proposed by Jürg Tschopp and colleagues in 2002 
(Martinon et al., 2002). This landmark work demonstrated the capacity of the protein 
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NOD, LRR and PYD domains-containing protein 1 (NLRP1) to regulate the 
secretion of IL-1β. NLRP1 was shown to form a protein complex with the adapter 
protein apoptosis-associated speck-like protein containing a CARD (ASC) which 
could lead to the activation of caspase-1 and thus result in the processing of IL-1β. 
This fundamental discovery heralded the beginning of a new branch of immune 
research that has furthered our understanding of the response to infection as well as 
autoimmunity.  
The production and secretion of IL-1β and IL-18 are more tightly regulated than 
most other inflammatory cytokines. Their activation is dependent upon both protein 
translation and a secondary activating signal (Martinon et al., 2009; Schroder and 
Tschopp, 2010). The secretion of these cytokines after activation is known as 
unconventional protein secretion and is independent of the (ER)/Golgi-dependent 
pathway but dependent on caspase-1 (Keller et al., 2008). The precise mechanisms 
by which protein trafficking out of the cell occurs after processing by the 
inflammasome is still a subject of debate (Lopez-Castejon and Brough, 2011). 
Understanding these regulatory events is vitally important, due to the destructive 
effect these cytokines can have on the host, as the dysregulation of these cytokines 
has been implicated in a variety of auto-inflammatory diseases (Mills et al., 2013; 
Sedimbi et al., 2013). Monocytes and macrophages are major producers of IL-1β and 
IL-18 (Kahlenberg and Dubyak, 2004), but other cell types have also been shown to 
display inflammasome activity under specific conditions, such as keratinocytes 
(Feldmeyer et al., 2007).  
The inflammasome is a multi-protein complex, capable of responding to a wide 
variety of danger signals (Figure 1.2) and inducing a pro-inflammatory state which 
can further trigger a necrotic form of cell death called pyroptosis (Y. Chen et al., 
1996; Fink and Cookson, 2006). A number of members of the NLR protein family 
make up the majority of the known sensors capable of inducing the assembly of an 
inflammasome upon recognition of a triggering molecule (Martinon et al., 2002). 
ASC, which is an essential component for all canonical inflammasomes, then 
associates with the activated sensor and oligomerises to form a large complex that 
manifests as a large single protein speck in microscopic analysis (Sahillioglu et al., 
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2014; Yamamoto et al., 2004). Interestingly, this polymerisation is a characteristic of 
prion formation and mutation of the regions associated with this prion activity 
negates its signalling potential (Cai et al., 2014). Pro-caspase 1 is then recruited to 
this multi-protein scaffold and cleaved to its active form, which can subsequently 
cleave and activate pro-IL-1β and pro-IL-18 (van de Veerdonk et al., 2011). 
A key feature of inflammasome signalling is the requirement of two distinct signals 
before assembly and subsequent cleavage events can occur; this highlights the 
degree of regulation involved in IL-1β and IL-18 release and emphasises their 
importance as key mediators of inflammation (van de Veerdonk et al., 2011). Signal 
1 or the priming signal is required for the initial transcription of inflammasome 
components such as pro-IL-1β and NLRP3. This signal involves activation of NF-κB 
due to the stimulation of PRRs such as TLRs (Schroder and Tschopp, 2010). Signal 
2 can range from DAMPs such as alum (Franchi and Núñez, 2008) and extracellular 
ATP (Mariathasan et al., 2006) to PAMPs such as nigericin (Mariathasan et al., 
2006) and flagellin (Zhao et al., 2011). This signal leads to the maturation of IL-1β 
and IL-18. While signal 1 is required for optimal IL-18 secretion, unlike IL-1β, pro-
IL-18 does not require upregulation during signal 1 as it is constitutively expressed 
(Kahlenberg et al., 2011). 
There is a high degree of diversity in the range of PAMPs and DAMPs which can 
lead to inflammasome activation; this is due to the number of different sensors which 
can initiate inflammasome assembly. Despite this variation in recognition, the key 
protein-protein interactions within the different activated inflammasomes are 
analogous (Latz et al., 2013). The adapter ASC is composed of a pyrin domain and a 
caspase activation and recruitment domain (CARD) (Masumoto et al., 1999). 
Homotypic interaction with the upstream sensor molecule occurs mainly through 
pyrin interaction (Vajjhala et al., 2014). The proteins NOD, LRR and CARD-
containing 4 (NLRC4) and RIG-I are the exceptions, as their interaction with ASC is 
facilitated by CARD interaction (Poeck et al., 2010; Pothlichet et al., 2013; Proell et 
al., 2013). Interaction between caspase-1 and ASC occurs through CARD 
interaction, resulting in the self-cleavage of caspase-1. 
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A number of inflammasomes have been characterised to date and include NLRP1, 
NLRP3, NLRP6, and NLRC4. Other inflammasomes have also been described that 
are not part of the NLR family (Latz et al., 2013). These include two PYHIN family 
members, absent in melanoma 2 (AIM2) and interferon gamma-inducible protein 16 
(IFI16) and RIG-I (Latz et al., 2013; Martinon et al., 2009). 
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Figure 1.2 Activation and signalling of the inflammasome 
See section 1.8 for a detailed description of the factors with lead to inflammasome 
assembly as well as the mechanism by which signal transduction occurs. 
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1.8.1 NLRP1: The First Known Inflammasome 
NLRP1 was the first protein to be associated with inflammasome activation 
(Martinon et al., 2002). It is a member of the NLR family of proteins and shares 
structural similarities with the other members. There are 14 members of this family, 
with each member containing a LRR and nucleotide-binding domain (NBD). NLRP1 
is unique among inflammasome forming members of the NLR family as it contains 
both PYD and a C-terminal CARD domain (Chu et al., 2001).  
The only known activators of NLRP1 to date is muramyl dipeptide (MDP) a 
bacterial cell wall component (Martinon et al., 2004). However, determining the 
function of human NLRP1 using standard murine models is complicated by the 
genetic differences between mouse and human NLRP1 (Boyden and Dietrich, 2006). 
The mouse genome contains NLRP1a, NLRP1b and NLRP1c which are all orthologs 
to human NLRP1. Studies into murine NLRP1b have described Bacillus anthracis 
toxin as an activator. NLRP1b lack a PYD domain, which further complicates the 
comparison between human and murine NLRP1 signalling (Boyden and Dietrich, 
2006). 
NLRP1 exists in an auto-repressed state in the cell and the precise mechanisms of its 
activation remain controversial. It has been hypothesised that the LRR domain is the 
site of ligand binding, as is the case in TLRs (Tschopp et al., 2003). However, a 
recent study shows that while MDP can bind NLRP1 directly in vitro, the crystal 
structure of the LRR domain of NLRP1 lacks a MDP binding site (Reubold et al., 
2014). Instead of acting as a direct binding site, the LRR domain may instead 
sterically hinder activation of NLRP1 prior to ligand binding, as selective deletion of 
the LRR domain has been shown to result in spontaneous NLRP1 oligomerisation 
(Faustin et al., 2007). Another possibility is that cytosolic receptor nucleotide-
binding oligomerisation domain-containing protein 2 (NOD2) is the key MDP 
receptor and upon recognition leads to the association with NLRP1, facilitating its 
activation (Ferwerda et al., 2008). Furthermore, NLRP1 has been shown to result in 
caspase 1 cleavage, independent of ASC association. However, interaction with ASC 
leads to a more robust response (Faustin et al., 2007; Van Opdenbosch et al., 2014). 
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Caspase-1 activation can also lead to pyroptosis, which has been shown to be 
supressed by Bcl-2 and Bcl-XL. These anti-apoptotic proteins can directly bind 
NLRP1 and function to downregulate its activity (Bruey et al., 2007). Conversely, 
NLRP1 can also interact with the apoptosome regulator apoptotic protease activating 
factor 1 (Apaf1) and facilitate enhanced induction of apoptosis (Chu et al., 2001). 
Despite having few known activators, NLRP1 has been implicated in many auto-
inflammatory conditions. SNPs in NLRP1 have been shown to be a risk factor in 
autoimmune Addison’s disease (Żurawek et al., 2010) and rheumatoid arthritis (Sui 
et al., 2012) and can increase the susceptibility of patients with vitiligo to associated 
autoimmune diseases (Y. Jin et al., 2007).  
 
1.8.2 NLRP3 Responds to Cellular Stress  
NLRP3 is the most characterised and studied of the inflammasomes to date; despite 
this, many of the molecular mechanisms by which ligand recognition and activation 
occurs remains poorly understood. NLRP3 contains LRR, PYD and NBD domains 
and requires both ASC and caspase-1 for initiation of the inflammasome (Masumoto 
et al., 2003). NLRP3 has a wide range of known triggers for its activation including 
extracellular adenosine triphosphate (ATP), nigericin (Mariathasan et al., 2004) and 
monosodium urate crystals (MSU) (Martinon et al., 2006); this ability to respond to 
numerous diverse PAMPs and DAMPs distinguishes this receptor among all the 
inflammasomes as the most versatile. The NLRP3 dependent inflammasome was 
also shown to play a role in the modulation of the response to intracellular adenoviral 
DNA and the subsequent IL-1β response, which demonstrates the importance of the 
inflammasome in viral immunity (Muruve et al., 2008). It is thought that NLRP3 
does not directly associate with its various activators, but instead can be activated by 
a generic pathway of cell stress or perhaps facilitated by other activating proteins 
(Horvath et al., 2011). Many models for activation have been proposed and 
demonstrated, including: mitochondrial damage and the release of reactive oxygen 
species (ROS) (Zhou et al., 2011), potassium (K
+
) efflux (Pétrilli et al., 2007), 
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calcium (Ca
2+
) signalling (Lee et al., 2012) and lysosomal disruption during 
incomplete phagocytosis (Hornung et al., 2008). A combination of some or all of 
these pathways may contribute to the complex signalling of NLRP3. 
After ROS was shown to play a role in IL-1β secretion (Cruz et al., 2007), the first 
hypothesised pathway to link the generation of ROS to the inflammasome was via 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. As a result of 
incomplete phagocytosis of crystals, NADPH oxidase was thought to produce ROS 
and thus lead to the activation of NLRP3 (Dostert et al., 2008; Hewinson et al., 
2008). This hypothesis has been challenged recently, with studies indicating that the 
use of ROS inhibitors blocked NLRP3 upregulation during the priming stage, but did 
not affect the activation and assembly of NLRP3 when administered after priming 
(Bauernfeind et al., 2011). Conversely, the absence of NADPH in mouse models has 
been shown to result in a hyper inflammatory state due to increased γδ T-cell activity 
(Romani et al., 2008). Patient data has supported this model, as patients with chronic 
granulomatous diseases (CGDs) display a defective NADPH system and yet exhibit 
increased IL-1β release (van de Veerdonk et al., 2010). While the role of NADPH in 
the inflammasome remains controversial, a different pathway involving both ROS 
and the mitochondria has recently been demonstrated (Zhou et al., 2011). It has been 
suggested that ROS itself is not an absolute requirement for NLRP3 activation, as 
the oxazolidinone antibiotic linezolid does require ROS signalling. Destabilisation of 
the mitochondria however is required, since cyclosporine A stabilisation of the 
mitochondria or inhibition of the mitochondrial surface protein cardiolipin blocked 
NLRP3 activation. This suggests that direct interaction with the mitochondria may 
be vital for inflammasome assembly to proceed  (Iyer et al., 2013).   
Intracellular ion homeostasis has also been shown to play a role in the initiation of 
NLRP3 inflammasome assembly. Increased levels of Ca
2+
 in the cytosol is capable 
of promoting NLRP3 assembly while also downregulating cellular cyclic AMP 
(cAMP), a known inflammasome inhibitor (Lee et al., 2012). Interestingly, a recent 
study demonstrated that increased concentration of extracellular Ca
2+ 
is also capable 
of leading to inflammasome assembly through the signalling of G protein-coupled 
calcium sensing receptors (Rossol et al., 2012). The authors determined that necrotic 
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cells could be a source of this calcium, which implicates calcium signalling in the 
amplification of the inflammatory response and potentially in sterile inflammation. 
K
+
 efflux was shown to regulate IL-1β secretion before the discovery of the 
inflammasome (Walev et al., 1995) and has since been directly shown to regulate the 
NLRP3 inflammasome assembly (Pétrilli et al., 2007). Recent work has implicated 
K
+
 efflux as being the common signalling trigger required to achieve inflammasome 
activation in response to particulate matter and bacterial pore-forming toxins  
(Muñoz-Planillo et al., 2013). Indeed, lysosomal disruption during incomplete 
phagocytosis promotes inflammasome activation (Hornung et al., 2008) by 
triggering the opening of K
+
  pores leading to a drop in cytosolic K
+ 
(Muñoz-Planillo 
et al., 2013). While the NLRP3 inflammasome has been studied extensively, many 
questions relating to its activating triggers and assembly still remain. 
Recent clinical research has demonstrated that dysregulation of NLRP3 signalling 
can both initiate and exacerbate a wide variety of auto-inflammatory and metabolic 
conditions. Accumulation of the endogenous particulate MSU in joints has long been 
known to be a major causative agent in Gout (Wollaston, 1797) and MSU itself is 
known to induce NLRP3 signalling in macrophages (Martinon et al., 2006).   
Studies linking NLRP3 polymorphisms with autoimmune diseases have yielded 
inconsistent results, with some studies demonstrating a link (Bidoki et al., 2016; 
Roberts et al., 2010), while others showed contrary results (Pontillo et al., 2012; 
Wang et al., 2015). However, a recent meta-analysis has highlighted an association 
of an NLRP3 polymorphism (rs10754558 C/G) with an increased risk of 
autoimmune disorders (Lee and Bae, 2016). 
 
1.8.3 NLRP6 Maintains Gut Homeostasis 
Structurally, NLRP6 is similar to NLRP3 as it contains LRR, PYD and NBD 
domains but the precise nature of its early activation remains unclear (Chen, 2014). 
Early work demonstrated the capacity for NLRP6 to co-localise with ASC (Grenier 
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et al., 2002), yet to date there has been no conclusive biochemical evidence which 
elucidates its role in the assembly of an inflammasome. 
Much of the interest in NLRP6 relates to its role in intestinal homeostasis. Nlrp6 
deficient mice exhibited colitogenic gut microflora profiles with increased levels of 
Bacteroidetes (Prevotellaceae family) which has been associated with inflammatory 
bowel disease (IBD) (Kleessen et al., 2002). A more severe inflammatory phenotype 
is also observed upon induction of dextran sodium sulfate (DSS) colitis (Elinav et 
al., 2011). Interestingly, co-housing Nlrp6
-/-
 with wild type mice for 4 weeks lead to 
the transference of this colitogenic microbiota profile to the wild type, subsequently 
enhancing the inflammatory effect of DSS induced colitis. This alteration of the 
microflora can also lead to an increase in secreted IL-6, which modifies the 
proliferation of resident epithelial cells, leading to increased tumorigenesis (B. Hu et 
al., 2013). 
Conversely, NLRP6 may also contribute to suppressing the immune response during 
bacterial infection. Nlrp6
-/-
 mice when exposed to Escherichia coli, Listeria 
monocytogenes and Salmonella typhimurium were shown to be highly resistant to 
infection (Anand et al., 2012). This correlated with an increase in circulating 
neutrophils and a more robust NF-κB response upon TLR stimulation. 
 
1.8.4 NLRC4 and the NAIP family 
Similar to the other NLRs which form an inflammasome, NLRC4 contains a LRR 
and NBD. However, it lacks a PYD and instead contains a CARD domain (Z. Hu et 
al., 2013). The interplay between NLRC4 and the neuronal apoptosis inhibitor 
proteins (NAIPs) results in the formation of an inflammasome in response to a 
variety of different PAMPs of bacterial origin. Flagellin within the cytosol was first 
shown to lead to a NLRC4 dependent caspase 1 cleavage independent of TLR5 
(Franchi et al., 2006). Further work has shown that NAIP5 and NAIP6 function 
upstream of NLRC4 in the response to L. pneumophila and are indispensable in 
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facilitating the formation of the inflammasome in response to this bacteria. 
Contrastingly, NLRC4 recognition of P. aeruginosa and S. typhimurium can occur 
independently of both NAIP5 and NAIP6 (Lightfield et al., 2008). This is due to the 
capacity of NLRC4 to respond to the type III secretion systems (T3SS) from Gram-
negative bacterial origin (Miao et al., 2010b). T3SS is capable of injecting various 
virulence factors into the cytosol of cells, which can shape the cells response to the 
pathogen. It consists of more than 20 proteins which exists as a needle shaped 
complex present on the bacterial envelope (Galán and Wolf-Watz, 2006; Miao et al., 
2010b). NAIP2 was identified as the specific receptor for the bacterial needle protein 
CprI in humans, which facilitated the action of NLRC4  (Zhao et al., 2011). Flagellin 
did not associate with NAIP2, which highlights the NAIP family as critical 
inflammasome components capable of dictating the specific response to bacterial 
signals. 
The interaction between the NAIP family and NLRC4 remains poorly understood. It 
has been hypothesised that upon ligand binding, NAIPs are released from an auto-
inhibitory state and oligomerise, which further allows the oligomerisation of NLRC4 
(Guo et al., 2015). Similar to NLRP1, the LRR domain may inhibit the function of 
the NAIPs and NLRC4, as shown through deletion studies (Kofoed and Vance, 
2011). Phosphorylation of NLRC4 has also been demonstrated to be critical for 
caspase-1 recruitment to the inflammasome (Qu et al., 2012), but this 
phosphorylation has been shown to occur independently of NAIP5. Interestingly, a 
two-step model has been hypothesised where subsequent interaction with NAIP5 or 
NAIP1/2 is required to produce the conformational change of phosphorylated 
NLRC4, which facilitates its activation (Matusiak et al., 2015). 
As with the other inflammasomes, NLRC4 is capable of processing IL-1β and IL-18 
into their active forms. However, NLRC4 may contribute to bacterial clearance 
independent of these cytokines. S. typhimurium for example was shown to replicate 
in macrophages, but were cleared by neutrophils due to the generation of ROS  
(Miao et al., 2010a). Caspase-1 induced pyroptosis of the infected macrophages 
functioned not only in the clearance of infected cells, but also served as a mechanism 
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to release intracellular bacteria into the extracellular space allowing for subsequent 
phagocytosis by neutrophils.  
 
1.8.5 AIM2 and IFI16: The DNA sensors 
Unlike the other inflammasomes discussed, AIM2 and IFI16 are not members of the 
NLR family, but instead belong to a family of hematopoietic interferon-inducible 
nuclear proteins with a 200-amino acid repeat (HIN-200). They contains a PYD and 
a HIN domain (Albrecht et al., 2005; Ludlow et al., 2005) and due to this are also 
known as the PYHIN family of proteins (Hornung et al., 2009). AIM2 has been 
shown previously to function in the regulation of cell growth (Choubey et al., 2000) 
and to possibly play a role in colorectal tumorigenesis (Mori et al., 2001) by 
mediating the regulation of interferon-stimulated genes (ISGs) (J. Lee et al., 2012). 
IFI16 has been implicated in various cancers and functions in the response to DNA 
damage (Fujiuchi et al., 2004). 
The recognition of cytoplasmic DNA can be mediated by a number of different 
receptors including TLR9 (Hochrein et al., 2004), DNA-dependent activator of IFN-
regulatory factors (DAI) (Takaoka et al., 2007) and NLRP3 (Muruve et al., 2008). 
Whilst NLRP3 plays a role in responding to intracellular adenoviral DNA, it is not 
involved in the recognition of transfected poly(deoxyadenylic-deoxythymidylic) 
(poly(dA-dT)), a synthetic analogue of double stranded B-DNA (dsDNA). Instead, 
the IL-1β release upon poly(dA-dT) transfection requires both ASC and caspase-1 
and this is triggered by the upstream inflammasome sensor AIM2 (Fernandes-
Alnemri et al., 2009; Hornung et al., 2009). Since its discovery as a novel 
cytoplasmic dsDNA receptor, AIM2 has been shown to be involved in the response 
against Francisella tularensis (Fernandes-Alnemri et al., 2010), Listeria 
monocytogenes (Kim et al., 2010; Sauer et al., 2010) and Legionella pneumophila 
(Ge et al., 2012).  
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The crystal structure of AIM2 complexed with dsDNA has been determined and is 
the first inflammasome receptor that has been demonstrated to directly bind to its 
ligand (Jin et al., 2012). Further structural and binding studies show that the PYD 
and HIN domains strongly interact prior to dsDNA association, indicating its auto-
inhibition, similar to other inflammasomes (Jin et al., 2013, 2012). AIM2 is thought 
to oligomerise and act as a platform for ASC binding and further caspase-1 
signalling. This platform is also capable of activating caspase-8 independent of 
caspase-1 and leads to apoptosis of the cell (Pierini et al., 2012). Interestingly, a 
similar interplay between apoptosis and pyroptosis is observed upon NLRP1 
inflammasome assembly, which highlights the important role inflammasomes can 
play in orchestrating cell death. 
IFI16 is primarily localised in the nucleus and has been shown to act as a dsDNA 
sensor, utilising STING, TBK-1 and IRF3 to induce and IFN-β response 
(Unterholzner et al., 2010). Notably, this study determined that unlike AIM2, IFI16 
did not interact with ASC upon cytoplasmic transfection of dsDNA. Recent work has 
shown that in response to kaposi sarcoma-associated herpesvirus (KSAH) which 
replicates in the nucleus, IFI16 can associate with ASC and form an inflammasome 
(Kerur et al., 2011). The reason for this disparity is possibly due to the requirement 
of a foreign DNA signal in the nucleus. This study also represents the first 
demonstration of an inflammasome assembling in the nucleus.  
 
1.8.6 The RIG-I Inflammasome 
The role of RIG-I in the production of type I interferon in response to viral infection 
is well understood (Loo and Gale, 2011). It is a DExD/H box RNA helicase 
containing two CARD domains and shares both structure and function with 
melanoma differentiation-associated gene 5 (Mda5) (Kawai et al., 2005). RIG-I can 
detect dsRNA from replicating viruses in the cytosol and upon recognition, associate 
via CARD-CARD interaction with mitochondrial antiviral signalling (MAVS) (Seth 
et al., 2005; Yoneyama et al., 2004). This association causes the formation of a 
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signalling platform on the mitochondria leading to the recruitment of IKKε and 
IKKα/IKKβ which can phosphorylate IRF3 and IκB respectively, triggering the 
activation of a pro-inflammatory and anti-viral response (Meylan et al., 2005).  
An emerging role of RIG-I is its potential to form an inflammasome and result in IL-
1β maturation. Unlike the IRF/IFN signalling of RIG-I described above, 
inflammasome assembly through RIG-I is independent of MAVS signalling (Poeck 
et al., 2010). However, recent work has shown that during infection of lung 
epithelial cells by Influenza A virus (IAV), RIG-I initially signals through a MAVS 
dependent pathway, leading to a type I interferon response (Pothlichet et al., 2013). 
Secreted IFN-β initiates a positive feedback loop, further upregulating RIG-I, which 
is required for its inflammasome assembly. This demonstrates the potential of RIG-I 
to be involved during both signal 1 and signal 2. 
 
1.8.7 The Non-canonical and Emerging Inflammasomes 
The initial characterisation of the function of caspase-1 in published IL-1β studies 
used Casp1
–/–
 mice (Kuida et al., 1995; Li et al., 1995). It was recently determined 
that these mice were in fact Casp1
–/–
Casp11
–/– 
 double knock out mice, an error 
which occurred due to the close proximity of both genes in the genome (Kayagaki et 
al., 2011). Using a Casp11 bacterial artificial chromosome (BAC) transgene, the 
authors generated a functional Casp1 knockout which confirmed the role of caspase-
1 in IL-1β and IL-18 secretion. Interestingly, this work also implicated caspase-11 
functioning in a non-canonical inflammasome, independent of caspase-1, NLRP3 
and ASC. Caspase-11 activation has since been shown to lead to detrimental levels 
of cell death due to intracellular Salmonella infection in the absence of caspase-1 
(Broz et al., 2012).  
It was recently discovered that intracellular LPS could activate a non-canonical 
inflammasome (Kayagaki et al., 2013). Only the specific serotype LPS O111:B4 in 
combination with cholera toxin B (CTB) could elicit this response, due to O111:B4 
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binding CTB which acts as a raft facilitating the entry of LPS into the cell. 
Transfection of any LPS serotype achieved this activation, demonstrating the 
existence of an intracellular LPS receptor which acts independent of TLR4. Caspase-
11 is only found in mice, however recent work on the human homologues caspase-4 
and -5 has shown that both are involved in IL-18 secretion independent of caspase-1, 
which potentially links their functionally with caspase-11 (Knodler et al., 2014). 
LPS recognition is directly mediated by caspase-11/4/5 binding to LPS in a CARD 
dependent manner, resulting in their oligomerisation and subsequent activation (Shi 
et al., 2014). 
The requirement of a third activating signal in the inflammasome has also been 
hypothesised. During Gram-negative bacterial infection, type I IFNs are secreted in a 
TLR4 dependent manner, leading to its autocrine association with the interferon 
receptors IFNα/βR1 and IFNα/βR2 (Rathinam et al., 2012). This leads to the 
downstream upregulation and activation of caspase-11, which synergises with the 
NLRP3 inflammasome, facilitating heightened IL-1β release. This non-canonical 
pathway is dependent on TRIF signalling through TLR4, but not MyD88 (Broz et 
al., 2012).   
NLRP7 and NLRP12 have also recently been shown to form inflammasomes in 
response to bacterial lipopeptides (Khare et al., 2012) and Yersinia pestis (Vladimer 
et al., 2012) respectively. Future work is likely to uncover other inflammasome 
forming proteins which may have implications in other inflammatory diseases. 
 
1.8.8 Crosstalk between TLRs and NLRP3 
As discussed, the assembly of the inflammasome requires two distinct signals; the 
first is a priming signal that results in downstream activation of NF-κB. This 
signalling can be achieved upon stimulation of a variety of TLRs, but also IL-1R and 
tumour necrosis factor receptor (TNFR) (Bauernfeind et al., 2009). It was originally 
thought that signal 1 served only to upregulate pro-IL-1β which would be cleaved 
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upon recognition of a second signal. However, recent work has challenged this 
simplistic model and has shown it to be incomplete. There is in fact a complex and 
nuanced crosstalk involving inflammasome components which occurs during 
priming. A variety of post-translational modifications resulting from initial TLR 
signalling are capable of modulating the assembly of the inflammasome (De Nardo 
et al., 2014). 
The first protein based post-translational modification described was the conserved 
76-amino-acid polypeptide protein ubiquitin (Ciehanover et al., 1978; Hershko et al., 
1980). The covalent addition of ubiquitin to a target protein is known as 
ubiquitination, and is fundamentally important in a wide range of cellular functions, 
including innate signalling. The formation of ubiquitin chains can be linked through 
various lysine residues on the ubiquitin protein, leading to a variation in cellular 
outcomes. Lysine 48 (K48) linked ubiquitination is generally considered to signal for 
proteosomal degradation (Chau et al., 1989), while K63 linked polyubiquitination is 
associated with signal transduction and protein stability (Chen, 2005). It is an ancient 
process which is conserved even in plant immunity (Trujillo and Shirasu, 2010). 
Deubiquitination of NLRP3 by the deubiquitinating enzyme (DUB) BRCC3 has 
been shown to be essential to the initiation of the NLRP3 inflammasome (Juliana et 
al., 2012; Py et al., 2013). This deubiquitination occurs after signal 2, allowing 
NLRP3 to oligomerise and associate with ASC. Knockdown of BRCC3 inhibits the 
activation of the NLRP3 inflammasome and thus regulates IL-1β secretion. 
Interestingly, NLRC4 and AIM2 activation were not affected by the pharmacological 
inhibition of DUBs, which demonstrates the difference in regulation between 
inflammasome sensors. 
Priming of ASC prior to its interaction with NLRP3 is also a key molecular switch 
required for aggregation of stable specks and thus the formation of the 
inflammasome. Phosphorylation of ASC occurs in a Jnk/Syk dependent manner and 
is required for ASC oligomerisation, possibly via association and trafficking along 
microtubules to the site of speck formation (Hara et al., 2013). Ubiquitination by the 
linear ubiquitin assembly complex (LUBAC) also plays an important role in the 
priming of ASC. Linear ubiquitination, or M1-linked ubiquitination, results from the 
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linking of the N-terminal methionine of one ubiquitin and the C‐terminal Gly76 of 
another forming head to tail linear linkages (Kirisako et al., 2006; Pickart and 
Fushman, 2004). LUBAC consists of a combination of the proteins HOIP, HOIL-1L 
and Sharpin (Gerlach et al., 2011) and together can lead to the linear ubiquitination 
of ASC. These ubiquitin complexes remain complexed to ASC during speck 
formation, potentially demonstrating that a complete deubiquitination event is not 
required prior to complex formation (Rodgers et al., 2014). 
A20, which is also known as TNFAIP3, is a known negative regulator of the innate 
response. It is capable of regulating NF-κB signalling by both functioning as a DUB 
and deubiquitinating RIP and also catalysing the formation of K48 ubiquitination of 
RIP, leading to its degradation (Wertz et al., 2004). Cells from A20-deficient mice 
showed spontaneous activation of the NLRP3 inflammasome is response to TLR 
stimulation alone, implicating it as a possible regulator of the inflammasome  
(Duong et al., 2015). A20 was shown to associate with both caspase-1 and pro-IL-1β 
and localises with the inflammasome complex upon activation. Further, it was also 
observed that pro-IL-1β associates in a complex with RIPK1, RIPK3, caspase-1, 
caspase-8 and K63 ubiquitin. Pro-IL-1β could indeed be ubiquitinated during signal 
1 prior to NLRP3 inflammasome assembly and this ubiquitination was increased in 
A20 deficient cells, which can support signal propogation and lead to increased IL-
1β processing. This work demonstrates the regulatory role which A20 plays during 
inflammasome priming by inhibiting IL-1β ubiquitination.  
Our understanding of the molecular modifications which trigger an active 
inflammasome are still incomplete, but it is clear that there is a complex interplay 
occurring between the priming and activating signals which can shape the response. 
Ubiquitination of IL-1β, NLRP3 and ASC during LPS priming has been shown to 
critically regulate inflammasome activation (Duong et al., 2015; Hara et al., 2013; 
Py et al., 2013). To date, no specific E3 ligase has been identified which can 
facilitate this ubiquitination. To this end, the focus of the work presented in this 
thesis is to investigate the role of the E3 ligase Pellino2 in the ubiquitination and 
subsequent regulation of the NLRP3 inflammasome. 
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1.9 The Pellino Family 
Ubiquitination of a target protein requires the actions of 3 separate enzymes: an El 
ubiquitin-activating enzyme, an E2 ubiquitin-conjugating enzyme and an E3 
ubiquitin–protein 1igase (Ciechanover et al., 1982; Hershko et al., 1983). In humans, 
there are two E1 enzymes which are capable of initiating the ubiquitin conjugating 
cascade, Uba6 and Ube1 (Jin et al., 2007). The E1 protein binds both ubiquitin and 
ATP and catalyses the adenylation of the ubiquitin c-terminal, leading to its 
activation (Ciechanover et al., 1982). E1 then recruits one of a number of E2 
enzymes, facilitating the transfer of the activated form of ubiquitin to the E2 (Wijk 
and Timmers, 2010). The final step involves an E3 protein ligase, which facilitates 
the transfer of ubiquitin from E2 to a target substrate (Hochstrasser, 2006). There are 
approximately 35 active E2 enzymes in humans (Wijk and Timmers, 2010) and 
hundreds of  E3 proteins. E3 proteins are a large and diverse group, due to their 
requirement to bind to a large variety of target substrates (Berndsen and Wolberger, 
2014).  
The Pellino family of proteins were first characterised as a component of the 
Dorsal/Cactus signalling complex in Drosophila melanogaster, which is a critical 
signalling system during embryogenesis (Prothmann et al., 2006). Dorsal is a 
member of the Rel family of proteins and is inhibited in the cytoplasm by the protein 
cactus prior to activation, similar to NF-κB in mammals (Lemaitre et al., 1996). 
Using Pelle as a bait in a yeast two-hybrid screen, Pellino was demonstrated to be a 
Pelle (IRAK) interacting protein (Großhans et al., 1999). Pellino homologues were 
also identified in Caenorhabditis elegans (Rich et al., 2000) and the notochord of 
Ciona intestinalis (Hotta et al., 2000). Vital components of TLR signalling have 
been largely conserved between vertebrates and invertebrates (Medzhitov and 
Janeway, 2000) and this is also the case for the Pellino family, which highlights 
them as evolutionarily important molecules. Three mammalian Pellino proteins have 
been discovered and genetically mapped. The genes PELI1 and PELI2 that encode 
the proteins Pellino1 and Pellino2 were first successfully mapped to chromosomes 2 
and 14 in humans (Resch et al., 2001; Rich et al., 2000). PELI3 was the final 
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annotated member of the family, which was mapped to chromosome 11 in humans 
and encodes two splice variants of Pellino3, the larger Pellino3a and the smaller 
Pellino3b (Jensen and Whitehead, 2003a). 
Early work suggested that functionally the Pellino family acted as scaffolding 
proteins during TLR signalling. However, through homology analysis it was 
proposed that Pellino proteins contain a CHC2CHC2 really interesting new gene 
(RING)-like finger motif, differing slightly from a classical C3HC4 RING domain 
(Schauvliege et al., 2007, 2006). The RING domain is a feature of a sub-family of 
E3 ubiquitin ligases and the presence of a putative RING-like domain in Pellino 
proteins suggested that they may have E3 ligase activity. Indeed, the Pellino proteins 
were demonstrated to polyubiquitinate IRAK-1 when co-expressed with either 
Pellino1, 2 or 3 (Schauvliege et al., 2006). Further, Pellino proteins exhibiting a 
single point mutation in the RING domain were co-expressed with IRAK1 in order 
to assess the E3 ligase function of the Pellino proteins. The Pellino RING motif was 
determined to be dispensable in IRAK1 binding, but crucial to the inducing IRAK1 
polyubiquitination. Pellino1 was further demonstrated to act as an E3 ligase which 
could catalyse Lys63-linked polyubiquitin chains on IRAK1 and IRAK4, allowing 
for the subsequent phosphorylation and ubiquitination of Pellino1 (Butler et al., 
2007; Schauvliege et al., 2006). All members of the Pellino family are structurally 
similar; they each contain a RING domain and a forkhead-associated (FHA) domain, 
which is usually associated with phosphothreonine-binding activity. This cryptic 
FHA domain was not apparent from the primary sequence, but was resolved through 
x-ray crystallography of the 15–275 amino acid n-terminal region (Lin et al., 2008). 
Mutation of the amino acid involved in phosphothreonine binding inhibits IRAK1 
interaction, indicating that it is the FHA and not the RING domain which mediates 
protein-protein interaction with IRAK1 (Lin et al., 2008). Pellino3 shares an amino 
acid identity of 84% and 85% with Pellino1 and Pellino2 respectively. Pellino3 also 
has a longer N-terminal domain by 27 and 25 amino acid compared to Pellino1 and 
Pellino2. The third exon of Pellino3a also contains a 24 amino acid insert in the N-
terminus (Jensen and Whitehead, 2003a). 
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1.9.1 Pellino1 Modulates NF-κB Activity 
Despite the structural similarities between the members of the Pellino family, many 
recent studies have focused on the characterisation of the distinct physiological 
functions of the individual members (Humphries and Moynagh, 2015). Using both 
siRNA knockdown and protein overexpression, Pellino1 was initially shown to be 
required during TLR and IL-1R signalling for the activation of NF-κB (Jiang et al., 
2003). Pellino1 was hypothesised to target the IRAK4-TRAF6 complex due to the 
homology of the Pellino family with the Pelle protein in Drosophila (Großhans et al., 
1999). Pellino1 was shown to be capable of interacting with IRAK1, IRAK4, TRAF-
6, and TAK1 (Jiang et al., 2003). Smad2 was also shown to be capable of inhibiting 
the interaction with Pellino1 and the IRAK1/TRAF6 complex, leading to an 
inhibition of NF-κB signalling (Choi et al., 2006). MAPK signalling was unaffected 
during knockdown of Pellino1, indicating a targeted effect on NF-κB (Jensen and 
Whitehead, 2003b).  
The generation of a Pellino1 knockout mouse has led to a more complete 
understanding of the physiological relevance of Pellino1. Pellino1 was demonstrated 
to play a pivotal role in the TLR activation of NF-κB through the interaction and 
ubiquitination of RIP1, which facilitated activation of the IKK complex and thus NF-
κB (Chang et al., 2009a). Pellino1 was indespensible for TLR3-NF-κB signalling, 
but only partially required during TLR4 signalling, while IRF3 activation was 
unaffected in the Pellino1-deficient mouse. Interestingly, this work demonstrated 
that Pellino1 was not required for IL-1R, TLR2 or TLR9 signalling, highlighting the 
Myd88 independent function of Pellino1 (Chang et al., 2009a). However, the recent 
generation of a Pellino1 kinase-dead knock-in mouse has questioned the role of 
Pellino1 in TLR3 signalling (Enesa et al., 2012). Pellino1[F397A] mutant knock-in 
mice exhibited an inactive Pellino1 RING domain which abolished its E3-ligase 
activity. This mouse model demonstrated a reduced IFNβ response upon TLR3 
signalling, while no difference was observed in RIP1 polyubiquitination or IKK 
complex and MAP kinase activation. This discrepancy between knockout and knock-
in mutant needs to be addressed, but potentially highlights a functional role of 
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Pellino1 independent of its E3-ligase activity (Enesa et al., 2012). The total loss of 
Pellino1 may also result in the differential upregulation or compensation of the other 
Pellino1 proteins, leading to their exaggerated function.  
Pellino1 also plays a role in the negative regulation of T cell activation. Pellino1 was 
demonstrated to be capable of acting as an E3 ligase for the NF-κB subunit c-Rel and 
promote c-Rel’s polyubiquitination by K48 ubiquitin linkage (Chang et al., 2011). 
This leads to its degradation in activated T-cells and the suppression of NF-κB 
activation. Pellino1-deficiency led to accumulation of c-Rel and a spontaneous 
activation of T-cells. Peli1
-/-
 mice also developed T cell mediated autoimmunity and 
presented with splenomegaly, as well as increased immune cell infiltration to organs. 
Serum autoantibody levels were similarly increased (Chang et al., 2011). Pellino1-
deficiency has been shown to be protective in experimental autoimmune 
encephalomyelitis (EAE). It was determined that Pellino1 is specifically required for 
NF-κB activation in microglial cells, which are mediators of EAE induction (Xiao et 
al., 2013). Pellino1 was shown to function downstream of TRAF6 and mediate 
TRAF3 degradation and the activation of c-IAP. This results in the activation of 
MAPK signalling, leading to the upregulation of pro-inflammatory genes and 
contributing to the pathogenesis of EAE. This work highlights the difficulty in 
clarifying the role of Pellino1 as its functional relevance can be tissue specific. 
 
1.9.2 The Physiological Role of Pellino2 Remains to be 
delineated 
To date, Pellino2 has been primarily studied in the context of IL-1 and TLR 
signalling using over-expression and RNAi-based knockdown approaches. Pellino2 
has been shown to interact with IRAK1 when overexpressed and was determined to 
be required during IL-1 and TLR signalling (Yu et al., 2002). Using shRNA 
knockdown techniques, Pellino2 was shown to be required for IL-1 and TLR4 
induced polyubiquitination of IRAK1 (Kim et al., 2012). A Pellino2 RING mutant, 
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which lacks E3 ligase activity, was incapable of promoting IRAK1 ubiquitination. 
This highlights the importance and requirement of the E3 ligase activity of Pellino2 
during this ubiquitination event. The activation of the MAPK pathways, JNK and 
ERK, by TLR4 and IL-1β, were also inhibited in the Pellino2-knockdown cells. 
Finally, the levels of  secreted IL-6 and TNFα were decreased in knockdown cells, 
which was attributed to impaired mRNA stability (Kim et al., 2012). Pellino2 has 
also been shown to interact with BCL10 during TLR4 signalling and induce NF-κB 
activation (Liu et al., 2004).  
However, the physiological role of Pellino2 remains ambiguous. To date, no research 
using a Pellino2-deficient mouse has been published. The work in this thesis aims to 
clarify the functional roles of Pellino2-deficiency in the immune system. 
 
1.9.3 Pellino3 and its Role in Innate Immune Signalling 
Early work into establishing the function of Pellino3 focused primarily on its role in 
TLR and IL-1 signalling (Butler et al., 2005; Xiao et al., 2008). This is due to 
discovery of Pellino3 as an IRAK1 interactor (Jensen and Whitehead, 2003a). It was 
originally shown that Pellino3 could activate both c-jun and Elk-1, but not NF-κB. It 
was hypothesised that differential levels of expressed Pellino3 in tissues could direct 
a cellular response towards either a MAPK dependent response in the case of high 
Pellino3 expression or a NF-κB response in tissues exhibiting low Pellino3 
expression (Jensen and Whitehead, 2003a). Over-expression studies further 
established a role for Pellino3 in the P38 MAPK pathway and the activation of 
cAMP response element-binding protein (CREB) (Butler et al., 2005). Pellino3b 
overexpression also inhibited IL-1-induced IRAK1 degradation, via stabilisation in a 
Lys-63-linked polyubiquitination dependent manner. This resulted in the inhibition 
of TAK1-dependent NF-κB activation (Xiao et al., 2008). Pre-treatment of the 
macrophage cell line RAW 264.7 with oxLDL (oxidized low density lipoproteins) 
inhibits TLR4 signalling through TRIF, resulting in reduced levels of IFNβ (Tzieply 
et al., 2012). The authors proposed that this inhibition is mediated by Pellino3 via 
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mono-ubiquitination of TRAF family member-associated NF-κB activator (TANK) 
which hinders the recruitment of TBK1 and TRAF3, inhibiting the activation of 
IRF3. While these studies are vital in shaping our understanding of Pellino biology, a 
more physiologically relevant model was required to further elucidate the role of 
Pellino3. To do this, a Pellino3-deficient mouse was generated in our laboratory and 
these mice demonstrated normal viability, growth and development. This mouse has 
since been used to demonstrate the importance of Pellino3 in a variety of innate 
immune processes (Figure 1.3). 
Pellino3-deficiency was shown to have no effect on the production of pro-
inflammatory cytokines via TLR stimulation (Siednienko et al., 2012). However, 
type I interferons induced by TLR3 stimulation was shown to be augmented in 
Pellino3-deficient cells, which implicated Pellino3 as a negative regulator of TLR3 
signalling. A new pathway was elucidated showing that TRAF6 can ubiquitinate 
IRF7 and promote nuclear translocation and induce type I IFN. Pellino3 was shown 
to induce K63-linked polyubiquitination of TRAF6, which blocks the interaction of 
TRAF6 with IRF7 and so repress nuclear translocation and type I IFN expression 
(Siednienko et al., 2012).  
Due to previous work demonstrating the requirement of Pellino1 in the 
ubiquitination of RIP1 (Chang et al., 2009a), the possible role of Pellino3 in RIP 
biology has also been examined.  It was shown that Pellino3 targets RIP1 to control 
cell fate in response to TNF stimulation (Yang et al., 2013b). TNF was first 
described in 1975 as having a strong cytotoxic effect on tumours (Carswell et al., 
1975). It is now understood to have a wide range of actions including the modulation 
of apoptosis, cell survival and immune signalling (Flynn et al., 1995; Nagata and 
Golstein, 1995; Sugarman et al., 1985). While TNFα is capable of binding both 
TNFR1 and TNFR2, only TNFR1 contains death domains, which facilitate the 
formation of protein complexes resulting in the signalling for cell death (Tartaglia et 
al., 1993). Upon TNFR1 stimulation, TNFR1-associated death domain protein 
(TRADD) is recruited to the receptor and in turn recruits RIP1 (Hsu et al., 1996; Liu 
et al., 1996). RIP1 is ubiqutinated via a complex of E3 ubiquitin ligases including 
TRAF2, TRAF5, cIAP1, and cIAP2, resulting in the recruitment of IKKβ and 
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activation of NF-κB (Ea et al., 2006; Vince et al., 2009; Zheng et al., 2010). 
However, unmodified RIP1 can hinder NF-κB activity and instead leads to the 
formation of the death-inducing signalling complex (DISC) containing Fas-
associated death domain (FADD) and caspase-8. This complex leads to the 
activation of caspase-8 and the initiation of apoptosis (Kim et al., 2000; Kischkel et 
al., 1995). In effect, the ubiquitination of RIP1 represents a signalling crossroads 
which can influence cell death or survival. Pellino3, via its FHA domain, was shown 
to interact with RIP1 and block recruitment of RIP1 into DISC thus promoting cell 
survival. This role of Pellino3 is independent of its E3 ligase activity, which 
highlights the diverse functionality of this protein  (Yang et al., 2013b).  
Pellino3 is also capable of directly binding RIP2 and is required for the induction of 
its ubiquitination in a NOD2 dependent manner (Yang et al., 2013a). NOD2 is 
cytosolic receptor, responsible for the recognition of bacterial peptidoglycan and the 
subsequent activation of NF-κB (Inohara et al., 2001; Ogura et al., 2001) NOD2 has 
been shown to play an important role in gut homeostasis and loss-of-function 
mutants of NOD2 have been linked with Crohn's disease (Ogura et al., 2001a). 
Following ubiquitination, RIP2 further recruits TAK1, TAB2 and TAB3 and leads to 
NF-κB and MAPK activation. Interestingly, analysis of the colons of patients with 
Crohn's disease showed a downregulation of Pellino3 levels when compared to 
healthy controls. This corresponds to experimental colitis models carried out in mice, 
where Peli3
-/- 
mice showed enhanced inflammation during late stage colitis, despite a 
reduction in NOD2 signalling (Yang et al., 2013a).  
Pellino3-deficient mice subjected to a high-fat diet (HFD) show exacerbated 
inflammation and insulin resistance. Pellino3 levels were also shown to be reduced 
in the adipose tissue of HFD mice, which also correlated with reduced Pellino3 
expression in human abdominal adipose tissue from obese patients (Yang et al., 
2014). IL-1β transcription levels are a key factor in mediating insulin resistance and 
inflammation (Lagathu et al., 2006; Xu et al., 2003). This transcription of IL-1β 
during obesity is mediated in part by HIF-1α stability and translocation to the 
nucleus (Cramer et al., 2003; Semenza and Wang, 1992; Tannahill et al., 2013). 
Pellino3 was shown to interact with and ubiquitinate TRAF6, which blocks further 
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ubiquitination of HIF-1α, resulting in its degradation. Pellino3-deficient cells exhibit 
increased stabilisation and ubiquitination of HIF-1α, resulting in increased IL-1β 
levels and inflammation (Yang et al., 2014). These studies illustrate the importance 
of Pellino3 in acting as a molecular switch which can influence not just the fate of an 
individual cell, but also the overall immune response. The recent evidence 
elucidating the roles of Pellino3 in patients demonstrates its potential as a therapeutic 
target in the future. 
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Fig 1.3 The roles of Pellino3 in innate immune signalling  
Described in detail in section 1.9.3. Red arrows represent inhibition (A) Blue arrows 
indicate TLR3 signalling. (B) Black arrows indicate TNF signalling. (C) Green 
arrows indicate HFD signalling. (D) Orange arrows indicate NOD2 signalling. 
Chapter 1: Introduction 
44 
 
1.10 Project aims 
Recent research has elucidated distinct roles for both Pellino1 and Pellino3 in innate 
immune signalling. However, due to the lack of a knockout mouse model for 
Pellino2, its physiological relevance remains to be delineated. In light of this, we 
used a newly generated Pellino2-deficient mouse to address the following objectives: 
- To define the effect of Pellino2-deficiency on TLR and IL-1R signalling 
- To explore the role of Pellino2 in inflammasome activation 
- To investigate the physiological relevance of Pellino2-deficiency 
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2.1 Materials 
2.1.1 Reagents 
Reagents Supplier 
Agar Sigma-Aldrich 
Agarose Promega 
Ampicillin Sigma-Aldrich 
APS Sigma-Aldrich 
BSA Sigma-Aldrich 
Bradford reagent dye Bio-Rad 
Bromophenol blue Sigma-Aldrich 
CHAPS Sigma-Aldrich 
Chloroform Sigma-Aldrich 
CLO97 Invivogen 
Coomassie Blue (G250) Sigma-Aldrich 
CpG type A ODN 1585  Invivogen 
CpG type B ODN 1666 Invivogen 
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DirectPCR Lysis Reagent (Tail) Viagen Biotech 
DMEM Invitrogen 
DMSO Sigma-Aldrich 
DNA ladder & Loading dye Promega 
dNTPs 
DSS 
Promega 
Sigma-Aldrich 
DTT Sigma-Aldrich 
E.coli-TOP10 competent cells Invitrogen 
EDTA Sigma-Aldrich 
Ethanol Sigma-Aldrich 
Ethidium bromide Sigma-Aldrich 
FBS Invitrogen 
Flagellin Invivogen 
Glycerol Sigma-Aldrich 
Glycine Sigma-Aldrich 
GoTaq®
 
polymerase Promega 
GoTaq® Green Master Mix Promega 
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HEPES Sigma-Aldrich 
HCl Merck 
H2O2 Sigma-Aldrich 
Igepal Sigma-Aldrich 
Isopropanol Sigma-Aldrich 
Kanamycin Sigma-Aldrich 
Lipofectamine 2000 Invitrogen 
LPS Enzo Life Sciences 
LB Sigma-Aldrich 
Magnesium Chloride Sigma-Aldrich 
Methanol The British Drug 
Houses (BDH) 
Molecular Biology Grade Water (RNase and DNase Free) Sigma-Aldrich 
OptiMEM Invitrogen 
Pam2CSK4 Invivogen 
Pam3CSK4 Invivogen 
PBS Oxoid 
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Penicillin / Streptomycin / Glutamine Invitrogen 
PMSF Sigma-Aldrich 
Poly(I:C) Invivogen 
Prestained molecular weight marker  Invitrogen 
Protease inhibitor cocktail Roche 
Protein A/G-agarose Santa Cruz 
Proteinase K Qiagen 
Protogel National Diagnostics 
Random primers Invitrogen 
RNase Zap Ambion 
SDS Sigma-Aldrich 
Milk powder Sigma-Aldrich 
NaCl Sigma-Aldrich 
NaOH Sigma-Aldrich 
Na3VO4 Sigma-Aldrich 
Na3PO4 Sigma-Aldrich 
H2SO4 Sigma-Aldrich 
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Synthetic oligonucleotides MWG Biotech 
TEMED Sigma-Aldrich 
TMB Sigma-Aldrich 
Tris-base Sigma-Aldrich 
Tris-HCl Sigma-Aldrich 
Trition-X-100 Sigma-Aldrich 
Trypsin/EDTA Invitrogen 
Tween-20 Sigma-Aldrich 
Zymosan Invivogen 
Blasticidin Invivogen 
Zeocin Invivogen 
2-Mercaptoethanol Gibeco 
Ponceau s Sigma-Aldrich 
Acetic Acid Fisher-Scientific 
WesternBright ECL HRP Substrate Advansta 
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2.1.2 Kits 
Kit   Supplier 
Murine CXCL1 ELISA Kit   R&D Systems 
Murine IL-1β ELISA Kit   R&D Systems 
Murine IL-6 ELISA Kit   R&D Systems 
Murine RANTES ELISA Kit   R&D Systems 
Murine TNFα ELISA Kit   R&D Systems 
Plasmid Plus Midi Kit   Qiagen 
SensiMix SYBR No-ROX Kit    Bioline 
 
2.1.3 Antibodies 
2.1.3.1 Antibodies for Immunoblotting 
Primary Antibody Supplier Dilution Diluent 
ASC Santa Cruz 1:200 5% Milk TBST 
Caspase-1 p10 Santa Cruz 1:200 5% Milk TBST 
Chapter 2: Materials and Methods 
52 
 
Caspase-1 p20 Adipogen 1:1000 5% Milk TBST 
ERK Cell Signalling 1:1000 5% BSA TBST 
FLAG M2 Sigma-Aldrich 1:2000 5% Milk TBST 
IKK-β Cell Signalling 1:1000 5% BSA TBST 
IκB-α Santa Cruz 1:200 5% Milk TBST 
IL-1β Adipogen 1:1000 5% Milk TBST 
IRAK-1 Cell Signalling 1:1000 5% Milk TBST 
JNK Cell Signalling 1:1000 5% BSA TBST 
Myc-Tag (9B11 Cell Signalling 1:2000 5% Milk TBST 
NLRP3 Adipogen 1:1000 5% Milk TBST 
Phospho-p38 Cell Signalling 1:1000 5% BSA TBST 
Phospho-ERK Cell Signalling 1:1000 5% BSA TBST 
Phospho-IκB-α Cell Signalling 1:1000 5% BSA TBST 
Phospho-JNK Cell Signalling 1:1000 5% BSA TBST 
Phospho-cJUN Cell Signalling 1:1000 5% BSA TBST 
Phospho-IKK-α/β Cell Signalling 1:1000 5% BSA TBST 
Ubiquitin Santa Cruz 1:200 5% Milk TBST 
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K48 Ubiquitin Abcam 1:1000 5% Milk TBST 
K63 Ubiquitin Abcam 1:1000 5% Milk TBST 
β-actin Sigma-Aldrich 1:5000 5% Milk TBST 
 
Secondary Antibody Supplier Dilution Diluent 
IRDye® 680RD Goat anti-
Mouse 
Li-cor 1:5000 5% Milk TBST 
IRDye® 800CW Goat anti-
Rabbit 
Li-cor 1:5000 5% Milk TBST 
IRDye® 800CW Donkey 
anti-Goat 
Li-cor 1:5000 5% Milk TBST 
Anti-mouse HRP Cell Signalling 1:2000 5% Milk TBST 
 
2.1.3.2 IFN-β ELISA Antibodies 
Antibody Supplier Dilution Function 
Rat anti-Mouse IFN-β Santa Cruz 1:1000 Capture 
Rabbit anti-Mouse IFN-β PBL Interforn Source 1:2000 Detection 
anti-Rabbit HRP Promega 1:2000 Reporter 
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2.1.4 Cell Lines 
Name Description  
HEK293 Human embryonic kidney 293 cells  
L929 Murine aneuploid fibrosarcoma cell line  
J558 Myeloma cell line induced by by mineral oil injection 
in BALB/c mice, transduced with murine GM-CSF 
sequence. 
 
 
2.1.5 Primer Sequences 
2.1.5.1 Real-Time PCR Primers 
Targeted Gene Sense Primer Sequence 5’-3’ 
Antisense Primer Sequence 5’-3’ 
HPRT AGGGATTTGAATCACGTTG 
TTTACTGGCAACATCAACAG 
IL-1β GGATGATGATGATAACCTGC 
CATGGAGAATATCACTTGTTGG 
NLRP3 GATGCTGGAATTAGACAATG 
GTACATTTCACCCAACTGTAG 
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Peli1 ACATGCCAACGGAGTGAAGC 
AGCGGCCAATCTGGAACA 
Peli2 AACGACCCATACACACCACG 
TGTCCATCAGGGTTTTTCCAT 
Peli3 CCTTGTCCATGTAAGTTTCTC 
CAGAGTTCAGAAGTCTGGAACT 
 
 
2.1.5.2 Genomic DNA PCR Primers 
Allele Targeted 
 
Sense Primer Sequence 5’-3’ 
Antisense Primer Sequence 5’-3’ 
HPRT GCTTGCTGGTGAAAAGGACCTCTCGAAG 
CCCTGAAGTACTCATTATAGTCAAGGGCAT 
WT Peli2 Primers 
(A + B)  
CGTGTCCATCACTCTTAAATGAA 
GCACCATTGTACCTAAAGTAGAGAC 
KO Peli2 Primers 
(C + D)  
GCCTCTACAGGATGCTCATTT 
GGACAGTCATGCTAGTCTGAGG 
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2.1.6 Buffers 
Buffer Name Ingredients 
Block buffer (Immunoblotting) TBS, 0.1% (v/v) Tween-20 with 5 % (w/v) 
non-fat dry milk 
Block buffer (ELISA) PBS, 1% (w/v) BSA, Filtered Sterilised using 
0.02 μm filter 
Protein lysis buffer 50 mM HEPES pH 7.5, 10% (v/v) Glycerol, 
0.5% (w/v) CHAPS, 0.5% (v/v) Triton-X-100, 
250 mM NaCl. Prior to use: 1 mM Na3VO4, 1 
mM PMSF and protease inhibitor mixture 
cocktail 
Laemmli sample buffer 62.5 mM Tris-HCl, pH 6.8, 10% (w/v) 
glycerol, 2% (w/v) SDS, 0.7 M β-
mercaptoethanol and 0.001% (w/v) 
bromophenol blue 
Phosphate buffered saline (PBS) 2.7 mM KCl, 1.5mM KH2PO4, 137 mM NaCl 
and 8 mM Na2HPO4, pH 7.4 
Ponceau stain 0.1% (w/v) Ponceau S in 5% (v/v) acetic acid 
SDS running buffer 25 mM Tris, 192 mM glycine, 0.1% SDS 
Tris-acetate-EDTA (TAE) Buffer 40 mM Tris base, 0.1% (v/v) glacial acetic acid, 
1 mM EDTA 
Tris buffered saline (TBS) 25 mM Tris, pH7.4, containing 0.14M NaCl 
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Tris-EDTA (TE) buffer 10 mM Tris-HCl, 1 mM EDTA pH 8.0 
 
2.1.7 Gifts 
2.1.7.1 Cells 
HEK293: Prof. Douglas Golenbock (The University of Massachusetts Medical 
School, Worcestor, Massachusettes 01605, USA) 
WT iBMDM: Dr. Sinead Miggin (National University of Ireland Maynooth, Co. 
Kildare, Ireland) 
 
2.1.7.2 Constructs 
Human NLRP3: Dr. Ruaidhri Jackson (Yale School of Medicine, New Haven, 
Connecticut, USA) 
Human WT IRAK1: Dr. Marion Butler (National University of Maynooth, Co. 
Kildare, Ireland 
Human WT IRAK1 kinase-dead: Dr. Marion Butler (National University of 
Maynooth, Co. Kildare, Ireland 
Myc-tagged human WT Pellino2: Dr. Marion Butler (National University of 
Maynooth, Co. Kildare, Ireland 
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2.2 Methods 
2.2.1 Cell Culture 
2.2.1.1 Culture of HEK293T 
HEK293T cells were cultured in DMEM supplemented with 10% (v/v) heat 
inactivated FBS, penicillin G (100 μg/ml) and streptomycin (100 μg/ml) in a 37°C 
humidified chamber under a 5% CO2 atmosphere. Cell morphology and confluence 
were monitored daily. Once cells reached approximately 80% confluence, adherent 
cells were passaged using a 1% (w/v) Trypsin/EDTA solution in PBS. Cells were 
cultured for a maximum of 25 passages in order to avoid excessive genetic drift. 
 
2.2.1.2 Culture of immortalised BMDMs (iBMDMs) 
iBMDM cells from WT and IRAK1
-/-
 were cultured in RPMI supplemented with 
10% (v/v) heat inactivated FBS, penicillin G (100 μg/ml) and streptomycin (100 
μg/ml) in a 37°C humidified chamber under a 5% CO2 atmosphere. Cell 
morphology and confluence were monitored daily. Once cells reached approximately 
80% confluence, adherent cells were passaged using a cell scraper with PBS. Cells 
were cultured for a maximum of 25 passages in order to avoid excessive genetic 
drift. 
 
2.2.1.3 Culture of L929 Cells for Production of M-CSF 
containing conditioned media (M-CSF CM) 
L929 cells were cultured in DMEM supplemented with 10% (v/v) heat inactivated 
FBS, penicillin G (100 μg/ml) and streptomycin (100 μg/ml) in a 37°C humidified 
chamber under a 5% CO2 atmosphere. Cell morphology and confluence were 
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monitored daily. Once cells reached approximately 80% confluence, adherent cells 
were passaged using a cell scraper with PBS. For the generation of M-CSF CM, cells 
were counted using a haemocytometer and seeded at 5x10
5
 cells/ml with 40 ml 
DMEM in a T175
2
 culture flask for 7 days. CM was removed from the cells and was 
centrifuged at 600 g for 5 min. The supernatant was removed and subjected to 
further centrifugation at 600 g for 5 min in order to ensure the removal of any 
remaining cells. The supernatant was stored at -80°C for up to 6 months. Cells were 
cultured for a maximum of 25 passages in order to avoid excessive genetic drift 
. 
2.2.1.4 Culture of J558 Cells for Production of GM-CSF-
containing conditioned media (GM-CSF CM) 
J558 cells were cultured in RPMI supplemented with 10% (v/v) heat inactivated 
FBS, penicillin G (100 μg/ml) and streptomycin (100 μg/ml) in a 37°C humidified 
chamber under a 5% CO2 atmosphere. Blasticidin (10 µg/ml) was used every 4 
passages to select for GM-CSF producing cells. Cell morphology and confluence 
were monitored daily. Once cells reached approximately 80% confluence, non-
adherent cells were passaged by centrifugation at 600 g for 5 min. Prior to the 
generation of GM-CSF CM, cells were passaged in Blasticidin-free media for two 
passages. Cells were counted using a haemocytometer and seeded at 1x10
6
 cells/ml 
with 40 ml RPMI in a T175
2
 culture flask for 7 days. Once cells reached 
approximately 80% confluence CM was removed and was centrifuged at 600 g for 5 
min. The supernatant was removed and subjected to further centrifugation at 600 g 
for 5 min in order to ensure the removal of any remaining cells. The supernatant was 
stored at -80°C for up to 6 months. Cells were cultured for a maximum of 25 
passages in order to avoid excessive genetic drift. 
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2.2.1.5 Generation and culture of primary BMDMs 
Age (8-12 weeks) and gender matched WT and Peli2
-/-
 mice were sacrificed by 
cervical dislocation. Mice were first sterilised with 70% EtOH before removal of the 
femur and tibia under aseptic conditions in a laminar flow hood. Bone marrow was 
removed by flushing the bones with a 27¾ gauge needle containing 20 ml PBS. 
Cells were then pelleted by centrifugation at 600 g for 5 min. Red blood cell lysis 
(RBL) was carried out by resuspending the pellets in 1ml of Sigma-Aldrich RBL 
buffer and incubated at room temperature for 1 min. Lysis was terminated by the 
addition of 20 ml DMEM supplemented with 10% (v/v) heat inactivated FBS, 
penicillin G (100 μg/ml) and streptomycin (100 μg/ml) and cells were centrifuged 
again at 600 g for 5 min. Pellets were re-suspended in 10 ml DMEM and cells were 
counted using a haemocytometer. WT and Peli2
-/-
 cells were seeded at 2x10
6
 cells/ml 
with 25 ml DMEM in a T175
2
 culture flask. Supernatant media from cultured L929 
cells containing M-CSF was added to a final concentration of 20% (v/v). Cells were 
cultured in a 37°C humidified chamber under a 5% CO2 atmosphere for 3 days 
before media was carefully removed without displacing adherent cells. 25 ml of 
fresh DMEM supplemented with 20% M-CSF (v/v) was gently added and cells were 
cultured for a further 4 days, supplementing cells with additional 10 ml of M-CSF 
supplemented DMEM on day 3. Optimal cell growth was determined by examining 
cell morphology. Differentiated BMDM cells were collected by cell scraping and 
seeded in M-CSF free DMEM for further use. 
 
2.2.1.6 Generation and culture of primary BMDC 
Age (8-12 weeks) and gender matched WT and Peli2
-/-
 mice were sacrificed by 
cervical dislocation. Mice were first sterilised with 70% EtOH before removal of the 
femur and tibia under aseptic conditions in a laminar flow hood. Bone marrow was 
removed by flushing the bones with a 27¾ gauge needle containing 20 ml PBS. 
Cells were then pelleted by centrifugation at 600 g for 5 min. RBL was carried out 
by resuspending the pellets in 1ml of Sigma-Aldrich RBL buffer and incubated at 
RT for 1 min. Lysis was terminated by the addition of 20 ml RPMI supplemented 
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with 10% (v/v) heat inactivated FBS, penicillin G (100 μg/ml) and streptomycin 
(100 μg/ml) and cells were centrifuged again at 600 g for 5 min. Pellets were re-
suspended in 10ml RPMI and cells were counted using a haemocytometer. WT and 
Peli2
-/-
 cells were equalised and seeded at 2x10
6
 cells/ml with 40 ml RPMI in a 
T175
2
 culture flask. Supernatant media from cultured J558 cells containing GM-CSF 
was added to a final concentration of 20% (v/v). Cells were cultured in a 37°C 
humidified chamber under a 5% CO2 atmosphere for 3 days after which the cells 
were scraped and pelleted by centrifugation at 600 g for 5 min. Pellets were re-
suspended in 10 ml RPMI and cells were counted using a haemocytometer. WT and 
Peli2
-/-
 cells were equalised and seeded at 2x10
6
 cells/ml with 40 ml RPMI in 2 
T175
2
 culture flasks. Fresh RPMI supplemented with 20% GM-CSF (v/v) was gently 
added and cells were cultured for a further 4 days. Optimal cell growth was 
determined by examining cell morphology. Differentiated non-adherent BMDC cells 
were collected and seeded in GM-CSF free RPMI for further use. 
 
2.2.2 Molecular Biological Methods 
2.2.2.1 DNA Isolation for Genotyping 
3 week old mice were earpunched and the tissue sample was placed in a sterile 
eppendorf tube. Crude DNA samples were prepared by adding 100 μl of 
DirectPCR™ Lysis Reagent containing Proteinase K (0.4 mg/ml) was added to each 
sample and incubated at 55°C for between 5 and 12 hours. Proteinase K was 
inactivated by incubating at 85°C for 45 min. Extracted DNA was then diluted 1:10 
in DNase free water prior to being used as the template for genotyping PCR 
reactions. 
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2.2.2.2 Total Cellular RNA Extraction  
To avoid contamination of RNA samples, all reagents and labware used were 
certified as RNase free. Gloves were worn and changed frequently in order to avoid 
introducing RNase contamination. All surfaces were decontaminated with RNase 
Zap. 
BMDM, BMDCs and iBMDM cells were seeded at 1x10
6
 cells/ml with 3 ml media 
in 6-well plates for all mRNA analysis experiments. Harvesting for total RNA was 
carried out by first washing with PBS, scraping the cells and centrifuging at 6,500 g 
for 5 minutes at 4°C. Cell pellets were re-suspended with 500 μl of Trizol and 
incubated at RT for 5 minutes to ensure full homogenisation. 150 μl of chloroform 
was added and the mixture was first inverted and then vortexed for 5 sec. Samples 
were incubated at RT for 10 minutes, during which time phase separation begins. 
This is completed by centrifugation at 12,000 g for 15 minutes at 4°C. 150 μl of the 
upper aqueous phase was transferred to a new sterile tube, avoiding contamination 
with the red phenol-chloroform phase or the interphase. 150 μl of isopropanol was 
added to the aqueous phase and the mixture was first inverted and then vortexed for 
5 sec. Samples were incubated at RT for 5 minutes, followed by centrifugation at 
12,000 g for 15 minutes at 4°C. The isopropanol was carefully removed without 
disturbing the precipitated RNA pellet. 900 μl of 75% (v/v) EtOH was added to the 
pellet and vortexed briefly. Samples were centrifuged at 6,500 g for 5 min at 4°C, 
after which the ethanol was removed and the RNA pellets were air dried in a laminar 
flow hood for 10 minutes. The RNA pellet was re-suspended in 20 μl of RNase free 
water and incubated at 60°C for 10 minutes. A Nanodrop™ spectrophotometer was 
used to quantify the concentration of RNA in each sample. The ratio of the 
absorbance at 260 and 280 nm was used to assess the purity of the RNA sample, 
where a ratio of 1.8-2.0 indicated pure RNA. RNA samples were stored at -80°C. 
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2.2.2.3 First Strand cDNA Synthesis from Total Cellular 
RNA 
Complementary DNA (cDNA) is a DNA copy synthesised from mRNA. This 
reaction was carried out in a sterile microcentrifuge tube. 2 μg of quantified total 
cellular RNA was diluted in nuclease-free water to a final volume of 12 µl. 1 μl of 
random primers (0.5 μg) was added to the sample and incubated at 70°C for 5 min, 
followed by incubation of the sample on ice. The random primers consist of a 
mixture of hexamers and anchored-dT primers which results in an even coverage of 
the RNA template. The following master premix was prepared: 
 
Reagent Volume (μl) 
Bioscript Reverse Transcriptase (200u/μl) 0.5 
dNTPs (10mM) 1 
5X Bioscript Reaction Buffer 4 
Nuclease-free water 1.5 
 
After addition of the premix to the sample, mixtures were incubated at 25°C to 
facilitate primer annealing. The mixture was incubated at 42°C for 45 min. The 
reaction was then terminated by incubation at 85°C for 5 min, followed by chilling 
on ice. cDNA samples were stored at -20°C or immediately amplified by PCR. 
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2.2.2.4 Polymerase Chain Reaction (PCR) 
2.2.2.4.1 DNA Amplification by PCR 
Previously generated cDNA or whole genomic DNA (outlined in 2.2.2.1 and 2.2.2.3) 
were subjected to amplification using predesigned DNA primers (2.1.5.1) to target 
specific amplification of the region of interest. The reagents of the reaction premix 
described below were added on ice. 
 
Reagent Volume (μl) 
5X GoTaq® Reaction Buffer 5 
MgCl2 Solution (25mM) 2 
Sense Primers (100 pmol/μl) .25 
Anti-Sense Primers (100 pmol/μl) .25 
dNTPs (10mM) 1 
GoTaq® DNA Polymerase (5u/μl) .15 
Template DNA 2 
Nuclease-free Water 14.35 
 
Using a thermal cycler, samples were first incubated at 95°C for 5 minutes to 
facilitate denaturation of template DNA. Samples were then subjected to 30 cycles of 
first 95°C for 30 sec, followed by 60°C for 30 sec and 72°C for 1 min. Each stage of 
this cycling step encompassed denaturation, annealing and extension of the product, 
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respectively. A final extension of the product was carried out at 72°C for 10 min 
before the reaction was quenched by incubation at 4°C. PCR products were stored at 
-20°C or immediately quantified through gel electrophoresis or real-time PCR. 
 
2.2.2.4.2 Qualitative Analysis by Agarose Gel 
Electrophoresis 
Agarose gel electrophoresis was used for the purpose of genotyping to determine the 
presence or absence of amplified regions of interest from whole genomic DNA. 
Agarose gels were prepared using 1.5% (w/v) agarose in TAE buffer. This was 
achieved by heating the solution until the agarose had fully dissolved and 
subsequently cooled to below 50°C. SYBR® Safe DNA Gel Stain (1:10,000 
dilution) was added to allow visualisation of DNA and the gel was poured into a pre-
assembled gel tray with well combs. Solidified gel was placed into electrophoresis 
rig which was filled with TAE buffer. Samples were loaded alongside a 1 kb 
molecular size marker and subjected to electrophoresis at 90 volts. DNA product 
bands were visualised using ultraviolet (UV) light (254 nm) and image acquisition 
was carried out using a Syngene G box gel documentation system. 
 
2.2.2.4.3 Quantitative Real-time PCR Analysis 
Previously generated cDNA (outlined in section 2.2.2.4.1) were subjected to 
quantitative real-time PCR analysis, allowing for a comparative quantification 
between various DNA samples during the PCR amplification process. Specifically 
designed primers correlating to a targeted region of interest (Section 2.1.5) were 
used. The reagents of the reaction premix described below were added on ice. 
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Reagent Volume (μl) 
2X SensiMix™ SYBR® No-ROX 10 
Sense Primers (4 pmol/μl) 2.5 
Anti-Sense Primers (4 pmol/μl) 2.5 
Nuclease-free Water 3 
 
18 μl of the above reaction premix was added to a PLATE followed by 2 μl of 
previously prepared template DNA. The PCR was carried out using an Applied 
Biosystems Step One
TM
 real-time PCR instrument. Samples were first incubated at 
95°C for 5 minutes to facilitate denaturation of template DNA. Samples were then 
subjected to 30 cycles of first 95°C for 30 sec, followed by 57°C for 30 sec and 72°C 
for 45 sec. Each stage of this cycling step encompassed denaturation, annealing and 
extension of the product, respectively. SYBR green binds to double stranded DNA 
product during the annealing and extension stage, which after absorbance of 497 nm 
blue light, can be measured by emitted 520 nm green light. The cycling step was 
followed by a melt curve analysis, which requires the products to be heated from 
60°C to 90°C. One peak on the melt curve verified the presence of a single 
amplification product. Relative quantification of the targeted gene expression 
activity was determined using the Crossing Threshold (CT) method. The generated 
CT value reflected the target well exceeding a preprogramed fluorescence threshold, 
indicating the presence of a sufficient number of the target amplicons. The cycle 
which the CT value was reached was recorded and ΔCT value could be determined 
by subtracting the control gene CT value from the targets. The relative fold change 
of the genes was further determined using 2
-ΔCT
. 
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2.2.2.5 Transformation of Escherichia coli for Propagation 
of Plasmids 
One Shot® TOP10 chemically competent E.coli were used for plasmids propagation. 
100 ng (1 μl) of plasmid was added to 5 μl of TOP10 cells on ice. DNA and bacteria 
were mixed with a pipette and incubated on ice for 30 min. Mixing was carried out 
gently as cells are highly sensitive to temperature and mechanical lysis. Cells were 
heat-shocked for 30 seconds at 42°C and placed on ice for 2 min. 150 μl of pre-
warmed SOC medium at 37ºC was added to cells which were then incubated at 37 ºC 
on an Exceller E25 shaker at 220 revolutions per minute (rpm) for 1 h. 150 μl of the 
mix was then spread out on pre-warmed LB agar plates (LB broth with 1.5% (w/v) 
agar) containing 100 μg/ml ampicillin. The plates were inverted and incubated 
overnight at 37ºC. Colonies were then be selected from the plates for plasmid 
purification. Plates were stored at 4ºC for up to four weeks 
 
2.2.2.6 Large-scale Purification of DNA from E. coli 
100 ml LB broth containing ampicillin (50 μg/ml) was inoculated with a colony of 
transformed E. coli colony from section 2.2.2.5. The culture was incubated at 37 ºC 
on an Exceller E25 shaker at 220 rpm overnight. Large-scale plasmid purification 
was carried out using the high-speed plasmid midi kit from Qiagen. The bacterial 
cells were pelleted by centrifugation at 3,000 g for 25 min. The supernatant was 
discarded and plasmid DNA extraction was carried out as per manufacturer’s 
instructions. A Nanodrop™ spectrophotometer was used to quantify the 
concentration of DNA in each sample. The ratio of the absorbance at 260 and 280 
nm was used to assess the purity of the DNA sample, where absorbance of 1 unit at 
260 nm is ~50 μg/ml. DNA samples were stored at -20°C.  
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2.2.2.7 Transient Transfection of Mammalian Cells  
HEK293 cells were seeded at 2x10
5
 cells/ml (3 ml) in 6-well plates and incubated 
overnight. 1 ml of media was removed from each well. 1 μg of plasmid DNA for 
transfection was diluted in 250 μl of OptiMEM and mixed gently. 4 μl of 
Lipofectamine2000 was diluted into a separate vial containing 250 μl of OptiMEM. 
After a 5 min incubation, the solutions were combined dropwise and incubated for 
20 min. 500 μl of the DNA-Lipofectamine complexes were gently added to each 
well and left for 24 h before harvesting. 
2.2.3 Biochemical Methods 
2.2.3.1 Protein Extraction 
2.2.3.1.1 Extracellular Protein Extraction 
To avoid protein degradation, all equipment was pre-chilled and all steps in the 
extraction process were carried out on ice unless otherwise stated. In the case of 
adherent cells, extracellular protein was generated by removing conditioned medium, 
centrifuging at 6,500 g for 10 minutes at 4°C to remove any non-adhered cells, 
transferring the supernatant to fresh 1.5 ml tubes and storing at -20°C.To generate 
intracellular protein extracts, adherent cells (after removal of conditioned medium), 
were washed gently with PBS and then scraped in 1 ml PBS and transferred to fresh 
1.5 ml tubes. Samples were centrifuged at 6,500 g for 10 minutes at 4°C, after which 
the PBS was removed. In the case of semi-adherent cells, the media containing non-
adherent cells was removed and added to a 15 ml tube. Cells were scraped in 1 ml 
PBS and transferred to the same 15 ml  tube. Samples were centrifuged at 6,500 g for 
10 minutes at 4°C, after which the PBS was removed. Cells were re-suspended in 1 
ml PBS, transferred to a new 1.5 ml tube and once again centrifuged at 6,500 g for 
10 minutes at 4°C and the PBS was removed. In the case of both adherent and semi-
adherent cells, cellular pellets were re-suspended in 90 μl lysis buffer and incubated 
on ice for 30 min under constant agitation on an orbital shaker. Lysates were then 
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centrifuged at 12,000 g for 10 min at 4°C. 80 μl of the supernatant consisting of 
soluble proteins was transferred to fresh 1.5 ml tubes and stored at -20°C. The 
insoluble protein pellet was washed with 1ml PBS and then centrifuged at 12,000 g 
for 10 min at 4°C. PBS was removed and the wash step was repeated. Samples were 
then analysed for whole insoluble protein expression by SDS-PAGE or subject to 
chemical cross-linking analysis. 
2.2.3.1.2 Irreversible Chemical Crosslinking of Insoluble 
Protein Complex 
Washed insoluble pellets from above were re-suspended with 500 μl of PBS 
containing non-cleavable protein cross-linker disuccinimidyl suberate (DSS) (4 
mM). Samples were incubated at RT for 30 minutes under constant agitation on an 
orbital shaker. Samples were pelleted by centrifugation at 5000 g for 10 minutes. 
Cross-linked pellets were re-suspended in 50 μl 2x sample buffer and were incubated 
for 10 minutes at 100°C.   
 
2.2.3.2 Protein Immunoprecipitation 
2.2.3.2.1 Co-Immunoprecipitation to Investigate Protein-
Protein Interactions 
For overexpression studies, cells were transfected with protein expression constructs 
as in section 2.2.2.7 and after 24 h cells were harvested as below. To investigate 
endogenous interactions, cells were seeded at 1 x 10
6
 cells/ml (10 ml) in 10 cm tissue 
culture dishes and left overnight. After ligand stimulation, cells were placed on ice 
and the media was removed. Cells were gently washed with 3 ml ice cold PBS prior 
to being scraped in 1 ml PBS. Cells were transferred to 1 ml microfuge tubes and 
subjected to centrifugation at 6,500 g for 5 min. Excess PBS was removed without 
disturbing the pellet which was then re-suspended in 200 µl CoIP lysis buffer. 
Samples were left on ice on an orbital shaker under constant agitation for 20 min, 
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ensuring complete lysis of cells. This cellular lysate was then subjected to 
centrifugation at 12,000 g for 10 min. 20 µl of the protein lysate supernatant was 
removed and stored at this point to be used later as an input whole cell lysate control. 
The remaining protein lysate was removed from the insoluble pellet and transferred 
to a fresh 1.5 ml tubes. The volume of the sample was inceased to 1 ml using CoIP 
lysis buffer. Immunoprecipitation of the protein of interest was then carried out by 
addition of 1 µg of a respective antibody to each tube. Samples were incubated 
overnight at 4°C under constant agitation using a sample rocker. 40 µl of protein 
A/G beads were added to each sample followed by a further incubation at 4°C for 6 
h under constant agitation. Samples were centrifuged at 12,000 g for 1 minute and 
the supernatant was removed. 1 ml of CoIP lysis buffer was added to the bead pellet 
followed by several inversions of the tube. Samples were once again subjected to 
centrifugation and the wash step was repeated three more times. After the final wash 
step, all the supernatant was removed and 40 µl of 2X sample buffer was added to 
the beads. Samples were incubated at RT for 20 min before being vortexed and 
boiled for 5 minutes. Samples were then either stored at -20°C or directly subjected 
to SDS-PAGE.  
 
2.2.3.2.2 Immunoprecipitation to Investigate Post 
Translational Modifications 
For overexpression studies, cells were transfected with protein expression constructs 
as in section 2.2.2.7 and after 24 h cells were harvested as below. To investigate 
endogenous post translational modifications (PTM) of a protein of interest, cells 
were seeded at 1 x 10
6
 cells/ml (10 ml) in 10 cm tissue culture dishes and left 
overnight. After ligand stimulation, cells were placed on ice and the media was 
removed. Cells were gently washed with 3 ml ice cold PBS prior to being scraped in 
1 ml PBS. Cells were transferred to 1 ml tubes and subjected to centrifugation at 
6,500 g for 5 min. Excess PBS was removed without disturbing the pellet which was 
then re-suspended in 200 µl CoIP lysis buffer. Samples were left on ice on an orbital 
shaker under constant agitation for 20 min, ensuring complete lysis of cells. This 
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cellular lysate was then subjected to centrifugation at 12,000 g for 10 min. 20 µl of 
the protein lysate supernatant was removed and stored at this point to be used as a 
whole cell lysate control. The remaining 180 µl of protein lysate was removed from 
the insoluble pellet and transferred to a fresh 1.5 ml tubes. 20 µl of 10% (w/v) SDS 
was added to samples and left at RT for 5 min. Samples were then boiled for 5 min 
to facilitate complete disassociation of proteins. The sample was then split into two 
separate tubes and the volume of each tube was increased to 1 ml using CoIP lysis 
buffer in order to dilute remaining SDS. Immunoprecipitation of the protein of 
interest was then carried out by addition of 1 µg of a respective antibody to each 
tube. Samples were incubated overnight at 4°C under constant agitation using a 
sample rocker. 40 µl of protein A/G beads were added to each sample followed by a 
further incubation at 4°C for 6 h under constant agitation. Samples were centrifuged 
at 12,000 g for 1 minute and the supernatant was removed. 1 ml of CoIP lysis buffer 
was added to the bead pellet followed by several inversions of the tube. Samples 
were once again subjected to centrifugation and the wash step was repeated three 
more times. After the final wash step, all the supernatant was removed and the 
duplicate samples were recombined and wash once more. After centrifugation and 
complete removal of the supernatant, 40 µl of 2X sample buffer was added to the 
beads. Samples were incubated at RT for 20 min before being vortexed and boiled 
for 5 minutes. Samples were then either stored at -20°C or directly subjected to SDS-
PAGE.  
 
2.2.3.3 SDS-Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
SDS-PAGE was conducted as outlined by Laemmli (Laemmli, 1970) and modified 
by Studier (Studier, 1973). Samples and pre-stained molecular ladder (10-180 kDa) 
were denatured in SDS-PAGE sample buffer by boiling for 5-10 min prior to loading 
into individual wells. Electrophoresis was performed at a constant 60 V through a 
5% SDS polyacrylamide stacking gel and then through a 8-15% resolving gel at 90 
V for 1.5-2 h. The percentage of the resolving gel was chosen based on the size of 
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the targeted protein of interest, where higher percentage gels were used to priortise 
resolution of proteins of lower molecular weights. 
 
2.2.3.3.1 Immunoblotting 
Following separation by electrophoresis, the migrated proteins were transferred 
electrophoretically to nitrocellulose membranes by a Pierce G2 Fast Blotter semi-dry 
transfer unit. Electrical current (Amps) and transfer times varied depending on the 
size of the protein of interest. Pre-cut Whatmann paper and nitrocellulose were 
equilibrated with Pierce 1-Step Transfer Buffer 10 min prior to use. 3 layers of 
Whatmann paper were placed on the bottom surface of the transfer unit followed by 
a single layer of nitrocellulose. The resolving gel was washed briefly in transfer 
buffer before being place on the nitrocellulose while avoiding bubbles. 3 more layers 
of Whatmann paper were placed on top and the unit was closed. Transfer was carried 
out as per the settings below. 
 
Number of Gels Volts Amps < 20 kDA 20-100 kDA > 100 kDA 
1 25 1.3 5 min 7 min 10 min 
2 25 2.5 5 min 7 min 10 min 
3 25 3.8 5 min 7 min 10 min 
4 25 5 5 min 7 min 10 min 
 
After transfer was completed, membranes were briefly washed with deionised H2O 
before incubation with Blocking Buffer for 30 minutes on an orbital shaker at RT to 
inhibit non-specific antibody binding to a membrane. Membranes were then 
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incubated with primary antibody overnight in TBST containing 5% (w/v) skimmed 
milk powder as per dilutions given in section 2.13. The membranes were washed in 
TBST for 5 minutes under constant agitation. This wash step was repeated 3 times. 
Membranes were then incubated with a secondary antibody specific to the primary 
antibody (anti-mouse, anti-rabbit, anti-goat) in TBST containing 5% (w/v) skimmed 
milk powder at RT for 1 h. The membranes were again washed in TBST 3 times for 
5 minutes under constant agitation. Protein bands were then visualised using the 
Odyssey infrared imaging system from Licor Biosciences or using enhanced 
chemiluminescence (ECL). 
 
2.2.3.4 Enzyme-Linked Immunosorbent Assay (ELISA) 
2.2.3.4.1 TNF-α, IL-6, RANTES, CXCL1 and IL-1β ELISA 
Cell supernatant or serum samples were collected and stored at -80°C prior to 
analysis. 96-well NUNC “Maxisorb” plates were coated with 100 μl capture 
antibody diluted to a working concentration in PBS. Dilutions of capture antibody 
were lot specific. Plates were covered to avoid evaporation and placed on an orbital 
shaker overnight at RT. Antibody was aspirated from the plate and each well was 
washed three times with a wash buffer (0.05% Tween® 20 in PBS). After the final 
wash, plate was inverted and blotted against clean paper towels to ensure the 
removal of excess wash buffer. Plates were blocked by adding 300 μl of block buffer 
(1% (w/v) BSA in PBS filter sterilised (0.2 μm)) for 2 h. Reagent diluent was 
prepared for the IL-1β plate (0.1% (w/v) BSA in Tris-buffered Saline (20mM Trizma 
base, 150mM NaCl) filter sterilised (0.2 μm)) and the TNF-α, IL-6, RANTES, 
CXCL1 plates (1% (w/v) BSA in PBS filter sterilised (0.2 μm)). Samples were 
diluted in reagent diluent and added to each well. Standards were diluted in reagent 
diluent along a seven point standard curve using 2-fold serial dilutions with a top 
standard of 2000 pg/ml. Plates were covered to avoid evaporation and placed on an 
orbital shaker overnight at 4°C. Plates were washed as above and 100 μl of detection 
antibody was diluted to a working concentration in reagent diluent. Dilutions of 
capture antibody were lot specific. Plates were incubated for 2 h at RT and the wash 
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step was repeated. Streptavidin-HRP conjugate was diluted in reagent diluent as per 
lot specific instructions and 100 μl was added to each well. Plates were incubated in 
the dark at RT for 20 min and the wash step was repeated. 100 μl TMB (1.25 mM/l) 
solution was added to each well and the plates were covered and incubated at RT for 
20 min. 50 μl 1 N H2SO4 stop solution was added to stop the reaction. The optical 
density (OD) value of each well was measured at 450 nm with a correction at 590 
nm. A ELx800TM microplate reader with Gen5 Data Analysis Software was used to 
carry out the reading. The sample concentrations were determined by interpolating 
the sample absorbance from the known concentrations of the standard curve. 
Standards were assayed in duplicate while samples were analysed in triplicate. Data 
presentation and analysis were carried out using Graphpad Prism 5 software.  
 
2.2.3.4.2 IFN-β ELISA 
Cell supernatant or serum samples were collected and stored at -80°C prior to 
analysis. 96-well NUNC “Maxisorb” plates were coated with 100 μl of rat anti-
mouse IFN-β (0.1 μg/ml) diluted in PBS. Plates were covered to avoid evaporation 
and placed on an orbital shaker overnight at RT. Antibody was aspirated from the 
plate and each well was washed three times with a wash buffer (0.05% Tween® 20 in 
PBS). After the final wash, plate was inverted and blotted against clean paper towels 
to ensure the removal of excess wash buffer. Plates were blocked by adding 300 μl 
of reagent diluent (1% (w/v) BSA in PBS filter sterilised (0.2 μm)) for 2 h. Samples 
were diluted in reagent diluent and added to each well. Standards were diluted in 
reagent diluent along a seven point standard curve using 2-fold serial dilutions with a 
top standard of 3000 pg/ml. Plates were covered to avoid evaporation and placed on 
an orbital shaker overnight at 4°C. Plates were washed as above and 100 μl of rabbit 
anti-mouse IFN-β (500 ng/ml) diluted in PBS was added to each well. Plates were 
incubated for 2 h at RT and the wash step was repeated. Streptavidin-HRP conjugate 
was diluted 1:2000 in reagent diluent and 100 μl was added to each well. Plates were 
incubated in the dark at RT for 20 min and the wash step was repeated. 100 μl TMB 
(1.25 mM/l) solution was added to each well and the plates were covered and 
Chapter 2: Materials and Methods 
75 
 
incubated at RT for 20 min. 50 μl 1 N H2SO4 stop solution was added to stop the 
reaction. The OD value of each well was measured at 450 nm with a correction at 
590 nm. A ELx800TM microplate reader with Gen5 Data Analysis Software was 
used to carry out the reading. The sample concentrations were determined by 
interpolating the sample absorbance from the known concentrations of the standard 
curve. Standards were assayed in duplicate while samples were analysed in triplicate. 
Data presentation and analysis were carried out using Graphpad Prism 5 software.  
 
2.2.3.5 Bradford Assay 
Bradford assays were performed to quantitate protein concentration (Bradford, 
1976). Known concentrations of BSA standards and samples were diluted in 20 μl of 
water and mixed with 180 μl of Bradford assay reagent. The OD value of each well 
was measured at 590 nm. A ELx800TM microplate reader with Gen5 Data Analysis 
Software was used to carry out the reading. The sample concentrations were 
determined by interpolating the sample absorbance from the known concentrations 
of the standard curve. Standards were assayed in duplicate while samples were 
analysed in triplicate. Data and analysis were carried out using Graphpad Prism 5 
software. 
 
2.2.3.6 LDH Assay  
Phenol-free DMEM was used to avoid background signal in the detection phase of 
the assay. LDH release from cells was determined using a Pierce™ LDH 
Cytotoxicity Assay Kit. 10X Lysis Buffer was added to an untreated well 45 min 
prior to harvest to act as the maximum LDH activity control. Supernatant samples 
were collected and stored at -80°C prior to analysis. 50 µl of sample was added to a 
flat bottom 96 well plate followed by addition of 50 µl of reaction mixture. Samples 
were incubated at RT in the dark under gentle agitation for 30 min. 50 µl of stop 
solution was added to each well and The OD value of each well was measured at 490 
Chapter 2: Materials and Methods 
76 
 
nm with a correction at 680 nm. A ELx800TM microplate reader with Gen5 Data 
Analysis Software was used to carry out the reading. Samples were analysed in 
triplicate. Data presentation and analysis were carried out using Graphpad Prism 5 
software. 
 
2.2.3.7 In vitro Assay 
In vitro ubiquitination assay was carried out on ice by incubating 500 ng UBE1 (E1), 
400 ng Ubc13/Uev1A (E2), 2 µg ubiquitin, 300 ng NLRP3 and 300 ng Pellino2-myc 
(20 nM) in reaction buffer (5 mM Tris-HCl, pH 8.0, 2 mM MgCl, 2 mM ATP, 
Proteinase inhibitor-EDTA free 1/10 dilution) made up to 20 µl volume in Samples 
were incubated at 37 ̊C for 1 h. Samples were then immunoprecipitated (as in section 
2.2.3.2.2) and analysed by western blot.  
 
2.2.4 In Vivo Methods 
2.2.4.1 LPS Induced Sepsis Model 
2.2.4.1.1 Survival analysis 
Age (8-10 weeks), weight and sex matched. Mice were rehoused in pairs and 
allowed to acclimatise to the new surroundings overnight to avoid stress. Mice were 
weighed again prior to injection to determine LPS dose. Injection of either PBS 
control or 20 mg/kg ultrapure LPS was carried out i.p. using a 27 g needle. Mice 
were monitored every 8 hours and documented using an animal welfare scoring 
system. Animals were monitored for adverse clinical signs, matted fur, abnormal 
behaviour, response to stimulus and weight loss. Any animal with a total cumulative 
health score exceeding a pre-defined threshold was culled. All mice were culled at 
the 72 h end-point of the experiment. Data presentation and analysis were carried out 
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using Graphpad Prism 5 software. All experiments were performed in accordance 
with the regulations and guidelines of the Irish Department of Health and protocols 
approved by the Research Ethics committee of National University of Ireland 
Maynooth.   
 
2.2.4.1.2 Serum collection 
Mice were age (8-10 weeks), weight and sex-matched. Mice were rehoused in pairs 
and allowed to acclimatise to the new surroundings overnight to avoid stress. Mice 
were weighed again prior to injection to determine LPS dose. Injection of either PBS 
control or 20 mg/kg ultrapure LPS was carried out i.p. using a 27 g  needle. After 18 
hours, mice were sacrificed by cervical dislocation and blood was extracted. Whole 
blood was incubated at RT for 30 min to allow clotting. This was followed by 
centrifugation at 2,000 g for 10 minutes at 4°C. The resulting serum supernatant was 
removed and stored at -80°C. 
 
2.2.4.1.3 Isolation of Mouse Peritoneal Cavity Cells 
Mice were age (8-10 weeks), weight and sex-matched. Mice were rehoused in pairs 
and allowed to acclimatise to the new surroundings overnight to avoid stress. Mice 
were weighed again prior to injection to determine LPS dose. Injection of either PBS 
control or 20 mg/kg ultrapure LPS was carried out i.p. using a 27 g  needle. After 18 
h the mouse was euthanised, sprayed with 70% EtOH and mounted on a Styrofoam 
block. The peritoneum was exposed by removing the outer skin and injected using a 
27 g needle with 5 ml ice cold PBS (containing 3% FCS). The peritoneum was 
massaged to dislodge any attached cells and then the fluid was collected using a 25 g 
needle. The cell suspension was subjected to centrifugation at 2000 g for 10 minutes 
and the supernatant was discarded. Cells were then counted and stained for flow 
cytometric analysis. 
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3.1 Prologue 
The innate immune system represents the initial detection and response to a pathogen 
and is required for the subsequent initiation of the adaptive immune response. 
Inflammasomes are cytosolic supramolecular protein structures which play a critical 
role in the detection of danger-associated signals, as well as pathogen signals. A 
number of different inflammasome forming proteins have been discovered, including 
NLRP1, NLRP3, NLRP6, NLRC4, AIM2 and RIG-I (Latz et al., 2013). While the 
activating signals and formation of each inflammasome can differ, each culminates 
in the activation and secretion of IL-1β and IL-18, both of which strongly contribute 
to inflammation. A form of cell death called pyroptosis is also thought to be 
associated with inflammasome activation (Miao et al., 2010a). The signalling of 
NLRP3 differs to classical PRRs, as it requires two signals: A priming signal (signal 
1) and an activating signal (signal 2). The priming signal is primarily via NF-κB 
activation, usually through TLR signalling. NF-κB activation is required for the 
transcription of vital inflammasome components. This dual signal response is a 
tightly controlled signalling event, requiring recognition of a pathogen associated 
ligand as well as a danger signal (F. Bauernfeind et al., 2009).  
The NLRP3 inflammasome is capable of responding to a wide variety of different 
activating signals and as such, is thought to not bind any one ligand directly. It is 
therefore believed that a cellular event, such as potassium efflux, calcium signalling 
or lysosomal disruption may instead lead to its activation (Martinon et al., 2009). 
This leads to the upregulation of NLRP3 as well as the inactive pro-IL-1β. After 
priming, a second signal is required which leads to NLRP3 oligomerisation, which 
recruits the protein ASC and acts as a nucleus for ASC aggregation. This large 
protein complex can be visualised as a speck in the cytoplasm of the cell under 
fluorescence microscopy (Sahillioglu et al., 2014). Interestingly the speck itself is 
capable of acting as an activating signal of the NLRP3 inflammasomes of 
neighbouring cells when released during pyroptosis, resulting in an amplified 
inflammatory response (Baroja-Mazo et al., 2014). This NLRP3-ASC complex can 
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further act as a platform which recruits caspase-1 and converts it to its enzymatically 
active form, allowing for the further activation of IL-1β. 
Despite the research into NLRP3 inflammasome, the molecular details underpinning 
NLRP3 activation remain to be fully delineated. The post-translational events 
specifically regulating NLRP3 activation remain a key topic in research, as this can 
occur independently of protein translation. Deubiquitination of NLRP3 by BRCC3 
has been shown to be vital to its assembly (Juliana et al., 2012; Py et al., 2013).  
Phosphorylation may also play a role in the activation of NLRP3, however this has 
not been directly observed (De Nardo et al., 2014). The kinase activity of Syk (Gross 
et al., 2009), protein kinase R (PKR) (He et al., 2013) and TAK1 (Gong et al., 2010) 
have also been shown to induce NLRP3 activation. These studies demonstrate the 
complexity involved in NLRP3 signalling, as well as the importance of post-
translational modifications in facilitating its activation. 
Three mammalian Pellino proteins have been discovered and genetically mapped. 
(Jensen and Whitehead, 2003a). All members of the Pellino family are structurally 
similar; they each contain a RING domain and a FHA domain, which contains 
phosphothreonine-binding modules and mediates protein-protein interaction (Lin et 
al., 2008). Each Pellino protein also contains a RING domain, which are a feature of 
E3 ubiquitin ligases (Schauvliege et al., 2006). The functions of both Pellino1 and 
Pellino2 have been physiologically identified, but the function of Pellino2 remains 
ambiguous. Pellino2 has primarily been studied in the context of IL-1 and TLR 
signalling (Yu et al., 2002) using shRNA knockdown and over-expression 
techniques. Pellino2 was shown to be required for IL-1 and TLR4 induced 
polyubiquitination of IRAK1. The phosphorylation JNK and ERK were also 
inhibited during both TLR4 and IL-1β signalling in Pellino2-knockdown cells (Kim 
et al., 2012). Pellino2 was also shown to interact with BCL10 during LPS signalling 
(Liu et al., 2004). The work in this thesis aims to investigate the physiological role 
of Pellino2 using a newly generated Peli2
-/-
 mouse. 
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3.2 Results 
3.2.1 Generation and phenotypic observation of Peli2
-/-
 Mice 
Peli2
-/-
 mice were generated by Taconic Artemis using proprietary technology. In 
order to characterise the genotype of the mice used in this study, PCR analysis of 
DNA isolated from murine ear punches was carried out. PCR analysis using WT 
(Peli2
+/+
) and heterozygous (Peli2
+/–
) genomic DNA as a template resulted in the 
production of a fragment when using primers (a + b), corresponding with the WT 
Peli2 product (Fig. 3.1a). Primers (c + d) amplified a fragment in knockout (Peli2
-/-
) 
and heterozygous (Peli2
+/–
) genomic DNA, corresponding with the knockout Peli2 
product. Peli2
-/-
 was determined by the absence of the WT Peli2 fragment and the 
presence of the knockout Peli2 fragment. DNase free water (H20) was used as a 
negative control in place of the genomic DNA template. Primers amplifying the 
housekeeping gene HPRT were used as a positive control. mRNA levels were also 
examined in cells in order to assess the levels of Pellino2 mRNA expression and 
confirm knockdown. mRNA levels of Pellino2 were assessed by RT-PCR in 
BMDMs from WT and Peli2
-/-
 bone marrow. Total abrogation of Pellino2 mRNA 
was observed in Peli2
-/- 
cells, further demonstrating that Pellino2 expression has 
been effectively knocked out in Peli2
-/- 
mice (Fig. 3.1b). Finally, Peli2
-/-
 mice were 
monitored for the spontaneous generation of any aberrant phenotype. Pellino2 is not 
required for development since Pellino2-deficient mouse are viable, with breeding 
rates comparable with WT mice. No weight differences were observed between WT 
and Pellino2-deficient mice after 10 weeks of normal chow diet (Fig. 3.1c). Taken 
together, these results show that Pellino2 gene expression is absent in the Peli2
-/-
 
mice and that these mice are viable and develop normally. 
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3.2.2 Loss of Pellino2 has no effect on TLR-induced 
expression of pro-inflammatory cytokines 
Given that the other Pellino proteins have been shown to affect TLR signalling, the 
initial screens to elucidate a physiological role for Pellino2 focused on its potential 
involvement on mediating TLR-induced expression of pro-inflammatory cytokines. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were stimulated for 24 h with 
ligands for TLR2/6 (Pam2CSK4), TLR 2/1 (Pam3CSK4), TLR2/Dectin-1 
(Zymosan), TLR3 (Poly(I:C)), TLR4 (LPS), TLR5 (Flagellin), TLR8 (CLO75), 
TLR7/8 (CLO97) and TLR9 (CpG) and assessed for IL-6 and TNF-α expression. IL-
6 and TNF were initially chosen as both are well characterised pro-inflammatory 
cytokines that are strongly induced by TLRs. Cytokine protein levels were assessed 
by ELISA. Each TLR ligand promoted strong expression of IL-6 (Fig. 3.2a) and 
TNF-α (Fig. 3.2b) in macrophages from WT mice and comparable expression levels 
were observed in Peli2
-/- 
macrophages suggesting that Pellino2 is not involved in the 
TLR-induced expression of these pro-inflammatory cytokines. The effect of Pellino2 
deficiency on TLR-induced chemokine expression was also evaluated. Using 
RANTES (Fig. 3.3a) and CXCL1 (Fig. 3.3b) as TLR-responsive chemokines, the 
various TLR ligands were shown to induce comparable levels of their expression in 
WT and Peli2
-/-
 BMDMs. These results indicate that TLR induction of both pro-
inflammatory cytokines as well as chemokines are unaffected by the absence of 
Pellino2. 
 
3.2.3 Loss of Pellino2 has no effect on IFNβ secretion upon 
TLR stimulation 
In addition to the creation of a pro-inflammatory environment, TLR signalling can 
also play a key role in the recognition or viruses and the induction of anti-viral type I 
IFNs. Innate immune receptors that play key roles in mediating anti-viral responses 
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by inducing type I IFNs include TLR2/Dectin-1, TLR3, TLR4, TLR8, TLR7/8 and 
TLR9. BMDMs cultured from WT and Peli2
-/-
 bone marrow were stimulated for 24 
h with ligands for TLR2/Dectin-1 (Zymosan), TLR3 (Poly(I:C)), TLR4 (LPS), TLR8 
(CLO75), TLR7/8 (CLO97) and TLR9 (CpG). Protein secretion levels of IFN-β 
were assessed by ELISA. Each ligand lead to a detectable increase in IFN-β, 
however there was no observable difference in responsiveness between WT and 
Peli2
-/- 
BMDMs (Fig 3.4). This again suggests that Pellino2 does not contribute to 
the induction of TLR-responsive cytokines. 
 
3.2.4 Loss of Pellino2 has no effect on the induction of RLR, 
NLR or cytokine responsive genes. 
Given the findings that Pellino2 does not appear to mediate TLR signalling, the role 
of Pellino2 was next explored in other innate immune receptor families including the 
intracellular RIGI-like receptors (RLRs) and NOD-like receptors (NLRs). Various 
agents and ligands were chosen to stimulate these pathways.  ppp-dsRNA and Sendai 
virus (SeV) activate RIG-i (Baum et al., 2010), MDP activates NOD2 (Girardin et 
al., 2003) while transfected poly(I:C) is capable of activating MDA-5 (Gitlin et al., 
2006). Poly(dA:dT) transfection initiates a number of pathways including IPS-1 
(Kumar et al., 2006) and RIG-I (Ablasser et al., 2009). BMDMs cultured from WT 
and Peli2
-/-
 bone marrow were treated with transfection reagent alone or subjected to 
transfection for 24 h with ppp-dsRNA, Poly(I:C), Poly(dA:dT) and MDP. Cell 
supernatants were then assessed for IL-6 (Fig. 3.5a) and IFN-β (Fig. 3.5b). The 
transfected ligands induced the expression of these cytokines but there were no 
observable differences in responsiveness of WT and Pellino2-deficient cells. As a 
more physiologically relevant model, SeV was also studied as a viral-inducer of 
IFN-β expression. Again, WT and Pellino2-deficient cells showed similar levels of 
IFN-β expression in response to SeV challenge (Fig. 3.6). These data indicate that 
Pellino2 does not mediate the induction of NLR or RLR-responsive genes.  
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Since over-expression and knockdown studies have implicated a role for Pellino2 in 
cytokine signalling, especially pathways that employ the transcription factor NF-κB, 
Pellino2 was next examined for possible involvement in cytokine signalling 
pathways that activate NF-κB. BMDMs were screened for IL-6 secretion using 24 h 
treatments of IL-1β and TNF-α. Both WT and Pellino2-deficient BMDMs showed 
similar responsiveness to IL-1 and TNF (Fig. 3.7), which is in contrast to previous 
knockdown studies (Kim et al., 2012) and questions the role of Pellino2 in these 
pathways. 
 
3.2.5 Loss of Pellino2 leads to reduced secretion of IL-1β 
upon NLRP3 inflammasome activation 
The data above suggests that Pellino2 plays no role in regulating the expression of 
pro-inflammatory cytokines in response to stimulation of cytokine receptors, TLRs, 
NLRs or RLRs. While these assays focused on the expression of cytokines that are 
induced and secreted from cells via classical secretory mechanisms, IL-1β is a 
cytokine whose secretion is regulated differently than the other cytokines previously 
examined. IL-1β is initially translated in a precursor pro-IL-1β form that lacks a 
leader sequence and does not enter the classical secretory pathway upon 
upregulation. Instead it requires a secondary signal to allow its activation from an 
inactive to an active form. The assembly of an inflammasome is responsible for the 
processing of pro-IL-1β into its mature, bioactive form, with the NLRP3 
inflammasome being the best studied to date. The role of Pellino2 in NLRP3 
inflammasome activation of processing of IL-1β was next examined.   
Two different immune cell types, BMDCs (Fig. 3.8a) and BMDMs (Fig. 3.8b) from 
WT and Peli2
-/-
 bone marrow were stimulated with LPS for 3 hours. Cells were then 
left untreated or subjected to 40 min co-stimulation with either ATP or the bacterial 
pore forming toxin nigericin, each of which lead to the functional assembly of the 
NLRP3 inflammasome (Mariathasan et al., 2006). Protein secretion levels of IL-1β 
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were assessed by ELISA. Both ATP and nigericin co-stimulation with LPS resulted 
in the secretion of IL-1β fom WT cells whereas ATP or nigericin alone were 
ineffective. However, a significant reduction of IL-1β secretion was observed in 
Peli2
-/- 
cells. This data indicates that Pellino2 is required for optimal IL-1β secretion 
upon NLRP3 assembly.  
BMDCs were more sensitive to IL-1β secretion through LPS stimulation alone. This 
is possibly due to a more constitutively active inflammasome in this cell type, 
similar to what has been described in monocytes (Kahlenberg and Dubyak, 2004). 
Due to this, all further cellular work carried out using Peli2
-/-
 was in BMDMs to 
allow for more specific elucidation of the role of Pellino2 in inflammasome 
activation.  
 
3.2.6 Loss of Pellino2 is protective in an LPS induced sepsis 
model 
The physiological relevance of the role of Pellino2 in the secretion of IL-1β was then 
examined using an in vivo sepsis model. In a previous study investigating the role of 
Pellino1, Peli1
-/-
 mice have been shown to be resistant to LPS induced septic shock 
when compared with WT mice (Chang et al., 2009a). Due to the relevance of 
Pellino1 in this model, the effect of Pellino2 deficiency was investigated. To monitor 
survival, WT and Peli2
-/-
 mice were challenged with either intraperitoneal saline 
(control) or a lethal dose of LPS (20 mg/kg). Mice were monitored every 8 hours, 
with responsiveness and weight loss assessed. By 48 h, all WT mice had succumbed 
to the lethal effects of LPS, while 50% of Pellino2 mice survived until the 72 h 
endpoint (Fig. 3.9). During the experiment, both WT and Peli2
-/-
 mice lost a 
comparable percentage of weight (Fig. 3.10a). However, Peli2
-/-
 mice which 
survived the LPS lethal shock were able to recover their weight by day 7 (Fig. 
3.10b). 
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The mechanistic basis to the protective effects of Pellino2 against LPS-induced 
lethality was next explored by measuring the expression of pro-inflammatory 
cytokines in response to the in vivo administration of LPS. A separate cohort of 
animals was challenged with either intraperitoneal saline (control) or a dose of LPS 
(20 mg/kg). After 18 hours mice were sacrificed and serum was collected. ELISA 
assays were carried out on these samples to assess the levels of IL-6 (Fig. 3.11a), 
TNFα (Fig. 3.11b), RANTES (Fig. 3.11c), CXCL1 (Fig. 3.11d) and IL-1β (Fig. 
3.11c). Increased serum cytokine levels were detected in all LPS challenged mice. 
The LPS-induced levels of IL-6, TNFα, RANTES and CXCL1 showed no significant 
difference between WT and Peli2
-/-
 mice. However, Peli2
-/-
 mice showed a 
significant reduction in serum IL-1β levels.  
The protein Gr1 is highly expressed on the cell surface of neutrophils. Due to 
neutrophil infiltration playing a key role in sepsis (Pruitt et al., 1995), cellular 
trafficking of Gr1
+
 cells was examined. A separate cohort of animals was challenged 
with either intraperitoneal saline (control) or a dose of LPS (20 mg/kg). After 18 
hours mice were sacrificed and peritoneal cavity cells were isolated and stained with 
anti-GR1. Cells were then analysed by flow cytometry. While there is a reduction in 
the levels of GR1
+
 cells in the peritoneum of Peli2
-/-
 mice, this difference did not 
reach statistical significance (Fig 3.12). This may be due to the contribution of other 
chemokines such as RANTES which are unaffected by Pellino2-deficiency. Taken 
together, these results were consistent with cell-based data that proposes a specific 
role for Pellino2 in mediating the secretion of bioactive IL-1β and not other pro-
inflammatory cytokines. The decreased IL-1β levels in Peli2-/- mouse serum is 
consistent with reduced LPS-induced neutrophilia and lethality in these mice. 
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3.2.7 Loss of Pellino2 negatively affects Klebsiella-induced 
IL-1β secretion  
Examining the inflammasome using a dual signal approach is important in order to 
elucidate the precise molecular mechanisms of its activation. However, it was also 
necessary to examine a more physiologically relevant scenario in order to confirm if 
Pellino2 deficiency can impact the innate immune response to pathogenic challenge. 
Klebsiella pneumonia was used as it has been shown previously in studies to illicit 
an NLRP3 dependent IL-1β response (Hua et al., 2015; Willingham et al., 2009). 
BMDMs from WT and Peli2
-/-
 bone marrow were infected with K. pneumonia for 1 
h, after which infected media was removed and replaced with gentamicin treated 
media. Cells were incubated for 3 h and harvested. Cell supernatants were then 
assessed for IL-1β levels by ELISA. Low levels of secreted IL-1β were detected 
(Fig. 3.13a). Pellino2-deficient cells exhibited reduced secretion of IL-1β when 
compared with WT. The reduced expression of mature IL-1β in the absence of 
Pellino2 is likely due to deficiency in signal 2-induced activation of the 
inflammasome since Pellino2-deficiency has no effect on the ability of K. 
Pneumonia to induce Signal 1-type effects such as induction of pro-IL-1β (Fig 
3.13b) or NLRP3 (Fig 3.13c) at the mRNA and protein (Fig 3.13d) level. These 
results show that Pellino2 is required for optimal activation of the inflammasome 
during infection with K. pneumonia, which highlights a physiologically-relevant role 
for Pellino2 in inflammasome signalling. 
 
3.2.8 Cell death is unaffected by reduced IL-1β in Peli2
-/- 
cells 
Assembly of the inflammasome and secretion of IL-1β has been shown to be linked 
with a necrotic form of cell death, known as pyroptosis (Miao et al., 2010a). Pellino2 
was thus probed for its potential role in pyroptosis. BMDMs from WT and Peli2
-/-
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bone marrow were stimulated with LPS for 3 hours and left untreated or subjected to 
co-stimulation with either ATP for 40 min. Cells were harvested and stained with 
Annexin and PI in order to determine apoptosis. No difference in cell death between 
WT and Pellino2-deficent cells was observed (Fig 3.14a). LDH release from cells 
was also analysed. BMDMs from WT and Peli2
-/-
 bone marrow were stimulated with 
LPS for 3 hours. Cells were then left untreated or subjected to co-stimulation with 
either ATP for 40 min. Supernatants were harvested and used in the LDH assay. No 
difference was observed in the LDH release between WT and Pellino2-deficient cells 
and interestingly, inflammasome activation led to low overall LDH release from 
cells (Fig 3.14b).. Previous studies exploring LDH release during NLRP3 
inflammasome activation in BMDMs which used similar time-points have confirmed 
the finding that LDH release from cells shows no significant increase following pre-
treatment with LPS and 40 minute co-stimulation with ATP when compared with 
unstimulated cells (Baroja-Mazo et al., 2014). These results demonstrate that the 
difference observed in the secretion of IL-1β in WT and Pellino2-deficent cells is not 
due to a difference in cellular viability. 
 
3.2.9 Pellino2 selectively regulates activation of the NLRP3 
inflammasome 
While the above data suggests that Pellino2 has a role in the functioning of the 
NLRP3 inflammasome, it was important to determine if it has a role in the 
production of IL-1β via other inflammasome forming proteins. To this end cells were 
transfected with different ligands to trigger other canonical pathways of 
inflammasome activation. AIM2 is triggered by the synthetic dsDNA ligand 
Poly(dA:dT) (Hornung et al., 2009) while bacterial flagellin activates NLRC4 (Zhao 
et al., 2011). BMDMs from WT and Peli2
-/-
 bone marrow were stimulated with LPS, 
the ligand for TLR4 for 3 hours. Cells were then treated with transfection reagent 
alone or subjected to transfection with either Flagellin or Poly(dA:dT) for 18 h. Cell 
supernatants were then assessed for IL-1β levels by ELISA. All co-stimulations 
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induced IL-1β protein secretion, but there was no detectable difference between WT 
and Peli2
-/- 
macrophages (Fig. 3.15). LPS in combination with the transfection agent 
showed an increase in IL-1β, possibly due to the liposomes acting as a danger signal 
(Zhong et al., 2013). These results are consistent with the findings that Pellino2 
plays a specific role in the canonical inflammasome activation by NLRP3.  
 
3.2.10 Pellino2 does not affect NF-κB signalling through 
TLR4 
The molecular and mechanistic basis to the regulatory effects of Pellino2 on NLRP3-
mediated processing of IL-1β was next investigated. The regulation of the NLRP3 
inflammasome signalling is dependent upon two distinct signalling events which 
culminate in the activation and assembly of inflammasome components. Signal 1, or 
the priming signal, is dependent upon TLR activation and has been shown to play a 
key role in the upregulation and activation of NLRP3 (Bauernfeind et al., 2009; Qiao 
et al., 2012). Pellino2 has previously been implicated in having a role in NF-κB 
signalling (Liu et al., 2004; Yu et al., 2002) so its role in this pathway was first 
explored. The phosphorylation of IκBα and IKKβ are key indicators of NF-κB 
signalling and were chosen for examination. BMDMs from WT and Peli2
-/-
 bone 
marrow were stimulated with LPS over the indicated time-points (Fig. 3.16) and 
protein lysates were generated and probed with the appropriate antibodies. Pellino2 
had no effect on the phosphorylated or total states of IKKβ. Peak phosphorylation 
was observed early during the time-course, at 15 and 30 min post-stimulation. There 
appears to be a decrease in phosphorylation by 90 min with a secondary increase 
apparent at 6 h. Phosphorylated and activated IKKβ can further phosphorylate its 
down-steam substrate IκBα, which inhibits and sequesters the activity of NF-κB in 
the steady state. Upon IKK activation, IκBα is rapidly phosphorylated and 
ubiquitinated, leading to degradation by the 26S proteasome and thus facilitates the 
translocation of NF-κB to the nucleus (Zandi et al., 1997). Pellino2 does not have a 
role in the phosphorylation or degradation of IκBα. LPS induced rapid 
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phosphorylation of IκBα at 5 and 15 min in WT BMDMs with a second peak 
phosphorylation event also occurring at 6 h (3
rd
 panel Fig. 3.16), which mirrors the 
kinetics seen with IKKβ. IκBα phosphorylation is followed by decreased total levels 
of IκBα (4th panel Fig. 3.16). Similar temporal patterns of phosphorylation and 
degradation of IκBα are apparent in WT and Pellino2-deficient cells. These results 
show that Pellino2 does not mediate TLR4-induced activation of NF-κB. 
 
3.2.11 Pellino2 does not play a role during TLR4-induced 
MAPK signalling 
Previous work indicated a possible role for Pellino2 in facilitating robust MAPK 
signalling, specifically via JNK and ERK activation (Kim et al., 2012a). Also, given 
that recent work has shown that JNK is required for the formation of the NLRP3 
inflammasome (Hara et al., 2013), the role of Pellino2 in MAPK signalling was next 
investigated. BMDMs from WT and Peli2
-/-
 bone marrow were stimulated with LPS 
over the indicated time-points (Fig. 3.17) and protein lysates were generated and 
probed with the appropriate antibodies. The phosphorylation of JNK, ERK and p38 
all showed similar kinetic profiles. Phosphorylation was observed 15 and 30 min 
after stimulation and was subsequently lost. However, no difference was observed 
between WT and Pellino2-deficient cells. These results indicate that Pellino2 has no 
role in regulating the signalling and activation of MAPKs through TLR4.  
 
3.2.12 Pellino2 does not affect IL-1β induced MAPK or NF-
κB signalling 
The lack of a role for Pellino2 in TLR4-induced activation of NF-kB and MAPK 
pathways contrasts with previous reports, using overexpression and knockdown 
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approaches, that proposed a role for Pellino2 in mediating activation of these 
pathways in response to IL-1β (Kim et al., 2012). Therefore, it was important to 
characterise IL-1 signalling in Pellino2-deficient cells. BMDMs from WT and Peli2
-
/-
 bone marrow were stimulated with IL-1β over the indicated time-points (Fig. 3.18) 
and protein lysates were generated and probed with the appropriate antibodies. IκBα 
phosphorylation was used to determine NF-κB activity. The phosphorylation signal 
was highest after 5 minutes and steadily decreased over the time-course. After 90 
min, Pellino2-deficient cells showed a modest reduction when compared to WT 
cells, but the overall level of activation is weak since there is no observable 
degradation of IκBα. JNK and ERK phosphorylation were used to determine the 
activity of the MAPK pathways in response to IL-1. IL-1 caused activation of both 
kinases at early time points but no difference was observed between WT and 
Pellino2-deficient cells. These data question the role, if any, of Pellino2 in mediating 
IL-1β-induced activation of NF-κB or MAPKs. 
 
3.2.13 The expression levels of inflammasome components 
are not regulated by Pellino2  
While NF-κB and MAPK signalling pathways were unaffected by Pellino2-
deficiency, which suggests a lack of role for Pellino2 in Signal 1 of inflammasome 
activation, it is important to note that some of the important readouts of Signal 1 are 
transcriptional up-regulation of the genes encoding NLRP3 and pro-IL-1β. BMDMs 
from WT and Peli2
-/-
 bone marrow were stimulated with LPS over the indicated 
time-points and mRNA levels for IL-1β (Fig. 3.19a) and NLRP3 (Fig. 3.19b) were 
assessed by RT-PCR. IL-1β mRNA levels showed a robust induction in response to 
LPS which peaked at 6 h. NLRP3 mRNA levels also peaked at 6 h. No difference 
was observed in the upregulation of the inflammasome components between WT and 
Pellino2-deficient cells, again supporting a lack of role for Pellino2 in mediating 
Signal 1 in inflammasome activation.  
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To further corroborate these results, the translation of these components into protein 
was next assessed. BMDMs from WT and Peli2
-/-
 bone marrow were stimulated with 
LPS over the indicated time-points (Fig. 3.20) and protein lysates were generated 
and probed with the appropriate antibodies. Pro-IL-1β exists in an inactive form in 
the cytoplasm prior to activation by the inflammasome. The levels of pro-IL-1β 
mirrored the mRNA fold data, with a peak observed at 6 h. Increased NLRP3 protein 
levels was also induced across the time-points. LPS-induced protein levels of pro-IL-
1β and NLRP3 were equivalent in WT and Pellino2-deficient cells, which indicated 
that Pellino2 has no role in either the transcription or translation of inflammasome 
components. 
 
3.2.15 Pellino2 mediates NLRP3 Inflammasome-induced 
cleavage of Caspase-1 and pro-IL-1β  
Given that Pellino2 is not involved in the initial upregulation of inflammasome 
components during signal 1, its potential role in signal 2 was next examined by 
characterising the importance of Pellino2 in processing of pro-caspase 1 and pro-IL-
1β. BMDMs from WT and Peli2-/- bone marrow were stimulated with LPS for 3 
hours. Cells were then left untreated or subjected to co-stimulation with either ATP 
(Fig. 3.21a) or Nigericin (Fig. 3.21b) for 40 min. Conditioned media (supernatant)  
and cell samples were generated and probed with the appropriate antibodies. 
Supernatant samples were probed for the processed (activated) forms of IL-1β and 
caspase-1 which are cleaved and subsequently released from the cell upon co-
stimulation with LPS and ATP. Co-stimulation of WT cells with LPS and either 
ATP or nigericin as Signal 2 resulted in high levels of processed caspase 1 and IL-
1β, but processed levels of both molecules were greatly reduced in Pellino2-deficient 
cells. This is consistent with earlier ELISA analysis above that demonstrated 
decreased IL-1β in supernatants from Peli2-/- cells (Fig. 3.8). Pro-IL-1β levels in the 
lysate were also probed to assess if the decreased processed levels of IL-1β were due 
to lack of up-regulation of pro-IL-1β protein by Signal 1. As before, the levels of 
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pro-IL-1β are similar in WT and Peli2-/- cells suggesting that Pellino2 targets the 
processing step. It should be noted that co-stimulation of cells with LPS and ATP or 
nigericin results in decreased levels of pro-IL-1β in the cell lysates, but this is 
coincident with increased secretion of processed IL-1β into the cell supernatants.  
Later time-points were also used to determine if the role of Pellino2 during IL-1β 
processing could be influenced by a longer LPS priming step. BMDMs from WT 
and Peli2
-/-
 bone marrow were stimulated with LPS for either 6 or 24 hours. Cells 
were then left untreated or subjected to co-stimulation with ATP for 40 min. 
Supernatant and lysate samples were generated and probed with the appropriate 
antibodies. Reduced levels of cleaved IL-1β and caspase-1 were observed in 
conditioned media from Pellino2-deficient cells at all time-points (Fig. 3.22). 
Interestingly, the difference was most apparent after 24 hours pre-treatment prior to 
ATP. Reduced β-Actin levels were seen at the 6 h co-stimulation time-point, 
indicating the possibility of cell death, presumably by pyroptosis. These results 
indicate that Pellino2 has a function in regulating the activity of the NLRP3 
inflammasome upstream of caspase-1 and that Pellino2 can function to regulate IL-
1β processing independent of varying LPS incubation times.  
 
3.2.14 The role of Pellino2 in NLRP3 inflammasome 
activation is independent of priming agent 
All of the previous findings have focused on the use of LPS as a primary signal and 
it was important to confirm that the role of Pellino2 during inflammasome activation 
was independent of the priming signal. In order to examine this, zymosan was used 
as a trigger of TLR2/6 and Dectin-1 pathways that lead to robust NF-κB activation, a 
pre-requisite to upregulation of pro-IL-1β and NLRP3 (Bauernfeind et al., 2009). 
WT and Peli2
-/-
 bone marrow were stimulated with zymosan for 3 hours. Cells were 
then left untreated or subjected to 40 min co-stimulation with ATP. Supernatant and 
lysate samples were generated and probed with the appropriate antibodies. 
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Supernatant samples were probed for IL-1β while lysates were probed for IL-1β and 
β-Actin. Similarly to LPS pre-treatment, Pellino2-deficiency led to abrogated IL-1β 
secretion (Fig. 3.23). Conditioned media was also analysed by IL-1β ELISA, 
demonstrating reduced IL-1β secretion in Pellino2-deficient cells (Fig. 3.24), which 
verified the observations of the western blot. This suggests that the effects of 
Pellino2 on inflammasome activation are independent of the nature of Signal 1. This 
is further confirmed by Zymosan alone inducing the same levels of expression of 
pro-IL-1β and NLRP3 in WT and Peli2-/- BMDMs at both mRNA (Fig. 3.26a; 3.26b) 
and protein (Fig. 3.25) levels. 
 
3.2.16 Pellino2 is required for optimal inflammasome 
assembly 
The data presented above suggests that Pellino2 is contributes to inflammasome-
mediated activation of caspase-1. It was next investigated whether the 
inflammasome assembly itself was affected by Pellino2 deficiency. Upon 
inflammasome assembly, ASC aggregates with NLRP3 and forms protein scaffolds 
which are insoluble in NP-40 lysis buffer (Kang et al., 2015). BMDMs from WT and 
Peli2
-/-
 bone marrow were stimulated with LPS for 3 hours. Cells were then left 
untreated or subjected to co-stimulation with ATP for 40 min. NP-40 soluble and 
insoluble fractions were generated and probed with the appropriate antibodies. Co-
stimulation of WT cells with LPS and ATP resulted in accumulation of NLRP3 and 
ASC in the insoluble fraction consistent with assembly of the inflammasome 
complex (Fig. 3.27). Notably the levels of insoluble NLRP3 and ASC are reduced in 
Pellino2-deficient cells suggesting that assembly of the inflammasome is at least 
partially compromised in the absence of Pellino2. Interestingly, NLRP3 that is 
recruited to the insoluble fraction in Pellino2-deficient cells migrates as an apparent 
double-band which can be observed also. This may possibly indicate the presence of 
an additional post-translational modified form of NLRP3 when Pellino2 is absent. 
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To further assess the assembly of the inflammasome, the oligomerization status of 
ASC was compared in WT and Pellino2-deficient cells. BMDMs from WT and 
Peli2
-/-
 bone marrow were stimulated with LPS for 3 hours. Cells were then left 
untreated or subjected to co-stimulation with ATP for 40 min. NP40 soluble and 
insoluble fractions were generated as above with the latter being also subjected to 
disuccinimidyl suberate (DSS) crosslinking. Samples were then subjected to 
immunoblotting with the appropriate antibodies. Costimulation of WT cells with 
LPS and ATP resulted in the increased oligomerization of ASC in the insoluble 
fraction as manifested by the appearance of dimeric, trimeric and tetrameric forms of 
ASC (Fig. 3.28). There were reduced ASC polymers present in the insoluble fraction 
of Pellino2-deficient cells, again indicating reduced inflammasome assembly. These 
results further support a role for Pellino2 in the optimal assembly of the NLRP3 
inflammasome.  
 
3.2.17 Pellino2 positively contributes to NLRP3 
ubiquitination 
Deubiquitination events have been shown to play an important role in inflammasome 
formation. As NLRP3 deubiquitination is required for its recruitment to the 
inflammasome (Py et al., 2013; Rodgers et al., 2014), it was important to investigate 
the deubiquitination event in WT and Peli2
-/-
 cells. BMDMs from WT and Peli2
-/-
 
bone marrow were stimulated with LPS for 3 hours. Cells were then left untreated or 
subjected to co-stimulation with ATP for 40 min. Protein lysates were subjected to 
treatment with 10% SDS and boiling in order to disassociate protein-protein 
interactions. The samples were then immunoprecipitated using anti-NLRP3 
antibody. After western blot analysis, samples could be probed for covalently bound 
ubiquitin modifications. LPS treatment alone induced polyubiquitination of NLRP3 
in the WT cells but not in Pellino2-deficient cells (Fig. 3.29). Upon ATP stimulation, 
this ubiquitination in the WT cells was lost, as NLRP3 is deubiquitated and recruited 
to the inflammasome pellet. Pellino2-deficient cells exhibited no change in the status 
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of polyubiquitination upon co-stimulation. K63 ubiquitination of NLRP3 followed 
the same trend as pan-ubiquitin showed, as LPS treatment alone induced 
ubiquitination, while ATP co-stimulation induced a loss of ubiquitination. K48-
linked polyubiquitantion was also examined as it has been shown to be responsible 
for targeting proteins for proteasomal degradation (Chau et al., 1989). No K48 
ubiquitination was seen at any time-point, suggesting that protein degradation of 
NLRP3 is not a key factor in the reduced inflammasome formation apparent in 
Pellino2-deficient cells. Increased polyubiquitination was apparent with ATP alone, 
but this does not translate to inflammasome assembly, demonstrating the importance 
of the LPS signal to induce ubiquitination and subsequent deubiquitination. These 
results suggest that Pellino2 has a role in modulating the ubiquitination of NLRP3 
prior to inflammasome assembly in an LPS dependent manner. 
Ubiquitination during Signal 1 plays a key role in the formation of the 
inflammasome, as demonstrated by new research showing that ASC speck formation 
requires prior ubiquitination of ASC before assembly (Guan et al., 2015; Rodgers et 
al., 2014). Ubiquitination of pro-IL-1β (Duong et al., 2015) and caspase-1 (Rodgers 
et al., 2014) are also required for NLRP3 inflammasome activity. While the 
deubiquitination event regulating NLRP3 activation has been well characterised, the 
specific E3 ligase which controls the initial ubiquitination of NLRP3 remains to be 
elucidated. To further investigate the ubiquitination status of NLRP3 during signal 1, 
an LPS time-course was used to examine the temporal ubiquitination status of 
NLRP3. BMDMs from WT and Peli2
-/-
 bone marrow were stimulated with LPS for 
the indicated times (Fig. 3.30). Samples were then immunoprecipitated using anti-
NLRP3 antibody as before and probed for covalently bound ubiquitin modifications. 
In WT cells, LPS induced a robust polyubiquitination of NLRP3 after 3 h which was 
sustained after 6 h. Pellino2-deficient cells showed no observable LPS induced 
NLRP3 polyubiquitination. Using an anti-K63 antibody, it was determined that LPS-
induced K63-linked ubiquitination of NLRP3 in WT cells and this was absent in 
Pellino2 deficient cells (2
nd
 panel Fig. 3.30). 
The above work demonstrates that LPS initially induces ubiquitination of NLRP3 
with a second signal like ATP subsequently promoting its deubiquitination, resulting 
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in inflammasome activation. We hypothesised that the LPS-induced ubiquitination 
of NLRP3 may be a priming event, possibly for inflammasome assembly, but that 
deubiquitination subsequently needs to take place to trigger downstream effects of 
inflammasome activation. 
 
3.2.18 Pellino2 does not directly ubiquitinate or interact 
with NLRP3 
The above studies indicate that LPS-induced ubiquitination of NLRP3 is absent in 
Pellino2-deficient cells and this is associated with reduced inflammasome activation. 
It was next investigated whether Pellino2 could directly mediate this ubiquitination 
of NLRP3 and thus necessitated a prior assessment of the potential of Pellino2 to 
interact with NLRP3. The capacity for Pellino2 to directly ubiquitinate NLRP3 was 
tested using an in vitro ubiquitination assay. Recombinant ubiquitin, E1, E2, Pellino2 
and NLRP3 were incubated with ATP and a Tris buffer to allow for the 
ubiquitination event to progress. Immunoprecipitation was carried out using an anti-
NLRP3 antibody in order to assess the specific ubiquitination of NLRP3. IP samples 
were blotted for ubiquitin and WCL samples were blotted for ubiquitin. It was 
observed that while Pellino2 was able to induce the formation of ubiquitin free-
chains, it was unable to directly ubiquitinate NLRP3 (Fig 3.31).  
Interaction studies were carried out to assess whether Pellino2 could directly bind to 
NLRP3. To do this, an in vitro binding assay testing NLRP3-Pellino2 interaction 
was carried out. Recombinant Pellino2 and NLRP3 were incubated with an ATP 
containing buffer. Co-Immunoprecipitation was carried out using an anti-NLRP3 
antibody while the wash steps were retained. It was shown that recombinant Pellino2 
was lost during the first wash stage and was not immunoprecipitated with NLRP3 
(Fig 3.32a). The potential for NLRP3 and Pellino2 to interact in cells was next 
assessed by overexpression of NLRP3 and Pellino2. HEK293 cells were transfected 
with plasmids encoding Myc-tagged Pellino2 and NLRP3-V5. Pellino2 was 
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immunoprecipitated with an anti-Myc antibody and analysed for co-precipitated 
NLRP3 by Western blotting. NLRP3 could not be detected in these 
immunoprecipitates, suggesting that Pellino2 and NLRP3 do not interact with each 
other (Fig. 3.32b). As a positive control, Pellino2-IRAK1 interaction was 
investigated by similar co-immunoprecipitation analysis, since IRAK1 is a known 
protein interaction partner for Pellino2 (Lin et al., 2008). In keeping with previous 
reports, Pellino2 was shown to interact with IRAK1 (Fig. 3.32c). These results 
indicate no interaction between NLRP3 and Pellino2. 
While Pellino2 may not directly ubiquitinate NLRP3, the data presented has shown it 
to be involved in mediating this ubiquitination. Pellino2 may exert its function 
indirectly, mediated by other protein interactions with NLRP3. The inflammasome 
assembly is complex and may require numerous adapter molecules to facilitate its 
ubiquitination in vivo. 
  
3.2.19 IRAK1 stabilisation is unaffected by Pellino2 
deficiency 
Because it has been shown both here and previously (Yu et al., 2002) that Pellino2 
and IRAK1 can interact, the role of IRAK1 in the NLRP3 inflammasome was next 
assessed. Recent work has highlighted a possible role for IRAK1 in the early 
activation of the inflammasome (Lin et al., 2014). The authors showed that co-
stimulation with LPS and ATP resulted in reduced degradation of IRAK1 when 
compared to LPS alone, suggesting a possible role for IRAK stabilisation in 
inflammasome activation. To investigate the stabilisation of IRAK1, BMDMs from 
WT and Peli2
-/-
 bone marrow were stimulated with LPS alone or in combination 
with ATP over an indicated time-course (Fig. 3.33). Protein lysates were harvested 
and subjected to analysis by western blotting. Rapid IRAK1 degradation was 
observed after 15 min when treated with LPS alone. However, co-stimulation with 
both LPS and ATP resulted in modest stabilisation at 15 min. No difference was 
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observed in the levels of IRAK1 degradation between WT and Pellino2-deficient 
cells suggesting that any effects of Pellino2 on inflammasome activation are 
independent of stabilisation of IRAK1. Interestingly, basal levels of IRAK1 in 
Pellino2-deficient cells appear to be increased when compared with WT cells. 
 
3.2.20 IRAK1 is differentially ubiquitinated in Pellino2-
deficient cells 
Since their discovery, Pellino proteins have been thought to play a role in IRAK1 
activation (Jiang et al., 2003; Lin et al., 2008; Tzieply et al., 2012). The role of 
Pellino2 in the ubiquitination of IRAK1 during priming was next assessed. BMDMs 
from WT and Peli2
-/-
 bone marrow were stimulated with LPS for the indicated times 
(Fig. 3.34). Protein lysates were subjected to treatment with 10% SDS and boiling in 
order to disassociate protein-protein interactions. The samples were then 
immunoprecipitated using anti-IRAK1 antibody. After western blot analysis, 
samples were probed for covalently bound ubiquitin modifications. In both WT and 
Pellino2-deficient cells, LPS induced a robust polyubiquitination of IRAK1 after 15 
min which was lost after 30 min. A second phase of IRAK1 ubiquitination was 
observed in WT cells after 1 h, but this was not apparent in Pellino2-defficient cells. 
The type of linkages in the polyubiquitination chains was also probed using K63 and 
K48-ubiquitin-specifc antibodies. LPS primarily induces strong K48 ubiquitination 
in WT and Pellino2-deficient cells, and this is consistent with IRAK1 degradation in 
these cells (Ramadan and Meerang, 2011). These data indicate that early IRAK1 
ubiquitination that leads to degradation is unaffected in Pellino2-deficient cells and 
this is consistent with the lack of a role of Pellino on early NF-κB signalling (Section 
3.2.10). However the late phase ubiquitination of IRAK1 seems to be absent in 
Pellino2-deficient cells and it is interesting to speculate that this may lead to reduced 
inflammasome activation in these cells. 
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3.2.21 Loss of Pellino2 leads to increased NLRP3 
interaction with IRAK1 
It has been shown recently that IRAK1 and NLRP3 can interact with each other, at 
least when both proteins are over-expressed in cell lines (Fernandes-Alnemri et al., 
2013) and both proteins can co-localise in BMDMs (Lin et al., 2014). Because of 
this work, the importance of Pellino2 for the interaction of NLRP3 and IRAK1 was 
next assessed. BMDMs from WT and Peli2
-/-
 bone marrow were stimulated with 
LPS for the indicated times (Fig 3.35). Protein lysates were then immunoprecipitated 
using anti-NLRP3 antibody. After western blot analysis, samples could be probed for 
associated proteins. In WT cells, IRAK1 was observed to interact with NLRP3 only 
after 6 h stimulation. This manifested as bands of lower electrophoretic mobility that 
are usually associated with hyperphosphorylated forms of IRAK1. Interestingly, 
NLRP3 in Pellino2-deficient cells showed basal IRAK1 interaction, which was lost 
after initial LPS treatment. This interaction was re-established after 3 h and 
maintained. Analysis of the whole cell lysates demonstrated once again that basal 
levels of IRAK1 are increased in Pellino2-deficient cells. From these data, it is 
interesting to speculate that LPS induces interaction of hyperphosphorylated forms 
of IRAK with NLRP3 at later time points to terminate inflammasome activation. In 
the absence of Pellino2 this interaction is already apparent and this may contribute to 
reduced inflammasome activation in Pellino2-deficient cells. In such a model 
Pellino2 may serve to suppress basal IRAK1 phosphorylation and activation and so 
impair this negative regulatory pathway and allow for activation of the 
inflammasome. The LPS-induced interaction of hyperphosphorylated forms of IRAK 
with NLRP3 at later time points suggests that the regulatory effect of Pellino2 is lost 
at later times post LPS stimulation.  
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3.2.22 Pellino2 levels are affected by TLR activation 
The data presented above highlights a role for Pellino2 in the interaction of IRAK1 
and NLRP3 during later LPS time-points. In order to investigate the effect of LPS on 
Pellino2 expression, mRNA induction of the Pellino family were explored over an 
LPS time-course. These experiments revealed that LPS strongly suppresses the 
expression of Pellino2 and that this effect is selective for Pellino2 since other family 
members are induced in response to LPS (Fig. 3.36). BMDMs cultured from WT and 
Peli2
-/-
 bone marrow were stimulated for over the indicated time-course with LPS 
and mRNA was extracted. mRNA levels for Pellino1 (Fig. 3.36a), Pellino2 (Fig. 
3.36b) and Pellino3 (Fig. 3.36c) were assessed by RT-PCR. In WT cells Pellino2 
levels showed a marked decrease over the time-course, while Pellino1 and Pellino3 
levels increased with stimulation. This suggests that Pellino2 has a unique role 
during TLR activation, independent of the other members of the family. This effect 
is selective for Pellino2 since other family members are induced in response to LPS. 
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(a)    
 
 
(b) 
 
 
 (c) 
 
Figure 3.1 Characterisation of Peli2-deficient mice 
(a) Genotyping by PCR analysis of genomic DNA from ear punches. Primers a and b 
amplify the WT Peli2 in heterozygous mice and homozygous WT mice while 
primers c and d detect only the Peli2 knockout allele. Primers for HPRT were used 
as a genomic DNA control. Water was used as a negative control for the PCR 
reaction. (b) Quantitative real-time PCR of Pellino2 expression in cells from 
BMDMs isolated from WT and Peli2
–/–
. Analysis was carried out and mRNA levels 
are presented as a fold change relative to WT and normalised to HPRT expression 
(c) Sex and age matched mice were monitored for variations in weight (n=20 ) at 10 
weeks of age.  
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(a) 
 
(b) 
 
 
Figure 3.2 Effect of Pellino2-deficiency on TLR-induced expression of pro-
inflammatory cytokines 
BMDMs from WT and Peli2
-/-
 bone marrow were left untreated (UT) or stimulated 
for 24 h with Pam2CSK4 (10 ng/ml), Pam3CSK4 (10 ng/ml), Zymosan (5 µg/ml), 
Poly(I:C) (25 µg/ml), LPS (10 ng/ml), Flagellin (5 µg/ml), CLO75 (5 µg/ml), 
CLO97 (5 µg/ml), CpG (5 µM). Conditioned media was assayed by ELISA for 
levels of (a) IL-6 and (b) TNF. Data are presented as the mean of three independent 
experiments +/- SEM. Statistical significance was determined using two-tailed 
Student’s t-test. 
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(a) 
 
(b) 
 
 
Figure 3.3 Effect of Pellino2-deficiency on TLR-induced expression of pro-
inflammatory chemokines 
BMDMs from WT and Peli2
-/-
 bone marrow were left untreated (UT) or stimulated 
for 24 h with Pam2CSK4 (10 ng/ml), Pam3CSK4 (10 ng/ml), Zymosan (5 µg/ml), 
Poly(I:C) (25 µg/ml), LPS (10 ng/ml), Flagellin (5 µg/ml), CLO75 (5 µg/ml), 
CLO97 (5 µg/ml), CpG (5 µM). Conditioned media was assayed by ELISA for 
levels of (a) RANTES and (b) CXCL1. Data are presented as the mean of three 
independent experiments +/- SEM. Statistical significance was determined using 
two-tailed Student’s t-test. 
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Figure 3.4 Effect of Pellino2-deficiency on TLR-induced expression of IFN-β  
BMDMs from WT and Peli2
-/-
 bone marrow were left untreated (UT) or stimulated 
for 24 h with Zymosan (5 µg/ml), Poly(I:C) (25 µg/ml), LPS (10 ng/ml), CLO75 (5 
µg/ml), CLO97 (5 µg/ml), CpG (5 µM). Conditioned media was assayed by ELISA 
for levels of IFN-β. Data are presented as the mean of three independent experiments 
+/- SEM. Statistical significance was determined using two-tailed Student’s t-test. 
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(a) 
 
 
 
 
 
(b) 
 
 
 
 
 
 
Figure 3.5 Effect of Pellino2-deficiency on cytosolic pattern recognition 
receptors 
BMDMs from WT and Peli2
-/-
 bone marrow were treated with transfection reagent 
alone (Mock) or transfected for 24 h with Poly(I:C) (25 µg/ml), Poly(Da:Dt) (4 
µg/ml), MDP (50ng/ml), ppp-dsRNA (500 ng/ml). Conditioned media was assayed 
by ELISA for levels of (a) IFN-β and (b) IL-6. Data are presented as the mean of 
three independent experiments +/- SEM. Statistical significance was determined 
using two-tailed Student’s t-test. 
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Figure 3.6 Effect of Pellino2-deficiency on SeV infection-induced expression of 
IFN-β 
BMDMs from WT and Peli2
-/-
 bone marrow were not infected (NI) or infected for 
24 h with 1:1000 dilution SeV. Conditioned media was assayed by ELISA for levels 
of IFN-β. Data are presented as the mean of three independent experiments +/- SEM. 
Statistical significance was determined using two-tailed Student’s t-test. 
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Figure 3.7 Effect of Pellino2-deficiency on cytokine-induced expression of IL-6 
BMDMs from WT and Peli2
-/-
 bone marrow were either untreated (UT) or 
stimulated for 24 h with IL-1β (10 ng/ml) and TNF-α (10 ng/ml). Conditioned media 
was assayed by ELISA for levels of IL-6. Data are presented as the mean of three 
independent experiments +/- SEM. Statistical significance was determined using 
two-tailed Student’s t-test. 
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(a) 
 
(b) 
 
  
Figure 3.8 Effect of Pellino2-deficiency on IL-1β secretion during NLRP3 
inflammasome activation in BMDMs and BMDCs. 
(a) BMDCs or (b) BMDMs from WT and Peli2
-/-
 bone marrow were either untreated 
(UT) or stimulated for 3 h with LPS (10 ng/ml). Cells were then left untreated or 
subjected to co-stimulation with either ATP (2.5 µM) or Nigericin (1 µM). 
Conditioned media was assayed by ELISA for levels of IL-1β. Data are presented as 
the mean of three independent experiments +/- SEM. Statistical significance was 
determined using two-tailed Student’s t-test (*,  p < 0.05; **, p < 0.01). 
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Figure 3.9 Effect of Pellino2-deficiency on survival rates of mice during LPS 
induced septic shock. 
Survival rates of age, sex and weight matched WT and Peli2
-/-
 mice after 
intraperitoneal injection with either 20mg/kg LPS (n= 8) or PBS as a control (n= 3). 
Mouse health was monitored and moribund mice were euthanised (*,  p < 0.05 
(Mantel-Cox test)). 
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(a)   
 
 
(b) 
 
 
 
Figure 3.10 Weight loss and recovery of Pellino2-deficient mice during LPS 
induced septic shock. 
(a) Weight loss rates of age, sex and weight matched WT and Peli2
-/-
 mice after 
intraperitoneal injection with either 20mg/kg LPS (n= 8) or PBS as a control (n= 3). 
(b) Peli2
-/-
 mice weight recovery after 20mg/kg LPS (n= 4). 
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Figure 3.11 Effect of Pellino2-deficiency on serum levels of pro-inflammatory 
cytokines in response to administration of LPS 
Serum cytokine analysis of WT and Peli2
-/-
 mice 18 h after intraperitoneal injection 
with either 20mg/kg LPS (n= 11) or PBS as a control (n= 4). Mice were sacrificed 
and serum analysed by ELISA for (a) IL-6 (b) TNF (c) RANTES (d) CXCL1 and (e) 
IL-1β. Statistical significance was determined using two-tailed Student’s t-test (**, p 
< 0.01). 
(a) 
 
(b) 
 
(c) 
 
(d) 
 
                        
(e) 
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Figure 3.12 Effect of Pellino2-deficiency on peritoneal neutrophil infiltration in 
response to administration of LPS 
Influx of GR1
+
 cells into the peritoneum of of WT and Peli2
-/-
 mice 18 h after 
intraperitoneal injection with either 20mg/kg LPS (n= 6) or PBS as a control (n= 3). 
Cells were stained with isotype controls and anti-GR1. After staining the cells were 
examined through flow cytometry. Data represented as a percentage of total cells. 
Statistical significance was determined using two-tailed Student’s t-test. 
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   (a) 
 
(b)  (c)  
  (d)  
 
 
Figure 3.13 Effect of Pellino2-deficiency during K. pneumoniae infection. 
BMDMs from WT and Peli2
-/-
 bone marrow were either left uninfected (UI) or 
stimulated for 3 h with K. pneumoniae and TNF-α (10 ng/ml). (a) Conditioned media 
was assayed by ELISA for levels of IL-1β. Quantitative real-time PCR of (b) IL-1β 
and (c) NLRP3 was carried out and mRNA levels are presented as a fold change 
relative to WT UT and normalised to HPRT expression. (d) Lysates were generated 
and immunoblotted. Lysate samples were probed for NLRP3, IL-1β and β-actin as a 
loading control. Data are representative of 3 independent experiments. Data are 
presented as the mean of three independent experiments +/- SEM. Statistical 
significance was determined using two-tailed Student’s t-test. 
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Figure 3.14 Effect of Pellino2-deficiency on inflammasome induced cell death in 
BMDMs. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were either untreated (UT) or 
stimulated for 3 h with LPS (10 ng/ml). Cells were then left untreated or subjected to 
co-stimulation with either ATP (2.5 µM) for 40 min. Conditioned media was assayed 
for LDH release from cells and presented as a percentage of maximum LDH release 
from lysis treated cells. Data are presented as the mean of two independent 
experiments +/- SEM. Statistical significance was determined using two-tailed 
Student’s t-test. 
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Figure 3.15 Effect of Pellino2-deficiency on the activation of AIM2 and NLRC4 
inflammasomes. 
BMDMs from WT and Peli2
-/-
 bone marrow were left untreated or stimulated for 3 h 
with LPS (10 ng/ml). Cells were either treated with transfection reagent alone 
(Mock) or subjected to co-stimulation via transfection with flagellin (5 µg/ml) or 
poly(Da:Dt) (4 µg/ml). Conditioned media was assayed by ELISA for levels of IL-
1β. Data are presented as the mean of three independent experiments +/- SEM. 
Statistical significance was determined using two-tailed Student’s t-test. 
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Figure 3.16 Effect of Pellino2-deficiency on TLR4 induced activation of NF-κB. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (0) or 
stimulated for the indicated times with LPS (10 ng/ml). Cell lysates were generated 
and immunoblotted. Samples were first probed for p-IKKβ and p-IκBα followed by 
total levels of IKKβ, IκBα and β-actin as a loading control. Data are representative of 
3 independent experiments. 
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Figure 3.17 Effect of Pellino2-deficiency on TLR4 induced activation of 
MAPKs. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (0) or 
stimulated for the indicated times with LPS (10 ng/ml). Cell lysates were generated 
and immunoblotted. Samples were first probed for p-JNK, p-ERK and p-p38 
followed by total levels of JNK, ERK, p38 and β-actin as a loading control. Data are 
representative of 3 independent experiments. 
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Figure 3.18 Effect of Pellino2-deficiency on IL-1β induced activation of NF-κB 
and MAPKs. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (-) or 
stimulated for the indicated times with LPS (10 ng/ml). Cell lysates were generated 
and immunoblotted. Samples were first probed for p-JNK, p-ERK and p-IκBα 
followed by total levels of IκBα and β-actin as a loading control. Data are 
representative of 3 independent experiments. 
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Figure 3.19 Effect of Pellino2-deficiency on TLR4 induced IL-1β and NLRP3 
mRNA upregulation 
Quantitative real-time PCR of (a) IL-1β and (b) NLRP3 expression in cells from 
BMDMs  isolated from WT and Peli2
–/–
 mice and left untreated (UT) or stimulated 
with LPS (10 ng/ml) over the indicated time-course. Analysis was carried out and 
mRNA levels are presented as a fold change relative to WT UT and normalised to 
HPRT expression. Data are presented as the mean of three independent experiments 
+/- SEM. Statistical significance was determined using two-tailed Student’s t-test. 
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Figure 3.20 Effect of Pellino2-deficiency on TLR4 induced IL-1β and NLRP3 
protein upregulation. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (-) or 
stimulated with LPS (10 ng/ml) over the indicated time course. Cell lysates were 
generated and immunoblotted for IL-1β, NLRP3 and β-actin as a loading control. 
Data are representative of at least 3 independent experiments.  
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Figure 3.21 Effect of Pellino2-deficiency on the activation of the NLRP3 
inflammasome in BMDMs. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were either untreated (-) or 
stimulated for 3 h with LPS (10 ng/ml). Cells were then left untreated or subjected to 
co-stimulation with either (a) ATP (2.5 µM) or (b) Nigericin (1 µM) for 40 min. Cell 
Supernatants and lysates were generated and immunoblotted. Supernatant samples 
were probed for cleaved-IL-1β and caspase 1 p10. Lysate samples were probed for 
pro-IL-1β and β-actin as a loading control. Data are representative of at least 3 
independent experiments.  
 
(b) 
(a) 
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Figure 3.22 Effect of Pellino2-deficiency on the activation of the late NLRP3 
inflammasome. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (-) or 
stimulated for either 6 h or 24 h with LPS (10 ng/ml). Cells were then left untreated 
or subjected to co-stimulation with ATP (2.5 µM) for 40 min. Cell Supernatants and 
lysates were generated and immunoblotted. Supernatant samples were probed for 
cleaved-IL-1β and caspase 1 p10. Lysate samples were probed for pro-IL-1β and β-
actin as a loading control. Data are representative of at least 3 independent 
experiments.  
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Figure 3.23 Effect of Pellino2-deficiency on the activation of the NLRP3 
inflammasome using zymosan as a priming signal. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were either untreated (-) or 
stimulated for 3 h with Zymosan (5 µg/ml). Cells were then left untreated or 
subjected to co-stimulation ATP (2.5 µM) for 40 min. Cell Supernatants and lysates 
were generated and immunoblotted. Supernatant samples were probed for cleaved-
IL-1β. Lysate samples were probed for pro-IL-1β and β-actin as a loading control. 
Data are representative of at least 3 independent experiments.  
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Figure 3.24 Effect of Pellino2-deficiency on IL-1β secretion during NLRP3 
inflammasome activation using zymosan as a priming signal in BMDMs. 
BMDMs from WT and Peli2
-/-
 bone marrow were left non-treated (NT) or stimulated 
for 3 h with Zymosan (5 µg/ml), Cells were then left untreated or subjected to co-
stimulation with ATP (2.5 µM). Conditioned media was assayed by ELISA for 
levels of IL-1β. Data are presented as the mean of three independent experiments +/- 
SEM. Statistical significance was determined using two-tailed Student’s t-test (*,  p 
< 0.05). 
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Figure 3.25 Effect of Pellino2-deficiency on zymosan induced IL-1β and NLRP3 
protein upregulation. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (-) or 
stimulated with Zymosan (5 µg/ml) over the indicated time course. Cell lysates were 
generated and immunoblotted for IL-1β, NLRP3 and β-actin as a loading control. 
Data are representative of at least 3 independent experiments.  
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Figure 3.26 Effect of Pellino2-deficiency on zymosan induced IL-1β and NLRP3 
mRNA upregulation. 
Quantitative real-time PCR of (a) IL-1β and (b) NLRP3 expression in cells from 
BMDMs  isolated from WT and Peli2
–/–
 mice and left non-treated (NT) or stimulated 
with Zymosan (5 µg/ml) over the indicated time-course. Analysis was carried out 
and mRNA levels are presented as a fold change relative to WT NT and normalised 
to HPRT expression. Data are presented as the mean of three independent 
experiments +/- SEM. Statistical significance was determined using two-tailed 
Student’s t-test. 
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Figure 3.27 Effect of Pellino2-deficiency on the migration of NLRP3 
components to the NP-40 insoluble fraction. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (-) or 
stimulated for 3 h with LPS (10 ng/ml). Cells were then left untreated or subjected to 
co-stimulation with ATP (2.5 µM) for 40 min. NP-40 insoluble fraction and lysates 
were generated and immunoblotted. NP-40 insoluble fractions were probed for 
NLRP3 and ASC. Lysate samples were probed for NLRP3 and β-actin as a loading 
control. Data are representative of 3 independent experiments.  
 
 
 
Chapter 3: Results 
129 
 
 
 
Figure 3.28 Effect of Pellino2-deficiency on ASC oligomerisation during 
activation of the NLRP3 inflammasome in BMDMs. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (-) or 
stimulated for 3 h with LPS (10 ng/ml). Cells were then left untreated or subjected to 
co-stimulation with ATP (2.5 µM) for 40 min. Chemical crosslinking of NP-40 
insoluble fraction was carried out using DSS (4 mM) and lysates were also generated 
and immunoblotted. Pellet samples were probed for ASC. Lysate samples were 
probed for ASC and β-actin as a loading control. Data are representative of 3 
independent experiments.  
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Figure 3.29 Effect of Pellino2-deficiency on the ubiquitination of NLRP3 during 
LPS stimulation in BMDMs. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (-) or 
stimulated with LPS (10 ng/ml) for 3 h. Cells were then left untreated or subjected to 
co-stimulation with ATP (2.5 µM) for 40 min. Cell lysates were generated and 
immunoprecipitated (IP) using anti-NLRP3 antibody. IP samples were probed for 
Ubiquitn (Ub), K63-Ub, K48-Ub and NLRP3. Lysate samples were probed for β-
actin as a loading control. Data are representative of 3 independent experiments.  
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Figure 3.30 Effect of Pellino2-deficiency on the ubiquitination of NLRP3 during 
LPS stimulation in BMDMs. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (0) or 
stimulated with LPS (10 ng/ml) for indicated times. Cell lysates were generated and 
immunoprecipitated (IP) using anti-NLRP3 antibody. IP samples were probed for 
Ubiquitn (Ub), K63-Ub and NLRP3. Lysate samples were probed for NLRP3 and β-
actin as a loading control. Data are representative of 3 independent experiments.  
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Figure 3.31 Pellino2 fails to catalyse ubiquitination of NLRP3 in vitro 
In vitro ubiquitination assay was carried out by incubating 500ng UBE1 (E1), 400ng 
Ubc13/Uev1A (E2), 2µg ubiquitin, NLRP3 (200 nM) and Pellino2-myc (20 nM) in 
reaction buffer (5 mM Tris-HCl, pH 8.0, 2 mM MgCl, 2 mM ATP, Proteinase 
inhibitor-EDTA free 1/10 dilution) at 37̊C for 1 h. Immunoprecipitated (IP) was 
carried out using anti-NLRP3 antibody. IP samples were probed for ubiquitin (UB). 
Remaining sample was probed for UB to detect free-chains. Data are representative 
of 3 independent experiments.  
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Figure 3.32 Pellino2 does not interact with NLRP3. 
(a)  In vitro ubiquitination assay was carried out by incubating NLRP3 (200 nM) and 
Pellino2-myc (20 nM) in reaction buffer (5 mM Tris-HCl, pH 8.0, 2 mM MgCl, 2 
mM ATP, Proteinase inhibitor-EDTA free 1/10 dilution) at 37̊C for 1 h.. Whole 
sample was immunoprecipitated using anti-NLRP3 antibody. The three wash stages 
during immunoprecipitation were retained. Samples were blotted with anti-Myc 
antibody. Data are representative of 2 independent experiments (b) HEKT cells were 
transfected with empty vector (EV) alone or in combination with expression 
constructs encoding Pellino2-Myc (Peli2-Myc) and NLRP3-V. Cell lysates were 
generated and co-immunoprecipitated with an anti-MYC antibody. 
Immunoprecipitated (IP) samples and WCL samples were subjected to immunoblot 
(IB) for presence of Myc-tagged proteins and NLRP3. β- actin was used as a loading 
control. (c) HEKT cells were transfected with empty vector (EV) alone or in 
combination with expression constructs encoding Pellino2-Myc (Peli2-Myc) and 
IRAK1. Cell lysates were generated and co-immunoprecipitated with an anti-MYC 
antibody. Immunoprecipitated (IP) samples and WCL samples were subjected to 
immunoblot (IB) for presence of Myc-tagged proteins and IRAK1. β- actin was used 
as a loading control. ((b)/(c) Data provided by Dr. Fiachra Humphries) 
   (a) 
 
(b) 
 
(c) 
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Figure 3.33 Effect of Pellino2-deficiency on IRAK1 stabilisation during early 
inflammasome activation in BMDMs. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (-), 
stimulated for with LPS (10 ng/ml) or co-stimulate with LPS and ATP (2.5 µM) over 
a time-course. Lysates were generated and immunoblotted. Lysate samples were 
probed for IRAK-1 and β-actin as a loading control. Data are representative of 3 
independent experiments.  
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Figure 3.34 Effect of Pellino2-deficiency on the ubiquitination of IRAK1 during 
LPS stimulation in BMDMs. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (-) or 
stimulated with LPS (10 ng/ml) for indicated times. Cell lysates were generated and 
immunoprecipitated (IP) using anti-IRAK1 antibody. IP samples were probed for 
Ubiquitn (Ub), K63-Ub, K48-Ub and NLRP3. Lysate samples were probed for 
IRAK-1 and β-actin as a loading control. Data are representative of 3 independent 
experiments.  
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Figure 3.35 Effect of Pellino2-deficiency on the interaction of NLRP3 and 
IRAK1 during LPS stimulation in BMDMs. 
BMDMs cultured from WT and Peli2
-/-
 bone marrow were left untreated (-) or 
stimulated with LPS (10 ng/ml) for indicated times. Cell lysates were generated and 
coimmunoprecipitated (IP) using anti-NLRP3 antibody. IP samples were probed for 
IRAK1 and NLRP3. Lysate samples (WCL) were probed for IRAK-1, NLRP3 and 
β-actin as a loading control. Data are representative of 3 independent experiments.  
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Figure 3.36 The regulation of Pellino expression by LPS in BMDMs. 
Quantitative real-time PCR of (a) Peli1 (b) Peli2 and (c) Peli3 expression in cells 
from BMDMs  isolated from either WT mice and left untreated (UT) or stimulated 
with LPS (10 ng/ml) over the indicated time-course. Analysis was carried out and 
mRNA levels are presented as a fold change relative to WT NT and normalised to 
HPRT expression. Data are presented as the mean of three independent experiments 
+/- SEM.
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The generation of Pellino1 (Chang et al., 2009b) and Pellino3-deficient mice 
(Siednienko et al., 2012) has led to a rapid expansion of our understanding of the 
field of Pellino biology over the last number of years. Investigation into these 
proteins prior to the development of these models focused primarily on the use of 
overexpression and knockdown techniques. Knockout mouse models however have 
enhanced our understanding of the physiological relevance of both Pellino1 and 
Pellino3, which have been demonstrated to possess a diverse range of immunological 
functions. To date, a similar mouse model for the final member of the Pellino family, 
Pellino2, has not been published. The work in this thesis uses a newly generated 
Pellino2-deficient mouse model to demonstrate a novel physiological role for 
Pellino2 in the regulation of NLRP3 inflammasome activation. Whilst many of the 
molecular components of NLRP3 have been identified, the regulatory mechanisms 
controlling its assembly and activation have yet to be fully elucidated. The data 
presented here demonstrates for the first time that hyperphosphorylated IRAK1 can 
interact with NLRP3 at late time-points during inflammasome priming and may 
serve to hinder NLRP3 ubiquitination and subsequent activation (Fig. 4.1). In the 
absence of Pellino2, this interaction occurs prior to inflammasome priming and may 
contribute to the observed reduction in inflammasome assembly in these cells. It can 
be speculated that Pellino2 may serve to regulate the basal phosphorylation and 
subsequent activation of IRAK1 and thus limit the regulatory role of IRAK1 during 
NLRP3 inflammasome activation. In WT cells, Pellino2 is downregulated during an 
LPS time-course, leading to the increased interaction of hyperphosphorylated IRAK1 
with NLRP3 at later time-points. However, in Pellino2-deficient cells, this 
hyperphosphorylation of IRAK1 is unabated which results in heightened 
NLRP3/IRAK1 interaction, corresponding to reduced NLRP3 ubiquitination and 
subsequent inflammasome activation (Fig. 4.3). This work demonstrates a novel 
mechanism by which Pellino2 and IRAK1 work in concert to regulate the activation 
of the NLRP3 inflammasome and thus influence the secretion of IL-1β. 
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Figure 4.1 The role of Pellino2 and IRAK1 in the regulation of NLRP3 
Inflammasome assembly during priming 
The description of the role of both Pellino2 and IRAK1 in controlling the normal 
functioning of the NLRP3 inflammasome activation is highlighted in the discussion. 
Yellow circles containing “UB” represent ubiquitination event. Red circles 
containing “P” represent phosphorylation. 
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Prior to this work, Pellino2 was primarily studied in the context of IL-1 and TLR 
signalling (Kim et al., 2012a; Schauvliege et al., 2006). The lack of a Pellino2-
deficient mouse model dictated that previous research on Pellino2 has depended on 
the use of overexpression and knockdown techniques. Using shRNA knockdown, 
Pellino2 was shown to be required for IL-1 and TLR4 induced polyubiquitination of 
IRAK1. The further overexpression of a Pellino2 RING mutant abolished the 
capacity of Pellino2 to promote this ubiquitination, highlighting the importance of 
the E3 ligase activity of Pellino2 during this ubiquitination event. Furthermore, the 
phosphorylation of two key components of the MAPK pathway, JNK and ERK were 
also inhibited during both TLR4 and IL-1β signalling in Pellino2-knockdown cells 
(Kim et al., 2012b). Finally, the levels of secreted IL-6 and TNFα were decreased in 
knockdown cells, which was attributed to impaired mRNA stability (Kim et al., 
2012a). However, evidence presented in this thesis argues against a role for Pellino2 
in the regulation of pro-inflammatory cytokine secretion in response to TLR or IL-1β 
stimulation. Only when the cells were subjected to a second signal which caused the 
formation of the NLRP3 inflammasome was a role for Pellino2 in IL-1β secretion 
revealed. LPS and IL-1β-induced activation of the NF-κB and MAPK signalling 
pathways were fully intact in Pellino2-deficient cells. Furthermore, TLR induced 
expression of IL-1β, IL-6 and NLRP3 at the mRNA and protein levels were not 
affected by the absence of Pellino2. Previous studies have demonstrated a similar 
discrepancy between overexpression and knockout models. Pellino3 for example was 
shown to affect MAPK signalling through the use of overexpression (Butler et al., 
2005), but this effect was not seen in the Peli3
-/-
 mouse model (Siednienko et al., 
2012). Overexpression of any E3 ligase may result in loss of substrate specificity and 
so produce effects which are not directly attributable to the E3 ligase under study. 
Conversely, the generation of a mouse that is deficient in a single member of the 
Pellino family may lead to functional compensation by the remaining family 
members and may mask effects that are revealed by more acute knockdown 
approaches in cell models. 
Peli1
-/-
 mice were previously shown to be resistant to of LPS induced septic shock in 
combination with D-galactosamine. This acute model led to the death of all WT mice 
and 100% survival of Peli1
-/-
 mice. A high-dose LPS model was also used which 
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resulted in a lethality of 50% WT and 15% of Peli1
-/- 
mice. Cytokine analysis of the 
serum of mice showed severely abrogated TNF and IL-6 levels in the Pellino1-
deficient mice and this was attributed to effects on NF-κB signalling (Chang et al., 
2009). Similar to the phenotype observed in Peli1
-/-
, the data presented in this thesis 
shows that Pellino2-deficiency protected against the lethal effects and systemic 
inflammatory effects of LPS. However the mechanisms of protection in Peli1
-/-
 and 
Peli2
-/-
 differ. Pellino2 does not play a role in the propagation of the initial TLR 
signalling event and thus does not regulate NF-κB activity and instead mediates 
activation of NLRP3. This is consistent with a previously described role for NLRP3 
in mediating LPS-induced septic shock (Gong et al., 2015; Mao et al., 2013). In 
order to demonstrate the in vivo relevance of the regulatory effects of Pellino2 on 
inflammasome activation, the high-dose LPS model of sepsis was employed. 
Pellino2-deficient mice showed 50% survival after 48 h, while all WT mice had 
succumbed to septic shock. During the experiment, Peli2
-/-
 mice showed more 
responsiveness to stimuli and moved around cages more freely. All mice which 
survived recovered weight and showed no sign of illness after 72 h. While increased 
survival of Peli2
-/-
 mice in this model mirrored similar protection in Peli1
-/- 
mice, the 
measurement of serum cytokine levels again highlight differing mechanisms. Only 
levels of IL-1β in Peli2-/- mouse serum were shown to be reduced when compared to 
WT, while other pro-inflammatory cytokines such as IL-6, TNFα and RANTES were 
unaffected. In contrast many of these pro-inflammatory cytokines were reduced in 
Peli1
-/-
 mice. This highlights a situation in which members of the Pellino family may 
show similar functional effects but with different underlying mechanisms. Despite 
sharing similar homology, Pellino proteins have distinct signalling roles. This could 
in part be due to the differing expression profiles in tissue as has been demonstrated 
during Pellino1 signalling in microglial cells (Xiao et al., 2013). Pellino1 has been 
shown to regulate TLR signalling by degradation of TRAF3, which is an inhibitor of 
MAPK signalling. This function is specific to microglial cells, due to high levels of 
expressed Pellino1 in these cells. 
Inflammasomes are large multi-protein complexes involved in the maturation of the 
pro-inflammatory cytokines IL-1β and IL-18 (Lamkanfi and Dixit, 2014). Whilst 
many of the molecular components of NLRP3 have been identified the regulatory 
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mechanisms controlling its assembly and activation remain to be fully elucidated. It 
is capable of responding to a wide variety of cellular and pathogenic signals, making 
it unlikely to bind directly to a particular DAMP. Instead, it is thought to be a 
cellular sensor which can be activated in response to generic signals of cellular 
disruption such as K+ efflux from the cell (Muñoz-Planillo et al., 2013). NLRP3 
activation requires a priming signal and a secondary signal. During priming, both 
NLRP3 and IL-1β are upregulated via NF-κB signalling through TLRs. The 
secondary signal involves stimulation with an NLRP3 activating agent and results in 
the assembly of the inflammasome complex. NLRP3 first oligomerises by 
association with the NBD, allowing the formation of a PYD signalling platform 
(Horvath et al., 2011). This event leads to ASC aggregation by PYD-PYD 
association and the nucleation around the NLRP3 complex (Hara et al., 2013). This 
filamentous complex can further act as a platform which recruits caspase-1 via 
CARD-CARD interactions and result in its activation (Lu et al., 2014) (Fig. 4.2). 
Given that Pellino2-deficiency affected secreted levels of IL-1β, but had no impact 
on the NF-kB or MAPK pathways or upregulation of proIL-1β, mechanistic studies 
in this work especially focused on a role for Pellino2 during the secondary signal, 
which is required for inflammasome activation. The level of ASC oligomerisation, 
which results in the formation of inflammasome aggregation in the NP-40 insoluble 
fraction, is reduced in Pellino2-deficient cells. Caspase-1 cleavage is similarly 
reduced in these cells, implicating a role for Pellino2 upstream of the assembly of the 
inflammasome. Pellino2 has a role specifically in NLRP3 inflammasome assembly, 
as signalling by NLRC4 (Zhao et al., 2011) and AIM2 (Hornung et al., 2009) 
inflammasome, both of which can activate and secrete IL-1β, are unaffected in 
Pellino2-deficient cells. Based on these data, the molecular mechanisms regulating 
NLRP3 activation were explored.  
NLRP3 has recently been shown to require deubiquitination prior to assembly of the 
inflammasome (Juliana et al., 2012; Py et al., 2013). However, the initial regulation 
of NLRP3 ubiquitination has not been studied to date and the E3 ligase responsible 
remains to be identified. The work presented here demonstrates that NLRP3 
ubiquitination occurs during the inflammasome priming event and is associated with 
optimal inflammasome activation following signal 2. This initial NLRP3 
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ubiquitination is lost in Pellino2 deficient cells, which results in a lack of a 
deubiquitination event, hindering inflammasome assembly and activity. It is 
intriguing to speculate why NLRP3 requires both ubiquitination and subsequent 
deubiquitination prior to inflammasome assembly. The initial ubiquitination event 
may be required to bridge an interaction of NLRP3 with another unidentified adapter 
protein which may be required to promote the activation of NLRP3, similar to how 
the TAK1 and IKK complexes are recruited to ubiquitinated TRAF6 or RIP1 during 
NF-κB signalling (Ea et al., 2006). Alternatively, ubiquitination of NLRP3 may be 
required to block the interaction with proteins capable of binding to and hindering 
NLRP3 activity. Interestingly, a recent report investigating ubiquitination of the 
protein Dishevelled shows that ubiquitination of its DIX domain at K54 effectively 
acts as a negative signal and blocks its polymerisation and signalling. DUB activity 
is required to cleave DIX54-UB and thus promote Dishevelled assembly (Madrzak et 
al., 2015). It is possible that the deubiquitination step during NLRP3 activation only 
partially disassembles the formed ubiquitin chains, leading to an exposed mono-
ubiquitin which facilitates NLRP3 oligomerisation. Mono-ubiquitination has 
previously been demonstrated to be involved in membrane protein trafficking into 
the endocytoic pathway (Kerkhof et al., 2000). This highlights the possibility that 
NLRP3 ubiquitination and subsequent deubiquitination is required for the cellular 
localisation of NLRP3 which facilitates activation. Another alternative is that 
BRCC3 deubiquitinates NLRP3 at the LRR domain (Juliana et al., 2012) which 
promotes a conformational change in NLRP3, which alters the auto-inhibitory state 
of NLRP3, leading to its potential activation. Many of the critical details underlying 
the mechanisms which regulate the assembly of the inflammasome remain enigmatic 
and will require further work to fully discern the critical steps leading to optimal 
activation. 
While we show that Pellino2 does not directly bind to NLRP3 and cannot directly 
mediate its ubiquitination, it may exert its effects via an intermediary protein. To 
investigate this, the association of IRAK1 with NLRP3 was investigated, as IRAK1 
has been shown to interact both with Pellino2 (Lin et al., 2008) and NLRP3 
(Fernandes-Alnemri et al., 2013). We observed a hyperphosphorylated form of 
IRAK1 which only associated with NLRP3 at the 6 h time-point during LPS 
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stimulation in WT cells; while this interaction was apparent basally in Pellino2-
deficient cells. In Pellino2-deficient cells this interaction was lost during early LPS 
signalling, but re-established after 3 h. We speculate that Pellino2 may normally 
function to inhibit the NLRP3/IRAK1 interaction, however as Pellino2 is 
downregulated during LPS signalling, this regulatory effect of Pellino2 is lost and 
IRAK1 can associate with NLRP3, leading to inhibition of NLRP3 signalling. 
However, in the absence of Pellino2, IRAK1 pre-associates with NLRP3, which 
hinders its signalling potential. The role of IRAK1 in early inflammasome activation 
has been examined by a previous report (Lin et al., 2014). This study describes the 
role of IRAK1 as being required during NLRP3-dependent caspase-1 activation in 
the absence of a priming step. The roles for IRAK1 suggested by this group are not 
in conflict with our model, as they describe the effect of IRAK1 after 30 minutes 
when cells were co-stimulated with LPS and ATP, whereas we describe an alternate 
role for IRAK1 following a long priming event.  
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Figure 4.2 NLRP3 Inflammasome assembly and cytokine secretion 
Red scissors indicate cleavage event. Dark dotted box represents the insoluble 
protein fraction of the cell. Yellow circles containing “UB” represent ubiquitination. 
 
The work presented here does not specifically characterise the functional role of 
Pellino2 in the regulation of IRAK1. This is due to our inability to directly examine 
endogenous Pellino2, as no commercially available antibody could detect Pellino2. 
Future work will aim to address this issue by the generation of a flag-tagged Pellino2 
knock-in mouse, which will give us the ability to specifically immunoprecipitate 
Pellino2 and examine its protein interactions with other inflammasome components, 
as well as examining the cellular localisation of Pellino2 following inflammasome 
assembly. Using this knock-in mouse, it will also be possible to examine post-
translational modifications of Pellino2, such as ubiquitination and phosphorylation, 
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as well as determine the protein stability of Pellino2 following LPS stimulation 
which may provide invaluable insight into how Pellino2 is regulated.  
Throughout this study, we have used IL-1β as the functional readout of 
inflammasome activation. However, both IL-18 activation and cellular pyroptosis are 
also regulated by NLRP3 inflammasome activation. IL-18 has been implicated in 
mediating a range of inflammatory diseases, including myocardial dysfunction 
(Mallat et al., 2004; Woldbaek et al., 2005) and inflammatory bowel disease 
(Banerjee and Bond, 2008). However, more recent studies have identified IL-18 as 
having protective effects during gastrointestinal diseases. Nlrp3
-/- 
and Nlrp6
-/-
 mice 
are more susceptible to DSS induced colitis, which is thought to be due to decreased 
IL-18 secretion (Doyle et al., 2012; Elinav et al., 2011; Hirota et al., 2011). Further 
work is needed to fully disseminate the role of IL-18 in disease. The specialised form 
of inflammasome mediated cell death called pyroptosis is an important consequence 
of inflammasome activation. Two recent papers have demonstrated a novel role for 
the protein gasdermin D in mediating pyroptosis (Kayagaki et al., 2015; Shi et al., 
2015). Gasdermin D is cleaved by either caspase-1 or caspase-11 upon 
inflammasome assembly, allowing the N-terminal domain of gasdermin D to drive 
pyroptosis. The precise mechanisms by which gasdermin D mediates pyroptosis 
remain to be fully elucidated. The work carried out in this thesis did not investigate 
IL-18 or pyroptosis in detail; however, future studies elucidating their relevance to 
the regulatory roles of Pellino 2 may provide further insight into the functioning of 
Pellino2 in NLRP3 signalling. 
Dysregulation of the NLRP3 inflammasome and the resulting IL-1β release has been 
linked to the pathogenesis of a wide range of inflammatory diseases and is thus a 
potentially valuable therapeutic target. Diseases of aging are often associated with 
aberrant inflammasome activation. This is thought to be due to an accumulation of 
DAMPs such as amyloid-β, extracellular ATP and MSU which lead to chronic 
inflammasome activation (Kapetanovic et al.). For instance, NLRP3 activation has 
been linked with pathology in Alzheimer’s disease (Heneka et al., 2013) due to the 
ability of NLRP3 to sense amyloid-β, which stimulates the chronic activation of 
microglial cells (Halle et al., 2008). NLRP3 deficiency was shown to reduce the 
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volume of amyloid-β plaques and thus protect from loss of memory in mice (Heneka 
et al., 2013). Rheumatoid arthritis (RA) is another age-related disease and is 
associated with the chronic inflammation of joints; NLRP3 inflammasome activity 
has been shown to enhance joint destruction and further contributes to the pathology 
of RA (Walle et al., 2014). These studies highlight the inflammasome as a 
potentially valuable therapeutic target in the treatment of a variety of pro-
inflammatory diseases. 
Anakinra, an IL-1 receptor antagonist has been used to successfully treat the 
symptoms of a variety of auto-inflammatory diseases, including RA (Bresnihan et 
al., 1998). However, using Anakinra to suppress the activity of IL-1 has been linked 
with an increased risk of patients contracting serious infections due to a reduced 
ability to mount an effective immune response (Salliot et al., 2009). Further, 
targeting circulating IL-1 does not address the underlying dysregulation of 
inflammasome activity, which may still function to propagate the disease by 
inducing pyroptosis and IL-18 secretion. Due to these issues, the ability to 
selectively target the inflammasome during inflammatory disease may prove to have 
advantageous clinical outcomes. A number of recent studies have examined small 
molecule inhibitors of components of the inflammasome in order to regulate its 
activation. CRID3 has been shown to inhibit ASC oligomerisation upon NLRP3 
inflammasome activation (Coll and O’Neill, 2013, 2011) while the drug parthenolide 
directly inhibits NLRP3 by blocking its ATPase activity (Juliana et al., 2010). 
Targeting the inflammasome as a therapeutic approach to disease management is still 
an emerging field and thus the delineation of new pathways which regulate 
inflammasome activation could prove vital to identifying potential drug targets.  
Pellino2 may prove to be a viable therapeutic target, as it may serve to specifically 
regulate the NLRP3 inflammasome, while not affecting NF-κB signalling. Pellino2 
deficiency does not entirely block the activity of the inflammasome, but rather 
hinders its full activation. Therefore, the blockade of Pellino2 may serve to regulate 
acute and perhaps chronic inflammasome activation without entirely abrogating its 
activity, which may prove beneficial in ameliorating the risk of contracting a 
secondary infection during drug treatment. However, in order to confirm the 
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potential for Pellino2 as a drug target, further studies need to be carried out 
describing the role of Pellino2 in human cells. To date, both Pellino1 and Pellino3 
have been shown to have clinical relevance in human disease. Pellino1 was 
demonstrated to regulate the response of  airway epithelial cells to rhinovirus 
(Bennett et al., 2012) while Pellino3 was shown to be downregulated in the colon of 
patients with Crohn's disease (Yang et al., 2013a). Assessing the levels of Pellino2 in 
patients exhibiting NLRP3 dependent inflammatory diseases such as atherosclerosis 
(Merhi-Soussi et al., 2005) and gout (Tran et al., 2013) may help delineate the role 
of Pellino2 in human disease. Should Pellino2 prove to have a similar function in 
human cells, the creation of a small molecule inhibitor of Pellino2 may be a viable 
method of suppressing the activity of Pellino2. Such a drug may prove useful in 
abating NLRP3 dependent IL-1β secrection, without fully inhibiting its signalling, 
hopefully resulting in a reduction of side effects usually seen with IL-1β blockade. 
In conclusion, this thesis has described the importance of Pellino2 in facilitating 
robust NLRP3-dependent IL-1β secretion by affecting the ubiquitination state of 
NLRP3 during the priming signal. The possible role of IRAK1 as a regulator of 
NLRP3 activity has also been highlighted. Future work will be needed to describe in 
detail the precise mechanism by which Pellino2 modulates the activity of both 
IRAK1 and NLRP3 during this pathway. The biology of NLRP3 activation is a 
rapidly expanding and complex field and further understanding of the systems which 
regulate this receptor will have future clinical implications in the treatment of 
inflammatory diseases. 
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Figure 4.3 The effect of Pellino2-deficiency on NLRP3 Inflammasome assembly 
and cytokine secretion 
Differences between WT and Pellino2 deficiency are highlighted in the discussion. 
Red scissors indicate a cleavage event. Yellow circles containing “UB” represent 
ubiquitination. 
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